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A SYNTHESIS OF THEOPEDERIN D 
by Christopher Smith
A stereocontrolled synthesis of 18-O-methyl mycalamide B (1.5) and theopederin D (l.ld ) 
is reported in this thesis. 18-O-Methyl mycalamide B (1.5) was synthesised first and the 
route was adapted enabling a synthesis of theopederin D ( l. ld )  to be completed. The 
synthesis of theopederin D (l.ld )  included a metallated dihydropyran approach to couple 
the left fragment (1.72) and the right fragment (6.19) together and a reaction between 
oxirane (6.7) and a MOM ether to forge the cw-2,4,7-trioxabicyclo[4.4.0]decalin ring. An 
efficient large scale route was developed to provide substantial quanities of early 
intermediates of the right fragment (6.19) incorporating a highly enantioselective 
aymmetric reduction to generate (3-hydroxy ester (4.4) and a highly enantioselective 
asymmetric aldol reaction to also generate |3-hydroxy ester (4.4). A new highly 
diastereoselective synthesis of the left fragment (1.72) was developed starting from ethyl 
(S)-lactate (3.4). The absolute stereochemistry of an andvanced intermediate (6.20) was 
determined by X-ray crystallography.
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M molarity
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mp melting point
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MS molecular sieves
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ng nanogram
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NMR nuclear magnetic resonance
iv
PDC pyridinium dichromate
Ph phenyl
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ppm parts per million
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Pr propyl
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pyr pyridine
rt room temperature
s secondary
SAR structure activity relationship
SCUBA self-contained underwater breathing apparatus
SEM 2-(trimethylsilyl)ethoxymethyl
t tertiary
TBAF tetrabutylammonium fluoride
TBS te/t-butyldimethylsilyl
TBSCN fe/t-butyldimethylsilyl cyanide
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TEMPO 2,2,6,6-tetramethyl-1 -piperidinyloxy
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TFA trifluoroacetic acid
THF tetrahydrofuran
TLC thin layer chromatography
TMEDA N, N, N', A'-tetramethylethylenediamine
TMS trimethylsilyl
TPAP tertrapropylammonium perruthenate
Tr trityl
Ts para-toluenesulfonyl
UV ultraviolet
Chapter 1
A Review of the Literature Relating to 
Theopederin D
1.1 Structure and Isolation of Theopederin D
Theopederin D l . ld  (scheme 1.1), was isolated from a marine sponge of the genus 
Theonella. Specimens of the sponge were collected using SCUBA off Hachijo-jima Island 
300 km south-east of Tokyo. The structure of theopederin D l .ld  was elucidated at the time 
of isolation by a combination of mass spectroscopy, infra-red spectroscopy and nuclear 
magnetic resonance techniques including COSY, HMQC and HMBC1 .
QMe O
tOMe
OH
1.1 d Theopederin D
Scheme 1.1
The spectral features of theopederin D were reminiscent of mycalamide A2  and B3 (1.3 and 
1.4) and onnamide A 1.2,4 which are heterocyclic compounds from marine sponges Mycale 
and Theonella respectively (scheme 1.2). Comparison of the NMR spectroscopic data 
revealed that theopederin D contained the 01-C16 portion of the mycalamide skeleton and 
connectivities from H-16 to H-19 were observed from the COSY spectrum and an IR 
absorption at 1765 cm-1  indicated the presence of a butyrolactone, thus defining the structure 
of theopederin D. A range of five theopederins (A-E, l . la - l . l e ) 1 were isolated from the 
sponge Theonella whose structures were determined in a similar way to theopederin D. 
Interestingly all of the theopederins, mycalamides and onnamide A are closely related to the 
insect toxin pederin 1.6 (scheme 1.2) which was isolated in 1952 from the blister beetle 
Paederus fuscipes 5 and whose structure was determined some 16 years later6 after some 
elegant degradation studies7. The occurrence of such closely related compounds from such 
taxonomically remote animals as sponges and beetles may indicate the connection of a 
common precursor, possibly a symbiotic micro-organism8 .
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,OMe
COOH
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1.1 a-e 1.2 Onnamide A
1.1a
Theopederin A
OH OMe
1.1b
Theopederin B
1.1c
Theopederin C
1.1e R = OH Theopederin E
1.1d
Theopederin D
OMe iMe
,OMe OH
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OMeOR
OR
1.3 Mycalamide A (R, Rt = H)
1.4 Mycalamide B (R = Me, R-, = H)
1.5 18-O-Methyl Mycalamide B (R, R-, = Me)
1.2 Biological Evaluation
1.6 Pederin
OMe
Scheme 1.2
The biological evaluation of theopederin D ( l . ld )  has been hindered due to the small 
quantities available, allowing only a single piece of data to be collected; theopederin D was 
shown to be markedly cytotoxic against P388 murine leukemia cells with an IC5 0  of 1.0 
ng/mL. 1 There was however a more thorough biological evaluation of the mycalamides and 
due to their structural similarity to theopederin D (l.ld), it would be reasonable to assume a 
similar biological mode of action for theopederin D (l.ld) as for the mycalamides. Therefore 
it is relevant to mention the biological evaluation of the mycalamides in this thesis.
Mycalamides A and B (1.3 and 1.4) reveal potent in vitro cytotoxicity and in vivo antitumor 
efficacy against several leukemia and solid tumour model systems. Both mycalamide A and 
B (1.3 and 1.4) inhibited the replication of cultured murine lymphoma P388 cells at 
extremely low concentrations (P388 IC5 o's 0.7 ± 0.3 ngcm- 3  and 3.0 ± 1 . 3  ngcm- 3  
respectively). Furthermore, both inhibited HL-60, HT-29 and A549 human tumour cell 
replication IC50  < 5 nM and were active against P388 leukemia. Mycalamide A (1.3)
2
increased the life span of mice carrying ascitic lymphomas and a variety of ascitic and solid 
tumours.9
The mycalamides also reveal antiviral activity10 and a recent biological investigation of 
mycalamide A and analogues11 showed that 10-£/?z-mycalamide A and l-epi-10-epi- 
mycalamide A displayed potent antiviral activity against VZV (Varicella-zoster virus, TR's 
of 8  and <32 respectively) and low cytotoxicity against HEL cells (ICso's = 12.5 and >50.0 
|igcm~ 3 respectively). The results are significant because they show a structure activity 
relationship (SAR) for mycalamide A against viruses which is in the opposite sense to the 
SAR against tumours with regard to the C-7 and C-10 stereogenic centres.
In addition mycalamide A blocks T-cell activation in mice and is a 1000-fold more potent 
than cyclosporin A in this model. 12
SAR data for the cytotoxicity of the mycalamides against P388 leukemia cells, has been 
reported from a microscale derivatisation study using natural supplies of mycalamide13' 15. 
These experiments demonstrated that the a-hydroxyamido acetal functionality is essential for 
the in vitro P388 anti-leukemia activity. Acylation or alkylation of the 7-OH group resulted 
in the formation of derivatives with a 10-100-fold lower bioactivity. Methylation of both the 
amide nitrogen and the 7-OH caused a 1000-fold decrease in the bioactivity. Cleavage of the 
C8-N9 amide bond resulted in a total loss of biological activity. The product of 
deoxygenation at C-10 (1.7) was 40 times less bioactive than mycalamide A, suggesting the 
critical importance of the C-10 centre. Further evidence was provided by Kocienski and co­
workers showing the C-10 epimer to be 103-fold less active than the natural parent 
compound16. The microscale studies also demonstrated that O-methylation at C-18 of 
mycalamide B (1.4) gave increased bioactivity against P388 leukemia cells with an IC50 of 
0.07 ng/mL. Thus, 18-O-methyl mycalamide B 1.5 possess the same potency as pederin 1.6 
against P388 leukemia cells. Kocienski and co-workers synthesised 18-O-methyl 
mycalamide B17 1.5 and also showed that its inhibition of DNA synthesis (IC50  = 0.80 nM) 
and protein synthesis (IC50  = 1-65 nM) were similar to that of pederin (IC50  = 0.85 nM and 
1.84 nM respectively)16. A summary of the cytotoxicity data is given in scheme 1.3.
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.OH
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Scheme 1.3
1.3 A Summary of the Synthetic Approaches Towards the Mycalamides
There are no synthetic studies towards the theopederins A-E (l.la-e) reported in the literature 
to date, however there has been substantial work published regarding the synthesis of the 
related mycalamides17"28, onnamide A (1.2)29 and pederin (1.6)30'36 over a period of 21 
years to date. For our purposes we will only discuss the publications directed towards the 
mycalamides and onnamide A but wish to advise the reader that many lessons were learned 
during the synthesis of pederin and that they were applied (where necessary) to the synthesis 
of the mycalamides. We will not discuss every publication directed towards the mycalamides 
but will concentrate on those which are the most relevant to our work. There have been five 
authors who have made substantial contributions to the synthesis of the mycalamides, they 
are; Yoshito Kishi19,29, William Roush25' 28, Reinhard Hoffmann18’20,21, Tadashi 
Nakata11,23,24 and Philip Kocienski17,22. We will discuss the central contribution made by 
Kishi, Roush, Hoffmann and Kocienski relating to the synthesis of the mycalamides and 
onnamide A. A synthesis of mycalamide A (1.3) by Nakata24 was omitted from this 
discussion for it was similar to that described by Kishi.19
4
1.3a Yoshito Kishi
Yoshito Kishi reported the first synthesis of mycalamides A and B in 1990, which 
unambiguously defined their absolute stereochemistry.19 Kishi chose to disconnect across the 
C8-N9 bond splitting mycalamide into two fragments 1.8 and 1.9 (scheme 1.4). The left 
fragment 1.8 was prepared in two steps from an advanced intermediate 1.10 from Nakata's 
synthesis of pederin33’34. The right fragment 1.9 was prepared by an extensive elaboration of 
methyl oc-D-glucopyranoside 1.12 via the methoxy acetal 1.11. The transformation of 1.12 to
1.11 will not be discussed for the synthesis of 1.11 was improved during Kishi’s synthesis of 
Onnamide A.29
OMe
,OMe
s
OH
OH
OR
1.3 Mycalamide A (R = H)
1.4 Mycalamide B (R = Me)
OH
1.8 R, = DMPM
>OMe
1.9
OMe
>Me OBn
>OMe
1.10 1.11
1.12
Scheme 1.4
5
Conversion of 1.11 to mycalamide A and mycalamide B is shown in scheme 1.5.
•Me QBn
>OMe
Mei A
>OMekOMe
dr = 2:1
O
1.11 1.13 1.14
fcOMe
dr = 2:1
OMe
OH
ODMPM
O 1.8
1.9
OMe
kOMe
ODMPM
1.16a
F
+ 1.16b Unnatural epimer at C-10
Scheme 1.5 Reagents and conditions:
A 86% a) H2, Pd(OH)2 on C, EtOAc, rt; b) HCHO, HCI, 0°C 
B 72% a) MsCI, NEt3, DMAP, CH2CI2l -60°C  
b) " Bu„NN 3i CH2CI2, -78°C -»  rt 
H2l Pd on C, EtOAc, rt 
pTsCI, DMAP, CH 2CI2, rt 
a) 'BuOK, THF, rt b) DDQ, H 20
a) 'BuOK, THF, A 
NaOH aq, dioxane, rt
4 -MeOC6H4-(C6H5)2CCI, ('PrJzNEt, CH2CI2, rt 
Mel, NaH, DMF, 75°C 
PTSA, MeOH, rt 
Ac20 ,  DMAP, CH2CI2i rt 
H2, Pd on C, EtOAc, rt
i
78%
60%
76%
i
OMe
,OMe
OH
OH
OH1.3 Mycalamide A
kOMe
dr = 2:1
,OMe
L
OAc
1.4 Mycalamide B
1.14 1.17
The benzyl protecting group in 1.11 was removed by catalytic hydrogenation followed by 
treatment with paraformaldehyde/HCl(g) to return the hemiacetal 1.13. Standard 
transformations converted hemiacetal 1.13 to the azide 1.14 in 72% yield as a 2:1 mixture of 
inseparable diastereoisomers, a suitable precursor for mycalamide A. Conversion of the azide
6
1.14 to the azide acetate 1.17 returned a suitable intermediate for the synthesis of mycalamide 
B in five steps. Hydrogenation of the azide 1.14 gave the expected aminal 1.9 and *H NMR 
spectroscopy determined a 2:1 mixture of diastereoisomers at C-10 under basic or neutral 
conditions and a 1:4 mixture of diastereoisomers disfavouring the natural configuration under 
acidic conditions. The experiments determined the stereochemistry at C-10 should be 
addressed at the step of amide bond formation or thereafter. The coupling of the two 
fragments (1.8 and 1.9) was achieved by activating the carboxylic acid 1.8 with TosCl and 
adding 1.9 to give 1.16a (38%) and 1.16b (40%). Epimerisation of 1.16b to 1.16a using base 
OBuOK/THF/reflux) occurred smoothly to give exclusively the natural epimer. Finally two 
deprotection steps then released Mycalamide A. Mycalamide B was obtained from 1.14 using 
the same chemistry as described above, but the epimerisation of the unnatural epimer at C-10 
to the natural epimer interestingly only gave a 1:1 mixture of epimers.
In 1991 Kishi reported the first synthesis of onnamide A, once again unambiguously defining 
the absolute stereochemistry of the molecule.29 The synthesis employed an intermediate 
1.16a and a disconnection strategy (scheme 1.6) which were common to a previous synthesis 
of mycalamide A19.
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1.2 Onnamide A HN n h 2
OMe
kOMe
ODMPM
1.16a
ODMPM
1.8
kOMe
Scheme 1.6
After a synthesis of mycalamide A19 Kishi acknowledged the synthesis of dimethoxy acetal
1.11 from methyl a-D-glucopyranoside 1.12 (scheme 1.4) was limiting due to its length and 
therefore developed a new synthesis of 1.11 from the known ketone 1.18 which is shown in 
scheme 1.737. Stereoselective reduction38 of 1.18 and 0-methylation generated 1.19. 
Standard transformations converted 1.19 to its bis-acetate and a terminal olefin was 
introduced by an axially selective Lewis acid-mediated allyltrimethylsilane C-glycosidation 
at the anomeric C-15 position to return 1.20.39 Asymmetric dihyroxylation40 of olefin 1.20 
followed by diol protection, acetate hydrolysis, Swern oxidation41 and acetalisation gave 
1.11.
Ph
OMe
dr = 12:1
,OMe B.C
OMe
QBnA c
kOMe
D, E, F
1.18 1.19 1.20
'Me QBn
kOMe
Me(
dr = 6:1
1.11
Schem e 1.7 Reagents and conditions:
A 78% a) NaBH(OAc)3 , CeCI3, MeOH, 0°C; b) Mel, NaH, THF, rt
B 75% a) LAH, AICI3, Et20-CH2CI2, A; b) Ac20 ,  BF3«OEt2, rt
C 93% Trimethylallylsilane, TMSOTf, BF 3*Et20 , MeCN, 0°C
D 65% O s 0 4, N,N'-bis(2,4,6-trimethylbenzyl)-5,5)-1,2-diphenyl-
1,2-diaminoethane, CH2CI2,-9 0 °C  
protect a s carbonate (reagents not specified)
E i  PTSA, MeOH, A
F 84% a) Swern oxidation; b) (MeO) 3CH, PTSA, MeOH, 0°C->rt
1.11 was converted to the diol 1.21 (scheme 1.8) using steps previously described (Scheme 
1.5, steps A-Ea). The elaboration at C-18 of the diol 1.21 is shown in scheme 1.8 and is 
particularly relevant to our synthesis of theopederin D. 1.21 was converted to its 
corresponding epoxide 1.22 which was opened by a mixed cuprate prepared from 
TMSCCCH2CH2Li and lithium 2-thienylcyanocuprate to give a silylacetylene which was 
converted to stannane 1.23. Stille coupling42 with the S-iodo amide 1.24, isomerisation to the 
trans, trans, trans, product and removal of protecting groups returned onnamide A.
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OMe
kOMe
ODMPM
OH
OH1.21
OMe
kOMe
ODMPM
1.22
OMe
kOMe
OAc
SnBu3
OAc1.23
'MS
+
AcHI
AcN
E. F
OMe
kOMe
OH
NHOH
HI
COOH
1.2 Onnamide A
Scheme 1.8 Reagents and conditions:
A 85% p-TsIm, NaH, Imidazole. THF, 0°C -»rt
B 78% a) TMSCCCH2 CH2Li, lithium-2-thienylcyanocuprate, -30°C->rt; b) acetylate 
C 85% DDQ, CH2 Cl2l phosphate buffer, pH 7, rt
D 76% a) Ac20 ,  NEt3l CH2CI2; b) TBAF, THF, rt; c) "BuSnH, AIBN, C 6H6, A 
E 51% a)P d(P P h3)4, DMF, rt; b) l2, CH2CI2, rt 
F 59% a) TBAF, THF, rt; b) LiOH, MeOH, rt
The syntheses of mycalamides A and B and onnamide A by Kishi19,29 were pioneering, 
confirming the absolute stereochemistry of these molecules. Kishi also showed that in the 
closing stages of any synthesis towards the mycalamides or onnamide A acidic conditions 
should be avoided. The generation of the C-10 stereogenic centre was also highlighted as 
problematic showing that poor diastereocontrol was achieved when proceeding via aminal 
intermediate 1.17 and Kishi suggested an alternative approach may prove more efficient19.
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1.3b William Roush
In 1993 Roush published a new, highly diastereoselective synthesis of the trioxadecalin ring 
system25 of the mycalamides A and B. The key feature of the synthesis was the use of a 
Curtius rearrangement43 to install the C-10 aminal stereogenic centre as a carbamate 
derivative 1.25 as shown in Scheme 1.9.
c r ^ ' O  (PhO)2PON3, NEt3, THF O O ^ ^ O
OH. TMS(CHi),OH,A,72%
1.25
>OMe .OMe
O
Scheme 1.9
Roush anticipated completing the synthesis of mycalamide A by way of Af-acylation27 of 
carbamate 1.2644 with a suitable active ester of pederic acid26, however after repeated 
attempts employing a wide range of conditions none of the desired coupling product was 
observed. A summary of the attempts is shown in scheme 1.10.
OMe
COX 
ODMPM
X = OH 
X = CI 
X = F 
X = OTs
OMe
+
1.26
X
OMe
OMe
ODMPM
1.16a
Scheme 1.10
Despite the setback described in scheme 1.10 a workable synthesis was developed. Due to 
exhausted supplies of right fragment 1.26 an N-glucosyl pederamide derivative 1.33 was 
prepared (scheme 1.11). The imide 1.29 was prepared by A-acylation of 1.27 with 
benzyloxyacetyl chloride 1.28 which underwent a TiCU-mediated aldol condensation45 with 
aldehyde 1.30 46providing alcohol 1.31 as a single diastereoisomer. The excellent 
diastereoselectivity of the aldol reaction appears to be due to the tendency of P-alkoxy 
aldehydes to favour the generation of 1,3-anti products47 and not due to a high
11
diastereofacial bias on the part of the metal enolate.48 Swern oxidation41 followed by
treatment of p-keto imide with MeOH and camphorsulphonic acid returned the hemiketal 
unit 1.32. Swern oxidation followed by the Takai-Nozaki49 protocol introduced the exo- 
methylene unit. Finally, removal of the Teoc and benzyl ether protecting groups gave the N- 
glycosylpederamide 1.33. Efforts to use this procedure to synthesise mycalamide A are on 
going.
discussion which demonstrated that pederic acid could not be used to synthesise mycalamide 
A we will not discuss the route in this thesis.
a) LiHMDS, THF. -78°C
1.27 1.29
TiCI4l 'Pr2NEt 
CH2CI2, -78°C
1.30
a) Swern oxidation
b) CSA, MeOH
67% (2 steps)OH
1.32 1.31
a) Swem oxidation, 88%
b) Zn. CH2I2, TiCU, THF, 86%
cj TBAF, DMF, 0°C, 89% 
d) Na, NH3i -78°C , 74%
.OMe
1.33
Scheme 1.11
In 1997 Roush published a new approach to pederic acid 1.826 but in view of the above
12
1.3c Reinhard Hoffmann
Hoffmann published an approach to the trioxadeclin ring system of the mycalamides A and B 
in 199320 which was similar to that of Roush25, in that it included a Curtius rearrangement43 
to form the C-10 aminal diastereoselectively. Hoffmann however, planned to prepare the 
unnatural configuration at C-10 to allow a shorter more concise route and then epimerise the 
C-10 stereogenic to the natural configuration towards the end of the synthesis. A summary of 
the route is shown in scheme 1.12.
1.34
1.35
SnBu3
TiCU 
65% (ds >95%)
1.36
A, B
MeO OAc 
1.37
D.E.F
>TBS
MeO
OMe
COOH
(TBS
MeO
OMe
1.38 1.39 1.40
Schem e 1.12 Reagents and conditions:
a) NaH, Mel; b) H 2 S 0 4, Ac20 ,  AcOH; c) K2C 0 3, MeOH 
a) 0 3 , Ph3P; b) A c20 , pyr, DMAP 
Allyltrimethylsilane, B F 3»OEt2
K2C 0 3, MeOH; b) Swern oxidation 
a) l2 , KOH, MeOH; b) KOH aq 
(PhO)2PON3, NEt3, PhCH2OH, C6 H6) 80°C
A 63%
B 89%
C 99%
D
vO0sCO
E 55%
F I
G 79%
H 62%
I”
>TBS
MeO
OMe
1.41
Scheme 1.12
The addition of tributylprenylstannane 1.35 to the known aldehyde 1.3450’51 (scheme 1.12) 
gave alcohol 1.36 with good diastereoselectivity (de = 95%). Alcohol 1.36 was converted to 
the lactol acetates 1.37 in 5 steps which, followed by a stereoselective Lewis acid-mediated 
allylation52 to introduce the C-15 side chain, returned 1.38. Standard transformations gave 
the carboxylic acid 1.40, a suitable precursor for the Curtius rearrangement. The Curtius 
rearrangement was initiated with diphenyl phoshoryl azide53 followed by thermolysis of the 
acyl azide and trapping of the intermediate isocyanate with benzyl alcohol to furnish 
carbamate 1.41 as a single diastereoisomer.
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To synthesise mycalamide B Hoffmann proposed to epimerise the C-10 stereogenic centre of 
aldehyde 1.42a to the natural configuration 1.42b (scheme 1.13), thus benefiting from the 
choice of starting material 1.34, which allowed an efficient elaboration of the bicyclic 
framework. However, all attempts failed suggesting the equilibrium between 1.42a and 1.42b 
may lie on the side of 1.42a,18
OMe
1.42a
DBU, C6H6
1.42b
OMe /  '
1.43
MeOOi
OMe
o r O
Scheme 1.13
Then in 1996 Hoffmann proposed a novel strategy21 to construct the iV-acyl aminal bridge of 
Mycalamide B. He chose to disconnect mycalamide B across the C7-C8 bond giving rise to 
ester 1.44 and isocyanate 1.45 as left and right fragments respectively, Scheme 1.14.
OMe OMe
>OMe>OMe .OMe
OH
OTBSOH
OMe OMe
1.4 Mycalamide B 1.44 1.45
Scheme 1.14
The feasibility of the approach, shown in scheme 1.14, was successfully demonstrated in a 
model study,21 scheme 1.15.
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a) BuaSnLi
B) SEMCI 
55%
TBAF, DMPU
Scheme 1.15
Commercially available isocyanate 1.46 upon treatment with Bu3 SnLi followed by 
quenching with [2-(trimethylsilyl)ethoxy]methyl chloride (SEMCI) furnished 1.47 in 55% 
yield. The use of SEM for protection of the N-atom was a judicious choice, stabilising the 
formation of the lithio derivative 1.48 at low temperature. Generation of 1.48 in the presence 
of ester 1.44 gave 1.49 in 87% yield. Treatment of 1.49 with TBAF and DMPU removed the 
SEM group with concomitant reduction the keto function to return 1.50 with the C7-OH 
moiety, present in the mycalamides in a 3:1 ratio. The origin of the hydride for the reduction 
of the keto function is unknown.
In order to adopt the new approach shown in scheme 1.15 to prepare mycalamide B, 
carboxylic acid 1.55 with the natural configuration at the C-10 aminal had to be synthesised. 
Failure to epimerise 1.42a to 1.42a (scheme 1.13) caused Hoffmann to devise a new 
synthesis of 1.55 this time starting from benzylidene acetal 1.52 derived from D-arabinose 
1.51,54 scheme 1.16.
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D-arabinose 1.51 1.52 1.53
f h - Schem e 1.12
Steps A-F HO O'
Schem e 1.16 Reagents and conditions:
A 62% CH2BrCI. NaOH, Bu4NBr 
H20 ,  dioxane, 60°C, 2h 
B 100% HgCI2, AgNOa, Ag20 ,  0°C, 1.5 h 
C 94% THF, -30°C , 1.5 h
1.54 1.55
Scheme 1.16
Methylenation of benzylidene acetal 1.52 under basic conditions55"57 and subsequent 
hydrolysis of the dithioacetal moiety returned the aldehyde 1.53 in 62% yield. Chelation 
controlled (MgBr2 ) addition of prenylmagnesium chloride gave the desired homoallylic 
alcohol 1.54 as a single diastereoisomer. Conversion of 1.54 to the carboxylic acid 1.55 
followed the route developed in the C-10-epi series shown in scheme 1.12 (steps A-F). The 
completion of Mycalamide B has not yet been reported.
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1.3d Philip Kocienski
In 1996 Kocienski reported a synthesis of 18-O-methyl mycalamide B 1.617 based upon the 
use of a metallated dihydropyran approach developed during a synthesis of pederin 1.4.36 A 
retrosynthetic analysis is shown in scheme 1.17. The lithiated dihydro-27/-pyran 1.56 was 
prepared as described during a synthesis of pederin36 and oxalamide 1.57 was prepared from 
the enone 1.58 which was also previously reported after a synthesis of pederin.31,36
QMe C 
OH
1.5 18-O-Methyl
OMe
1.58
Scheme 1.17
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Conversion of enone 1.58 to 1.65 is shown in scheme 1.18.
NG„ OTBS
OMe OMe
OMe
1.59
.OTBSNIC,,
OMe
OMe
NO, .OTBS
OMe
OMe
1.60
C, D
OMe
OMe
F
OMe
OMe
1.63 1.62
G, H
OH OH
>OHNC„(
OMe
OMe
NO,,, .OH
OMe
OMe
1.61b d r= 1:13  1.61a
Ph
>OMe
OMe
OMe
Ph
OMe
1.64 1.65
Scheme 1.18 Reagents and conditions:
A 97% TBSCN, TBSOTf, CH2CI2, 0 oC, 3 h  
B 70% Oxone, 18-C-6, acetone, NaHCO 3 , PhH-H20 ,  5°C 
C 96% HF, MeCN, rt, 7 h 
D 94% BH3*SMe2 , THF, rt, 20 min 
E 83% HCIO4, MeOH-H20 ,  A, 30 h 
F 94% LAH, THF, 0°C, 10 min; A, 25 min 
G 83% PhCH(OMe) 2, PTSA, CH2CI2, rt, 2 h 
H 95% Swern oxidation
I 94% NaBH(OAc)3, CeCI3*7H20 ,  MeOH, 0°C, 30 min 
J 94% Me2S 0 4, BU4NHSO4, 50% NaOH, PhMe, rt, 2 h
Conjugate addition of TBSCN to enone 1.58 in the presence of TBSOTf gave the cyano-TBS 
enol ether 1.59 with very high 1,3-asymmetric induction. Epoxidation of 1.59 with 
dimethyldioxirane5 8 ' 60  gave a 3.5:1 mixture of diastereoisomers in favour of the desired 
epoxide 1.60. After separation of the diastereoisomers by column chromatography, 
hydrolysis and reduction of the ketone returned a mixture of diols 1.61a,b in an unfavourable 
ratio of 13:1 at C-13. The mixture, on treatment with perchloric acid in aqueous MeOH, 
transformed 1.61a exclusively to the ester 1.62. After reduction of 1.62, the triol 1.63 was 
converted to its benzylidene acetal before Swern oxidation41 furnished the ketone 1.64. A 
highly diastereoselective reduction38  of 1.64 and O-methylation returned the crystalline 
methyl ether 1.65 in 8 8 % yield (2 steps).
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The transformation of 1.65 to the oxalamides 1.57 and 1.71 is shown in scheme 1.19.
kOMe
OMe
OMe
A, B, C, D
QMEM
kOMe
OMe
OMe
QMEM
kOMe
OMe
OMe
1.65 1.66 1.67
kOMe
'OMe
dr = 1:4 OMe
kOMe
OMe
dr = 2:1 OMe
O ^
kOMe
OMe
dr = 1:1 OMe
1.68 1.69 1.70
kOMe
OMe
OMe
kOMe
OMe
OMe
1.57 dr = 1:2 1.71
Scheme 1.19 Reagents and conditions:
A 95% 
B 70% 
C 98% 
D 90%
E 70% 
F 88% 
G 71% 
H 88% 
I 77%
a) PTSA, MeOH, A, 6 h; b) PivCI, pyr, CH 2CI2, rt, 4 h
MEMCI, Bu4 NI, DMAP, ('Pr)2NEt, PhMe, 75-80°C, 15 h
LAH, Et20 ,  0°C, 25 min
Dess-Martin periodinane, CH2CI2, rt, 1 h
H2C=CHCH 2OH, PTSA, CH 2CI2, A, 22 h; then add ZnCI 2, A, 5 h
(HCHO)n, HCI(g), CH2CI2, rt, 85 min
RhCI[PPh3]3, DABCO, EtOH-H 20 ,  A, 1.75 h; Hg(OAc)2, THF-H20  
MsCI, DMAP, NEt3, CH2CI2; TASF, TMSN3, CH2CI2, -70->0,C , 8.5 h 
H2, 5% Pd-C, THF, rt; MeO 2C-COCI, DMAP, -20°C , 15 min
A series of five standard transformations converted benzylidene acetal 1.65 to its 
corresponding aldehyde 1.66 in 84% yield. Acid-catalysed acetalisation with allyl alcohol 
and removal of the MEM protecting group converted 1.66 to 1.67 which formed the required 
1,3-dioxane ring upon treatment with paraformaldehyde and HC1 gas. Removal of the allyl 
function in a single step proved problematic so a two step procedure was used. Isomerisation 
of the allyl ether 1.68 with Wilkinson's catalyst61 and hydrolysis of the resultant enol ether
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with the aid of mercuric acetate62 gave the hemiacetals 1.69. Conversion of 1.69 to the azides 
1.70 followed by reduction to their aminals and TV-acylation with methyl oxalyl chloride and 
DMAP returned the oxalamides 1.57 and 1.71 as a 2:1 diastereomeric mixture in favour of 
the unnatural stereochemistry at C-10.
To complete the synthesis of 18-O-methyl mycalamide B the left and right fragments (1.56 
and 1.57 respectively) were coupled together applying the metallated dihyropyran approach 
as developed during a synthesis of pederin36 (scheme 1 .2 0 ).
o o^-o
Mel >OMe
SePh
OMe
1.56 M = Li
OMe
1.57 1.72 M = SnMe:
0
fcOMe
SePh
OMe
OMe
1.73
C,D
OMe OMe
kOMe ,OMe
OBz OBz
SePh SePh
OMe OMe
OMe OMe
1.74a dr = 3:1 1.74b
E, F
OMe
kOMe
OH
OMe
OMe
1.5 18-O-Methyl mycalamide B
Schem e 1.20 Reagents and conditions:
A 4. stannane 1.72 (3 eq), n BuLi, THF-hexanes, -78°C , 15 min 
B 78% TMEDA, ester 1.57, THF, -78°C , 2 h
C 1 a) S-BU3 BHU, THF, -95°C , 15 min; b) CSA, MeOH-CH 2CI2, rt, 40 min 
D 76% BzCI, DMAP, ( iPr)2NEt, C H 2CI2, rt 
E 95% a) N a l0 4, M e0H -H20 ,  rt, 20 min; b) NEt3-PhH, A, 2 min 
F 92% LiOH, MeOH, rt, 30 min
51.8 % overall yield (8 steps)
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The lithiated dihydro-2#-pyran 1.56 in the presence of TMEDA coupled to the oxalamide 
1.57 giving the acylated dihyropyran derivative 1.73 in 64% yield. Reduction of the keto 
function in 1.73 with LiBH(s-Bu)3 at -95°C followed by the acid-catalysed addition of 
MeOH to the dihydropyran gave a pair of diastereoisomers which were separated after 
benzoylation. To install the exo-methylene function the phenyl selenide function was 
oxidised to a phenyl selenoxide and heated for 2 minutes causing elimination. The benzoate 
was removed by LiOH hydrolysis to give 18-O-methyl mycalamide B.
In 1998 we published a synthesis of mycalamide B 1.4 which exploited a Curtius 
rearrangement to install the C-10 stereogenic centre and the metallated dihydropyran 
approach to construct the acyl aminal bridge of mycalamide B 1.5 22  (scheme 1.21). The 
publication summarises some of the work presented in this thesis.
SePh
OMe OMe
1.4 Mycalamide B 1.56
>OMe
OTBS
OMe
Scheme 1.21
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Chapter 2 
Our Synthetic Approach to 
Theopederin D
2.1 Our Objectives
At the beginning of our study we set ourselves a list of objectives. They were:
• To design a synthesis towards theopederin D ( l.ld )  which could also be adopted to 
synthesise mycalamide A and B (1.3 and 1.4), onnamide A (1.2) and pederin from 
advanced intermediates.
• To develop the technology to synthesise derivatives of the natural products for biological 
screening.
• To form the stereogenic centres with a high degree of stereoselectivity.
• To use readily available and cheap starting materials and reagents.
• To avoid column chromatography for the purification of large scale intermediates.
We believed success would depend on our ability to develop a route that could provide 
suitably large quantities of early intermediates quickly and cheaply. We also needed to build 
a degree of versatility into the early intermediates allowing us to synthesise the theopederins, 
mycalamides, pederin and analogues without returning to the beginning of the route for each 
target. The practical implications were that column chromatography should be avoided for 
the purification of large scale intermediates, thus early reactions in our sequence should 
provide products which can be purified by distillation, recrystallisation or be used crude in 
the next step. In order to develop an efficient beginning to our synthesis we chose 18-O- 
methyl mycalamide B 1.5 as our initial target. 18-O-Methyl mycalamide B had already been 
synthesised within the Kocienski group allowing us to build on previous experience. 17 Once 
the synthesis of 18-O-methyl mycalamide B was complete our aim was to evaluate the route 
and redirect our synthetic effort towards a synthesis of theopederin D.
2.2 Synthetic Strategy
Our approach towards 18-O-methyl mycalamide B was based upon that already published by 
Kocienski et al making use of the successful lithiated dihydropyran approach to construct the
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acyl aminal bridge (chapter 1, scheme 1.20) . 17 Our retro synthetic analysis is shown in 
scheme 2 .1 .
OMe
>OMe
OH
OMe
OMe
1.5 18-O-Methyl mycalamide B
. XX
SePh
OMe
OMe
1.56
OMe 
1.57 Chapter 5
EtQY °
2.3
The target molecule was divided into two fragments by breaking the C6-C7 bond giving rise 
to the known lithiated dihydropyran 1.5636 and the known oxalamide 1.57.17 We proposed to 
synthesise the oxalamide 1.57 from the known diol 2.1 using similar chemistry to that 
described during a previous synthesis of 18-(9-methyl mycalamide B . 17 We examined the 
previous synthesis of diol 2.1 and concluded it was long (requiring a 3 step detour to insert 
the C-13 stereogenic centre), expensive (due to the high cost of chiral starting material [(£)- 
butan-l,2,4-triol]) and inflexible (the Cl 5-side chain functionality was introduced at the start 
of the route preventing any versatility in the C 15 side chain). Therefore we designed a new 
synthesis of diol 2.1 starting from P-keto ester 2.3 via enone 2.2. The synthesis of enone 2.2 
is discussed in chapter 4 and completion of the synthesis of 18-O-methyl mycalamide B via 
diol 2.1 is discussed in chapter 5. We also examined the previous synthesis of the lithiated 
dihydropyran 1.56 and concluded the route was also long and thus developed a shorter, 
highly diastereoselective route starting from ethyl (S)-lactate which is described in chapter 3.
Once the new synthesis of 18-O-methyl mycalamide B was complete, we evaluated the route 
to see how it could be adapted to the synthesis of theopederin D (l.ld ). We concluded the 
synthesis of the enone 2 .2  (scheme 2 .1) met all of our objectives that we set ourselves at the 
beginning of our study; however, the route after 2.2 needed further improvement. Our new 
approach (scheme 2 .2 ) once again included the lithiated dihydropyran approach to construct 
the acyl aminal bridge but in light of the work by Roush25 and Hoffmann18,20, using a 
Curtius rearrangement to install the C-10 stereogenic centre, we planned to install the C-10
iOMe
OMe
OMe
'Cl
2.2 Chapter 4 2.1
Scheme 2.1
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stereogenic centre via a Curtius rearrangement. We planned to leave the functionalisation of 
the C-15 side chain to the last stages of the synthesis incorporating a terminal olefin in the C- 
15 side chain as a "versatile synthetic handle". A retrosynthetic analysis of our approach 
towards theopederin D ( l.ld )  is shown in scheme 2.2 and our synthesis of theopederin D is 
described in chapter 6 .
OMe
kOMe
OH
1.1d Theopederin D
^ ^ C l ^ . S n M e B
- x .  •
'SeP h  
1.72 Chapter 3
OMe
£ X
2.2 Chapter 4
iMe
.OTBSPiv<
Scheme 2.2
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Chapter 3 
Construction of the Left Fragment
SePh
1.72
Vinyl stannane 1.72 is an intermediate common to our synthesis of 18-O-methyl mycalamide 
B 1.3 and theopederin D l . ld  and has been previously synthesised by Kocienski during a 
synthesis of pederin 1.5.36 The synthesis was considered to be too long and expensive and 
thus a more expedient synthesis was developed. Our approach was based upon two 
diastereoselective key steps: 1) 1,4-conjugate addition of a methyl cuprate to homochiral 
enoate 3.3 63,64and 2) diastereoselective allylation to the corresponding potassium enolate of 
p-methyl ester 3.2. Ethyl (Sj-lactate 3.4 was selected as the cheap chiral starting material 
(£ 1.60/mole). Our retrosynthetic analysis is shown in scheme 3.1.
SePh
SnMeg ^ ^ O C O A r
OTr
3.1
Ar= p-CIC6H4
X
OTBS OTBS
C 0 2Et
3.2
C 0 2t t
OHr
C 0 2Et
3.4
Ethyl (S)-lactate
Scheme 3.1
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3.1 The Synthesis of p-Chlorobenzoate 3.1
The synthesis of 3.5 from ethyl (^-lactate 3.4 is shown in scheme 3.2.
.OTBS
3.4 3.3 3.2 (dr >15:1) 3.5
(single diastereoisomer)
Schem e 3.2 Reagents and conditions:
A 99% TBSCI, Et3N, DMAP. CH2CI2. A. 24 h
B 77% a) DIBAL, CH 2CI2, -78°C , 30 min; b) Triethyl phosponoacetate, NaH, THF, rt, 40 min 
C 75% Me2CuLi, TMSCI, HMPA, THF-Et 20 ,  -95°C  (3.75 h) -> -50°C  (1 h)
D 80% KHMDS (1 eq), allyl bromide (5 eq), THF, -78°C , 3.5 h
45.7% overall (5 steps)
Ethyl (^-lactate 3.4 was converted to the ester enoate 3.3 using standard procedures65 in 
75% yield over 3 steps on a 244 mmol scale (scheme 3.2). Diastereoselective 1,4-conjugate 
addition of Me2 CuLi to ester enoate 3.3 in the presence of TMSCI at -95°C gave the (3- 
methyl ester 3.2 in a favourable 24:1 mixture of diastereoisomers6 3 ,6 4  as determined by 
integration of 13C NMR spectra signals [13C NMR (90 MHz, CDC13): 8  = 71.6 (major) and 
70.7 (minor) ppm]. The yield was 75% after short path distillation on a 95 mmol scale. 
Enolisation of p-methyl ester 3.2 using KHMDS and subsequent allylation afforded the 
corresponding ester 3.5 as a single diastereoisomer. The ester 3.5, after purification by short 
path distillation, was obtained in 80% yield.
Yamamoto64  proposed a model for the diastereoselectivity of 1,4-conjugate addition of 
organocopper reagents to y-alkoxy a,p-unsaturated carbonyl derivatives to explain the anti- 
stereoselectivity observed during the formation of 3.2. Yamamoto showed the OTBS group 
occupied the more sterically demanding "inside position" (*H NMR spectroscopic studies 
provided experimental evidence for this observation) and the methyl group occupied a 
position anti to the approaching nucleophile, which corresponds to the Cieplak electronic 
model66. Yamamoto also proposed that a chelation mechanism was not involved. Thus anti- 
approach of the nucleophile towards the conformer 3.6 shown in scheme 3.3 furnished ester 
3.2 in accordance with experimental evidence.
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'anti'
OTBS .OTBS
inside'
COzEtC 0 2Et
3.3 3.2 (dr >15:1)
NU" 3.6
Scheme 3.3
To rationalise the high diastereoselectivity observed for the allylation of the potassium 
enolate derived from 3.2 to give 3.5 we must consider models describing electrophilic attack 
on trigonal carbon adjacent to a chiral centre. Houk proposed a rule for electrophilic attack in 
open chain-structures on trigonal carbon adjacent to a chiral centre, which is summarised in 
scheme 3.4, drawing 3.7.67 The argument states the preferred conformation has the "small" 
(S) substituent partly eclipsing the double bond and the electrophile approaching from within 
the double bond anti to the "large" (L) group. It follows that electrophilic attack should take 
place from the opposite side to that of the corresponding nucleophilic attack on a carbonyl 
group, and the electrophilic rule should prove to be the opposite of Cram's rule68 which is 
summarised in drawing 3.8, scheme 3.4
does our work relating to the formation of 3.5. The stereochemistry can be explained via the 
eclipsed model as shown in scheme 3.5 where allyl bromide approaches the double bond anti 
to the C(CH3 )OTBS group to produce 3.5. The result indicates the high level of 
diastereoselectivity can be attributed to the much greater steric bulkiness of the 
C(CH3 )OTBS group over the CH3 group.
3.7
Electrophilic rule
3.8
Cram's rule
Scheme 3.4
Work by Fleming69,70  and Yamamoto71 on diastereoselectivity in the alkylation of enolates 
adjacent to a chiral centre has corroborated the "electrophilic rule" proposed by Houk67 as
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.OTBS
^1
C 0 2Et
3.3
OTBS .O TBS
Scheme 3.5
To continue the synthesis towards 3.1 (scheme 3.6), reduction of ester 3.5 to alcohol 3.9 
proceeded cleanly using DIBAL in 89% yield after Kugelrohr distillation. Subsequent 
protection of the primary alcohol 3.9 as its trityl ether 3.10 occurred in 94% yield. The TBS 
function was removed effectively by refluxing in a solution of TBAF and THF to give 
alcohol 3.11 which was used crude in the next step. Using the Mitsunobu protocol72 the C-2 
stereogenic centre was inverted to form the /7-chlorobenzoate ester 3.1 in 76% yield over two 
steps. The elimination product 3.12 (5%) was formed during the Mitsunobu inversion 
reaction but was easily removed by the first column chromatography of the synthesis.
OTBS OTBS OTBS
3.9
OTr
3.11
Schem e 3.6 Reagents and conditions:
A 89% DIBAL (2.1 eq). CH 2CI2. 5°C, 1 h
B 94% TrCI, Et3 N, DMAP, CH2CI2, rt, 12 h
C I  TBAF»3H20  (1 .8 eq), THF, A, 5 h
D 76% p-CIC6 H4C 0 2H, DIAD, Ph3P (1.75 eq each), THF, -10°C, 3 h
63.6% overall (4 steps)
OCOAr
3.12 5% 3.1 (mp 102.0-102.5°C) 
Ar= p-CIC6H4
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3.2 Completion of the Left Fragment Synthesis
Completion of the synthesis of left fragment (1.72) synthesis is shown in scheme 3.7.
V ^ O C O A r
OTr
3.1 (mp 102.0-102.5°C) 
Ar= p-CIC6H4
V ^ J C O A r
^ vv / v'co2h
OTr
3.13
OCOAr
3.14 (mp 69.5-70.0 °C)
SePh
V / 0H
SePh
3.16
V - O C O A r
SeP h
3.15
SePh
1.72
Scheme 3.7 Reagents and conditions:
A 53% RuC|3 (6-6 mol%), NalO 4 (4 eq), MeCN-CC l4-H 20 ,  rt, 5 h 
B 58% MeOH, PTSA (0.13 eq), rt, 24 h 
C 88% Ph2S e 2, NaBH4, EtOH, A, 11 h 
D l  ('Bu)2BuAIHLi, THF, -20°C , 3 h 
E 72% ^M HCI(aq), Et20 ,  rt, 24 h 
F 70% (a) KHMDS, HMPA, THF, -80°C; (b) PhN(Tf) 2 
(b) Me6Sn2, (Ph3P)4Pd
13.6% overall (6 steps)
The terminal olefin of 3.1 was subjected to Sharpless oxidation conditions to return 
carboxylic acid 3.13 in 53% yield.73 The trityl protecting group was removed with PTSA in 
MeOH to give a y-hydroxy carboxylic acid which spontaneously cyclised to the y-lactone 
3.14. We were fortunate to find that the y-lactone 3.14 was a highly crystalline compound 
allowing us to remove all minor diastereoisomeric impurities in a single recrystallisation. 
Cleavage of the alkoxy bond in y-lactone 3.14 by refluxing in an ethanol solution of sodium 
borohydride and diphenyl diselenide gave the required carboxylic acid 3.15 in 8 8 % yield.74 
To form 8 -lactone 3.17 the p-chlorobenzoate group had to be removed to leave the free 
alcohol 3.16. Saponification using 2M NaOH(aq) hydrolysed the ester function cleanly; 
however, 5% epimerisation was observed at the C-2 centre by 13C NMR spectroscopy. To 
avoid epimerisation at C-2 the ester 3.15 was converted to its corresponding alcohol 3.16 by 
reduction using an "ate complex"75, formed by the equimolar combination of nBuLi and 
DIBAL. Acidic work-up gave the required 8 -lactone 3.17 in 72% yield. Carboxylic acids are 
known to be inert towards the nBuLi-DIBAL "ate complex" which allowed us to selectively 
reduce the ester function in the presence of the carboxylic acid function in 3.15. Conversion
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of 3.17 to vinyl stannane 1.72 proceeded in 70% yield using conditions previously 
developed by Kocienski et a l36.
3.3 Conclusion
Vinyl stannane 1.72 was synthesised in 15 steps in 12.7% overall yield starting from ethyl 
(S)-lactate. The above sequence is an improvement on the previously published route36 with 
the improvements being made primarily at the beginning of the synthesis, employing a highly 
diastereoselective 1,4-conjugate addition of a methyl cuprate to enoate 3.3 and a highly 
diastereoselective allylation of the potassium enolate of 3.2. Both transformations were high 
yielding and avoided the use of column chromatography for purification.
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Chapter 4 
Synthesis of Dihydropyranone
2.2
Dihyropyranone 2.2 is an intermediate common to our syntheses of 18-O-methyl mycalamide 
B 1.517 and theopederin D L id .1 It is also an intermediate which may be applied towards a 
synthesis of pederin 1.66, onnamide A 1.24, the mycalamides A 1.2 and B 1.32,3 and the 
theopederins A-E l .la -e 1. In order to develop a synthesis that would produce all of these 
natural products, we aimed to prepare the dihydropyranone 2 .2  on a large scale using cheap 
starting materials and reagents and avoiding column chromatography. Control of the C-15 
stereogenic centre was identified as the most significant challenge.
4.1 Creation of the C-15 Stereogenic Centre
The C-15 stereogenic centre was created efficiently by two different routes. The first began 
by condensing the lithium enolate of ethyl isobutyrate 4.1 with 4-chlorobutanoyl chloride 4.2 
to give p-keto ester 4.3 followed by catalytic asymmetric hydrogenation (scheme 4.1). 
Enantioselective reductions of p-keto esters have been reported using biological or 
biochemical transformations7 6 "78 and enantioselective catalytic hydrogenation79' 81. We 
avoided biotransformation methods because they are highly substrate dependant often 
resulting in variable yields and poor enantioselectivity. In addition such methods can be 
impractical; for example, bakers' yeast reduces ethyl 3 -oxobutanoate to ethyl (S)-3- 
hydroxybutanoate in 88-97% ee and 70-80% yield, but in order to obtain high (95-97%) ee, 
the substrate concentration should be kept below 1 g/L82,83. Enantioselective catalytic 
hydrogenation of p-keto esters is an alternative complementary methodology79 ' 83 allowing 
easy control of the chiral outcome, access to both antipodes with equal ease and a higher 
substrate concentration than the biological version is tolerated. In 1987 Noyori and co­
workers83 reported the use of catalytic RuCl2 [(R)-BINAP] in methanol in conjunction with 
H2 (g) (1500 psi) to reduce P-keto esters with 99% ee in 99% yield after 46 hours. However, 
since the initial publication only two research groups reported the use of Noyori's procedure 
in a target-directed synthesis over a three year period84"86. The reason was probably due to 
the high pressure required and the difficulty in obtaining the air sensitive catalyst. In 1991,
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Taber80  reported the use of a RuCl2 [(R)-BINAP]#NEt3 catalyst that needed no purification 
and required a pressure of only 50 psi at 80°C to reduce p-keto esters with excellent ee. King 
and co-workers81 then demonstrated that the addition of 1 mol% of 2M methanolic HC1 to 
the reaction mixture as described by Taber accelerated the reduction allowing low pressure 
(40 psi) and low temperature (40°C) to be used and the reaction was complete after only 8 
hours. Therefore, catalytic asymmetric hydrogenation of P-keto ester 4.3 (scheme 4.1) using 
0 . 2  mol% of [(R)-(+)-2 ,2 '-bis(diphenylphosphino)-l,r-binaphthyl] chloro (p-cymene) 
ruthenium chloride 4.587 (available from Aldrich) in methanol at 120 psi and 40°C for 3 days 
gave the required (R ) configuration of the p-hydroxy ester 4.4 in 93% yield. The 
enantiomeric ratio was determined as 97:3 by integration of C14-Me singlets of the (R)- 
MTPA ester derivative from 4.4 [JH NMR (270 MHz, C6D6 ): 5 = 1.12 (major), 1.07 (minor) 
ppm]. A higher pressure of 120 psi and longer reaction time of 3 days was required to reduce
4.3 than that described by King81; this was due to the higher steric demand of the geminal- 
dimethyl group at C-14. To the best of our knowledge no other catalytic asymmetric 
reduction of a p-keto ester with a geminal-dimethyl group between the ketone and the ester 
has been reported in the literature.
MeOH, 3 days, 40°C  
93%
Ph1
4.5 [(ff)-BINAP][p-cymene]RuCl2
Scheme 4.1
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A second route to synthesise the same P-hydroxy ester 4.4 via a boron mediated asymmetric 
aldol reaction84,85 was also developed and is shown in scheme 4.2.
NaOCI, TEMPO 
KBr, NaHCOs
h 2o .  c h 2c i2
EtCX^ O
4.1
■OTMS
THF, rt, 1 h
4.10 (1 eq), THF,-78°C, 1.5 h
er = 97:3 l 4  44.6
Ck .OH
TosCI, NaOH, H20
NH2
4.8
Q>v .OH
b h 3*t h f
TOS
4.9
V ° ' BH
V ' - f
I Tos 
4.10
Scheme 4.2
Trimethylsilyl enol ether 4.6 and 4-chlorobutanal 4.7 were coupled mediated by homochiral 
borane 4.10. The enantiomeric ratio was determined as 97:3 by integration of the C14-Me 
singlets of the (fl)-MTPA ester derivative from 4.4. Enantiomerically pure borane 4.10 was 
prepared in two steps from cheap L-valine 4.8 and the iV-tosyl-L-valine 4.9 could be recycled 
from the asymmetric aldol reaction mixture in 98% yield. 4-Chlorobutanal 4.7 was prepared 
in 67-71% yield (450 mmol scale) by oxidation of 4-chlorobutanol using sodium 
hypochlorite and the free radical TEMPO under phase transfer conditions86. To obtain a good 
yield of 4-chlorobutanal 4.7 1.2 equivalents of sodium hypochlorite were required.
A conformation of 4.10 is represented diagramatically in scheme 4.3 and is based on MM2 
calculations performed by Kiyooka.84 The isopropyl group governs the position of the 
sulfonamide group and together they define the co-ordination site for the aldehyde. The 
aldehyde co-ordinates with its Si face exposed to nucleophilic attack whilst co-ordination 
exposing the Re face of the aldehyde to nucleophilic attack is disfavoured due to steric 
repulsion.
33
Nucleophile 
attacks at 
S/face
Favoured conformation Disfavoured confirmation
of aldehyde binding of aldehyde binding to boron
to boron
Scheme 4.3
To summarise, two separate reactions were developed to obtain chiral (3-hydroxy ester 4.4; an 
asymmetric aldol reaction (AAR) and a catalytic asymmetric hydrogenation (CAH). After a 
cost analysis of reagents and solvents the two procedures were found to be equally 
economical. The CAH however was a simpler reaction to perform in the laboratory requiring 
less reagent preparation. Unfortunately we were restricted to a 200 mL high pressure 
hydrogenator vessel allowing only 50 mmol batches of 4.4 to be prepared; therefore, we 
prepared the majority of p-hydroxy ester 4.4 using the AAR in 150 mmol batches using 3 
litre glassware. There is an example in the literature where a similar CAH was performed on 
a 1 Kg scale81 so we are confident in the suitability of the CAH reaction to be adopted for 
large scale preparation of 4.4.
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4.2 Conversion of (3-Hydroxy Ester (4.4) to Dihydropyranone (2.2)
Conversion of (3-hydroxy ester 4.4 to dihydropyranone 2.2 is shown in scheme 4.4.
c y o a
"XX.
Ac20. NEt3l DMAP
CH2CI2l rt, 12 h 
82%
4.4
.OEt
LDA (2 eq) 
THF, -78°C , 1.5 h
Ac<
67%
Cl
4.12 (mp 103-105°C)
Me2S0 4 , K2C 0 3 
18-C-6, CH2CI2 
rt. 12 h 
100%
cc
2.2
(42-43% overall)
DIBAL (1.2 eq)
C H2CI2, -78°C , 30 min 
85%
4.13
Scheme 4.4
The crude |3-hydroxy ester 4.4 from the asymmetric aldol reaction was converted to its 
corresponding acetate 4.11 using standard conditions in 74% yield over two steps and the 
pure p-hydroxy ester 4.4 from the asymmetric hydrogenation reaction was converted to the 
same acetate 4.11 using the same conditions in 82% yield over two steps (scheme 4.4). The 
acetate 4.11 was purified by short path distillation. Ring closure by Dieckmann 
condensation88 of the acetate 4.11 using two equivalents of LDA gave the highly crystalline 
p-keto lactone 4.12. P-Keto lactone 4.12 was purified to optical purity by three successive 
crystallisations (enantiomeric purity was determined by chiral HPLC after a further two 
steps). Five hundred grams (2.28 moles) of P-keto lactone 4.12 was prepared and we were 
able to store it indefinitely at room temperature. Enol ether 4.13 was formed by O- 
methylation of p-keto lactone 4.12 under phase transfer conditions, prior to reductive 
elimination with DIBAL to give the desired dihyropyranone 2.2 in 85% yield over two steps.
4.3 Conclusion
Optically pure dihyropyranone 2.2 was synthesised without the use of column 
chromatography in 42-43% yield over 5 steps from cheap starting materials. The 
dihyropyranone 2.2 formed a solid foundation on which to design syntheses of 18-O-methyl 
mycalamide B 1.5 and theopederin D l .ld  (chapters 5 and 6 ).
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Chapter 5
Synthesis of 18-0-Methyl Mycalamide B
OMe O
OMe
OH
OMe
OMe
18-O-Methyl mycalamide B 1.5 has previously been synthesised by Kocienski et al using a 
metallated dihydropyran approach to couple the two fragments. 17 The route introduced the 
C-17 and C-18 methoxy functionalities at the beginning of the synthesis therefore excluding 
the possibility of further elaboration to any other targets, particularly the theopederins. The 
route was also long including a three step detour to provide the correct stereochemistry at C- 
13 (chapter 1, scheme 18). The inefficiency at the beginning of the synthesis, the lack of 
versatility and the poor stereocontrol at C-13 caused us to develop a new synthesis that was 
more efficient, diastereoselective and more versatile, especially with regard to the C-15 side 
chain functionality. The keys steps are: (a) diastereoselective conjugate addition of a 
hydroxymethyl anion equivalent 5.1 to dihyropyranone 2.2; (b) oxidation of silyl enol ether
5.5 using dimethyl dioxirane; (c) diastereoselective Luche reduction38 of ketone 5.8 and (d) 
the metallated dihyropyran approach to couple the two fragments. 17,36
5.1 Introduction of the Stereogenic Centre at C -ll
To introduce the single carbon at C -ll we chose isopropoxymethyldimethylsilane Grignard
5 .1  as a hydroxymethyl  anion equivalent .  The addi t ion of 
(isopropoxydimethylsilyl)methylmagnesium chloride 5.1 to aldehydes and ketones is 
described in the literature.89 Attempts to add 5.1 to a,p-enones in the presence of a range of 
copper catalysts was also described in the literature; however, the addition occurred only to 
2-cyclohexenone.9 0  It is significant, therefore, that we were able to add Grignard reagent 5.1 
to enone 2.2 (scheme 5.1). The Grignard reagent 5.1 underwent 1,4-addition to 
dihydropyranone 2 .2  in the presence of CuBr*SMe2 with very high 1,3-asymmetric induction 
(the other diastereoisomer was not detected by ^  NMR spectroscopy). A rationale for the 
high 1,3-asymmetric induction is as follows; attack of the nucleophile syn to the C-15 side 
chain (top face) would create a boat-like enolate whereas attack of the nucleophile anti to the
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C-15 side chain (bottom face) creates a chair-like enolate which is of lower energy, thus 
accounting for the high diastereocontrol (scheme 5.1). A tentative stereochemical assignment 
of (US', 15R) was made based on a similar conjugate addition to a similar dihydropyranone 
used in a synthesis of pederin36. Confirmation of our assignment was made later on during 
our synthesis (vide infra). The isopropoxydimethylsilyl function was then converted to 
alcohol 5.3 using the Fleming-Tamao oxidation protocol91 "93 giving 5.3 in 87% yield after 2 
steps.
— Sr-QiPr
CuBr»SMe2 (8 mol %) 
THF. -7 8 °C  „
'P rO -^i MgCI 
5.1
Mg, THF
55-60°C
'PrO— j>i Cl
G2
iPrOH 
Imidazole 
CH2CI2) rt
5.2
h 2o 2, k f  
k h c o 3
THF, MeOH 
rt, 87% (2 steps)
ci—sr xiT
Rationale for the high 1,3-asymmetric control of the 
1,4-conjugate addition to dihydropyranone GG
"Nu"
Nu
Top face
Boat like enolate
0 = . _ Bottom face O ------- ► -o-
H
"Nu"
Nu
Chair like enolate
Nu,.
R = CH2CH2CH2CI "Nu" = 5.1
Scheme 5.1
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5.2 Introduction of the Stereogenic Centre at C-12
The alcohol 5.3 was converted to enol silane 5.5 in two standard transformations shown in 
scheme 5.2. To epoxidise enol silane 5.5 we chose the same epoxidation conditions as 
Kocienski et al used to epoxidise a similar enol silane 1.59 (chapter 1, scheme 18) during a 
synthesis of 18-O-methyl mycalamide B 1.5.17 Dimethyl dioxirane was generated in situ 
58,59 uncier phase transfer conditions60 converting enol silane 5.5 to the oxirane 5.6. Attack 
from the apparently more hindered face of the double bond generated the oxirane 5.6 as a 
single diastereoisomer as determined by its and 13C NMR spectra, however assignment of 
the oxirane stereochemistry was defined after the next step (vide infra).
)TBS
x ^ w 0TBS
5.5
OTBS
I  °
Oxone, acetone, 18-C-6
KHCOa, H20 ,  PhMe 
rt, 1 h 
(isolated crude)
5.6
Scheme 5.2
ci
TBSCI, NEta DMAP
CH2CI2l rt, 36 h 
94%
>TBS
Cl
TBSOTf, NEt3
CH2CI2, rt, 1.5 h 
(isolated crude)
5.3 5.4
A rationale for the stereochemical outcome of the epoxidation of enol silane 5.5 is not 
obvious, for the epoxidation appears to be directed towards the more hindered face of the 
double bond i.e. syn to the CH2OTBS group at C-l 1. Consider the two half-chair conformers 
A and B, scheme 5.3.
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OTBS
OTBS
top face blocked by a-Me which is 
nearly perpendicular to the rc-system
OTBS
C-15 side chain is gauche 
to both methyl groups
top face blocked by C-15 side chain
OTBS
TBSi
C-15 side chain is gauche 
to only o ne  methyl group
MM2:12.0 Kcal/moleMM2:12.5 Kcal/mole
Scheme 5.3
In the case of conformer A, the b-methyl and the CH2OTBS groups are splayed outwards 
while the a-methyl is nearly perpendicular to the 7t-system thereby possibly offering greater 
steric impediment to attack from the a-face. The steric impediment to attack on the a-face is 
rather more pronounced in the half-chair conformer B wherein the C-15 substituent occupies 
an axial position in a 1,3 relationship to the alkene. Indeed, conformer B may be the preferred 
conformer since the C-15 side chain enters into only one gauche interaction with the a-methyl 
whereas in conformer A, the C-15 side chain is engaged in gauche interactions with both 
methyls. In order to gain some insight into the relative energies of conformers A and B, an 
MM2 calculation was performed on the model compound C. The half-chair conformers D 
and E (scheme 5.4 and appendix B) were identified as energy minima with conformer E 
being nearly 0.5 Kcal/mole more stable than conformer D. Thus steric arguments alone could 
account for the facial selectivity of epoxidation—especially if the reaction takes place 
preferentially through conformer B.
In the more ambiguous case of conformer A, facial selectivity might be rationalised by 
torsional effects94  since epoxidation on the a-face leads to an eclipsing interaction between 
the OTBS group and the b-methyl whereas epoxidation on the (3-face leads to a more 
favourable gauche interaction (scheme 5.4). However, the same analysis based on conformer 
B would predict that epoxidation on the a-face would be preferred. In the absence of any 
further information, we prefer the explanation based on steric effects.
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Scheme 5.4
The oxirane 5.6 was then converted to the crystalline diols 5.7a and b as shown in scheme 
5.5.
?TBS ,0 lx rX t / OTBSXI,
rH QH
PTSA, H20 , MeOH, A, 18 h
86% (3 steps) 
dr = 15:1
5.6
XX
5.7a (rnp = 60-60.5°C) 5.7b  (mp = 63-63.5°C)
Cl
.OH
OH
5.7b
5 = 3.83, dd 
J = 8.5, 3.3 Hz
6 = 3.46, ddd 
J = 8 .1 .4 .6 , 3.0 Hz (12 R)
Z J U
^ ^ ^ c i  
5.7b (mp = 63-63.5°C)
Scheme 5.5
Initially treatment of 5.6 with 40% HF and acetonitrile gave the alcohols 5.7a,b as a 13:1 
mixture of diastereoisomers but in variable yield (40-77%). However, refluxing the oxirane
5.6 in aqueous methanol and pyridinium /7-toluenesulfonate gave the alcohols 5.7a,b as a 
15:1 mixture of diastereoisomers in 8 6 % yield. The diastereoisomers 5.7a and 5.7b were 
separated by crystallisation to give optically pure diol 5.7a followed by column 
chromatography of the mother liquor to give undesired diol 5.7b and additional diol 5.7a. 
The second method was the method of choice as the yields were consistently higher. The 
diastereomeric ratio at C-12 was determined by integration of doublets derived from the 
methine proton adjacent to the carbonyl [*H NMR (270 MHz, C6D6 ): 5 = 4.34 (minor) and 
4.29 (major)]. The conformation of the minor isomer 5.7b was determined as displaying an
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axial-axial relationship between the C- l l  and C-12 protons by examination of the vicinal 
coupling constants between Cl 1-H and C12-H in its *H NMR spectra [LH NMR (360 MHz, 
CDCI3): 8  = 3.83 (1H, dd, J = 8.5, 3.3 Hz, C12-H), 3.46 (1H, ddd, / =  8.1, 4.6, 3.0 Hz, Cl l -  
H) ppm]. The C12 stereogenic centre of 5.7b was therefore tentatively assigned as (12/?) and 
the corresponding centre of 5.7a was then assigned as (125) (scheme 5.5).
5.3 Introduction of the Stereogenic Centre at C-13
Before the introduction of the C-13 stereogenic centre, diol 5.7a was protected as its 
isopropylidene acetal 5.8 in 8 6 % yield using 2 -methoxypropene and pyridinium p- 
toluenesulfonate (scheme 5.6). The ketone 5.8 was then reduced using modified Luche 
conditions38 [(NaBH(OAc)3 , CeCl3»7 H2 0 , MeOH, 0°C] to give the alcohols 5.9a and 5.9b 
in 72% yield. The diastereomeric ratio was determined as 11:1 at C-13 by the integration of 
singlets derived from C14-Me singlets in the *H NMR spectrum of 5.9a,b [*H NMR (270 
MHz, C6D6): 8  = 0.88 (minor) and 0.78 (major)].
ci
5.7a (mp = 60-60.5°C)
2-methoxypropene, PTSA 
CH2CI2, 4.25 h, rt
86%
X
NaBH(OAc)3l CeCI3»7H20  
MeOH, 0°C, 4.25 h
72%, dr = 11:1
X
5.9a (mp = 96-97°C)
+
5.9b (mp = 89-90°C)
Scheme 5.6
An explanation for the high level of diastereoselectivity observed during an analogous 
reduction of ketone 1.18 has been offered by Hong and Kishi during a synthesis of onnamide 
A 1.229’95 and the same explanation was also offered by Kocienski and Davies for the same 
conditions to reduce a similar ketone 5.10 during a synthesis of 18-O-methyl mycalamide 
B1.517’96  (scheme 5.7).
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CeCI3»7H20
NaBH(OAc)3
CeCI3‘7H20
Scheme 5.7
It is accepted that the stereochemistry of nucleophilic addition to the carbonyl in 
cyclohexanones is controlled by a stereoelectronic factor stabilising the axial line of attack 
and steric factors opposing the axial line of attack as described by Cieplak.66 We suggest (as 
did Kishi and Kocienski for their systems) that for ketone 5.8 the axial line of attack in both 
conformers 5.8a and 5.8b (scheme 5.8) is hindered leaving only the equatorial line of attack. 
Thus we propose that the reduction proceeds via an equatorial intramolecular hydride 
delivery in which the boron bonds to the axially oriented a-alkoxy group of 5.8a in which the 
Ce3+ assists in the substitution of an acetate group on the boron. Experimental evidence 
supports the involvement of Ce3+ to activate the NaBH(OAc)3  for in its absence no reduction 
is observed. The equatorial intramolecular delivery of a hydride as described above could 
only occur in conformer 5.8a and not in conformer 5.8b therefore explaining the high 
selectivity observed during the reduction of ketone 5.8.
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Alcohol 5.9a was then subjected to phase transfer O-methylation conditions to give 5.11 in 
excellent yield (scheme 5.9). *H NMR spectroscopic analysis of 5.11 revealed a small vicinal 
coupling constant between C12-H and C13-H therefore allowing us to conclude the 3D 
conformation of 5.11 is as shown in scheme 5.9 with C12-H and C13-H adopting a trans- 
diequatorial relationship [*H NMR (270 MHz, CDCI3): 8  = 3.90 (1H, t, J  = 2.3 Hz, C12-H) 
and 2.84 (1H, d, J = 2.7 Hz, C13-H) ppm].
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5.4 Functionalisation of C-15 Side Chain
Having created the three contiguous stereogenic centres at C-l l ,  C-12 and C-13 we turned 
our attention to the C-15 side chain and the creation of the C-17 stereogenic centre. The route 
is outlined in scheme 5.10.
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Scheme 5.10
Attempts to introduce unsaturation at C17-C18 by elimination of chloride using base, or 
conversion of the chloride to its corresponding iodide followed by base catalysed elimination 
resulted in complex mixtures. A high yielding solution was to convert the chloride 5.11 to its 
selenide 5.12 (diphenylselenide, NaBHLt, A, 100%), oxidise to the selenoxide (NaIC>4 , 
MeOH, H2 O) and then heated at reflux for 10 min in a 1:1 mixture of toluene and 
triethylamine to eliminate selenoxide. Although three steps were involved they were quick 
and easy to perform returning the olefin 5.13 in 99% overall yield. Sharpless asymmetric 
dihyroxylation using hydroquinine 2,5-diphenyl-4,6-pyrimidindiyl diether 5.16 as ligand97 
converted olefin 5.13 to the diols 5.14a and 5.14b in 99% yield. The diastereomeric ratio was 
determined by *H NMR spectroscopy as 6.6:1 at C-17 by the integration of singlets derived 
from C14-Me [*H NMR (270 MHz, C6D6 ): 5 = 0.92 (minor) and 0.86 (major)]. The 
stereochemistry at the C-17 centre of 5.14a was tentatively assigned as (175) by comparison 
of the C-18 signals of the 13C NMR spectra with their respective signals in the 13C NMR 
spectra reported for mycalamide A [13C NMR (67.5 MHz, CDCI3 ): 6  = 66.5 ppm C-18 
mycalamide A; 8  = 66.0 ppm C-18 5.14a; 8  = 67.7 ppm C-18 5.14b). Confirmation of the 
assignment was determined after a further two steps. Bis-O-methylation of diol 5.14a 
(scheme 5.10) gave the required functionality in the C-15 side chain for 18-(7-methyl 
mycalamide B 1.5.
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5.5 Completion of Our Synthesis of 18-0-Methyl Mycalamide B (1.5)
Our strategy to construct the 2,4,7-trioxabicyclo[4.4.0]decane ring and complete our 
synthesis of 18-O-methyl mycalamide B was the same as that developed by Kocienski et al 
during a previous synthesis of 18-O-methyl mycalamide B, however our choice of protecting 
groups and reagents was altered to improve yields and efficiency. 17 Our synthetic route is 
summarised in scheme 5.11.
46
,OMe
OMe
OMe
kOMe
OMe
OMe
iPiv OH
kOMe
OMe
OMe
5.15 2.1 5.17
IPiv OTES
kOMe
OMe
OMe
IH OTES
kOMe
OMe
OMe
OTES
kOMe
OMe
OMe
5.18 5.19 5.20
IBn OTES
kOMe
Bnl
OMe
OMe
kOMe
BnOJ
6.5:1
OMe
OMe
kOMe
3:1
OMe
OMe
5.21 5.22ab 5.23
kOMe
OMe
OMe
Me MelkOMe
+
OMe
OMe
>OMe
OMe
OMe
5.24 1.71 dr = 2:1 1.57
Scheme 5.11 Reagents and conditions:
A J. PTSA, MeOH, rt, 45 min
B 99% PivCI, Pyr, CH 2CI2, rt, 4 h
C 99% TESCI, imidazole, DMF, rt, 2 h
D 98% DIBAL, CH2CI2,-7 8 ° C , 30  min
E i  Dess-Martin periodinane, CH 2CI2, rt, 40 min
F 90% a) (BnO) 3CH, CSA, CH2CI2, rt, 5 h; b) TBAF, THF, rt, 11 h
G 93% (HCHO)n, HCI(g), CH2CI2, rt, 1.5 h
H 87% H2, 5% Pd/C, EtOAc, rt, 17 h
I 74% MsCI, DMAP, NEt3, CH2CI2; TASF, TMSN 3, CH2CI2, -70->0°C , 8.5 h
J 57% H2, 5% Pd/C, THF, rt; MeO 2C-COCI, DMAP, -20°C , 15 min
1.5 18-O-Methyl mycalamide B
29.5% overall (13 steps)
The isopropylidene acetal 5.15 was hydrolysed to form the known diol 2.117 which allowed a 
comparison of analytical data; we were pleased to find our *13 and 13C NMR spectroscopic 
data for diol 2 .1  were identical to that reported in the literature17, thereby confirming all our
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previous stereochemical assignments. A standard sequence of protection and deprotection 
steps followed, returning the primary alcohol 5.19. Dess-Martin periodinane oxidation98 of 
5.19 furnished the unstable aldehyde 5.20 which was used immediately in the next step. 
Swem oxidation41 was unsuitable because traces of sulphur poisoned the palladium catalyst 
used later on during the synthesis. A two step, one pot procedure converted aldehyde 5.20 to 
dibenzyl acetal 5.21 using tribenzyl orthoformate99 and camphorsulphonic acid followed by 
the addition of TBAF. Triallyl orthoformate was used during a previous synthesis of 18-0- 
methyl mycalamide B but the allyl acetal proved problematic to remove, 17 whereas the 
benzyl group was easy to remove. The 1 ,3 -dioxane ring was installed by treatment of 5.21 
with paraformaldehyde in the presence of HCl(g) to give the benzyl acetals 5.22a,b in 93% 
yield (dr = 6.5:1, separated by column chromatography for characterisation). Hydrogenation 
of the 6.5:1 diastereomeric mixture of benzyl acetals 5.22a,b returned the hemi-acetals 5.23 
in 87% yield as a 3:1 mixture of diastereoisomers. It was at this point that our synthesis 
converged with a previous synthesis of 18-0-methyl mycalamide B . 17 Hemi-acetals 5.21 
were converted to azides 5.24 which were reduced to a sensitive mixture of aminals and 
immediately acylated with methyl oxalyl chloride in the presence of DMAP. A 1:2 mixture 
of diastereoisomers 1.57 and 1.71 were obtained in favour of the unnatural stereochemistry at 
C-10 in 57% yield over 2 steps. The oxalamides 1.57 and 1.71 were separated by column 
chromatography and their iH and 13C NMR spectra were identical to those reported in the 
literature. 17 The oxalamide 1.57 was converted to 18-0-methyl mycalamide B 1.5 in seven 
steps, as described in the literature17 .
5.6 Conclusion
On completing the synthesis of 18-0-methyl mycalamide B 1.5 we examined the route to 
determine how successful we had been in reaching our objectives set in Chapter 2. We 
thought the early part of the synthesis up to the dihydropyranone 2 .2  needed no alteration; the 
chemistry was efficient, suitable for large scale, avoided the use of column chromatography 
and the dihydropyranone 2.2 showed promise as a versatile intermediate. The next section of 
the synthesis to the diol 2 .1  was also efficient and suitable for moderate scale work, however 
the C-15 side chain functionality was introduced by this point. The synthesis would have 
been more versatile if the C-15 side chain functionality had been introduced later on, ideally 
after the left and right fragments had been coupled together. The last section of the right 
fragment synthesis of 18-0-methyl mycalamide B was similar to that which had already been 
described in the literature. We believed there were three areas of the right fragment (1.57) 
synthesis that need further attention; 1) the construction of the 2,4,7- 
trioxabicyclo[4.4.0]decane ring from diol 2.1 was a long sequence, requiring a 3 step 
protection-deprotection strategy to select a primary alcohol over a secondary alcohol for
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further elaboration; 2) the use of HCl(g) in conjunction with paraformaldehyde to form the 
1,3-dioxane ring 5.22a,b were very harsh conditions limiting other possible versatile 
functionalities in the C-15 side chain and 3) the creation of oxalamide 1.57 via azide 5.24 
gave only a 1:2 mixture of diastereoisomers in favour of the undesired oxalamide 1.71 in 
57% yield. The lack of diastereocontrol and low yield in the last two steps of the right 
fragment synthesis caused the loss of 81% of material, which was clearly unacceptable and 
should be improved.
After the above evaluation of the 18-O-methyl mycalamide B synthesis we decided to design 
a new synthesis to tackle the problems outlined above. We chose theopederin D (l.ld )  as our 
target because it had never been synthesised before and the lactone functionality in the C-15 
side chain would dominate our approach forcing us to develop a more versatile C-15 side 
chain. The route is described in chapter 6  of this thesis.
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Chapter 6 
Synthesis of Theopederin D
OMe O
£>Me
OH
Our experiences from the 18-O-methyl mycalamide (1.5) synthesis (chapter 5) caused us to 
develop a new approach to theopederin D ( l.ld ) in order to meet all our objectives set in 
Chapter 2. We also concluded that the synthesis of the early intermediate 2.2 met all of our 
objectives and therefore was a logical point to begin. In the light of the success of 
Hoffmann2 0  and Roush25 in introducing the C-10 aminal centre stereoselectively via a 
Curtius rearrangement, we decided to direct our second generation route towards an 
intermediate suitable for a Curtius rearrangement. In order to give the versatility required to 
enable us to synthesise any of the theopederins A-E l . l a - e 1, onnamide A 1.24, and 
mycalamide A 1.32 we incorporated a terminal olefin in the C-15 side chain which would 
serve as a "synthetic handle" for further elaboration. Our new approach is based on four key 
steps: 1) diastereoselective 1,4-conjugate addition of vinyl Grignard to dihydropyranone 2.2;
2 ) reaction of a methoxymethyl ether with a silyloxirane induced by phosphorous pentoxide;
3) Curtius rearrangement and trapping of the isocyanate intermediate with 
trimethylsilylethanol; 4) addition of a three carbon fragment to an aldehyde.
6.1 Introduction of the Stereogenic Centres at C-10 and C -ll
We chose to introduce a two carbon fragment at C-l 1 via a copper(I)-catalysed 1,4-addition 
of vinylmagnesium chloride to dihydropyranone 2.2, which proceeded with good 1,3- 
asymmetric control to give olefin 6.1 in 79% yield (scheme 6.1). A 15:1 mixture of 
diastereoisomers at C -ll was determined by *H NMR spectroscopic analysis by integration 
of the two doublet of doublet signals derived from C 1 2 -H2 [*H NMR, (360 MHz, CDCI3): 6  
= 2.85 and 2.81 (minor) and 2.55 and 2.67 (major) ppm]. A rationale for the good 
diastereocontrol of the 1,4-addition is the same as that given in chapter 5 for a similar 
transformation (scheme 5.1) and a stereochemical assignment of (1 IS) was made, also based
5 0
on a 1,4-addition to dihydropyranone 2.2 shown in scheme 5.1. Asymmetric dihydroxylation 
was used to convert olefin 6.1 to diol 6.2 in 75% yield employing hydroquinine 9- 
phenanthryl ether 6.4 as the chiral ligand. 100 A 13:1 mixture of diastereoisomers at C-10 was 
obtained as determined by NMR spectroscopic analysis by integration of signals derived 
from C14-Me NMR (360 MHz, CDC13): 6  = 1.28 ppm (minor) and 1.26 ppm (major)]. 
The primary alcohol of the diol 6.2 was selectively protected as its pivalate ester 6.3 which 
was highly crystalline allowing removal of all minor diastereomeric impurities by a single 
recrystallisation.
12
H2C=CHMgCI, Cul (5 mol%) 
THF, -95—»30°C, 3 h
79%, dr = 95:5 Cl
6.4 (1 mol %), K2Os0 4, 2H20  (1 mol%) 
K2C 0 3, KaFeCNe, 'BuOH, H20 ,  0°C, 3 h
75%, dr = 13:1
2.2 6.1
H
PivCI, pyr 
CH2CI2i 0°C, 1 h
Pi
78%
6.2
Cl
6.3 (mp = 69-70°C)
Cl 6 .4  Hydroquinine
9-phenanthryl ether
Scheme 6.1
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6.2 Construction of the Cis-2,4,7-trioxabicyclo[4.4.0]decane Ring
Conversion of 6.3 to epoxide 6.7 is outlined in scheme 6.2.
iMe
Piv<
TBSOTf, NEta 
CH2CI2> rt, 1.5 h
(isolated crude)
6.5 (mp = 42-43°C)
Piv(
MOMCI (3 eq), Bu4NI, (iPr)2NEt 
PhMe, 90°C, 2h
97%
Cl
6.3 (mp = 69-70°C)
IMe
Piv< •OTBS
6.6
iMe
.OTBSPiv<mCPBA, N%HP04 
CH2CI2, rt, 1 h
(isolated crude)
6.7
Scheme 6.2
The methoxymethyl ether (6.5) required for 1,3-dioxane formation was obtained as a white 
crystalline solid from the alcohol 6.3 in 97% yield (scheme 6.2). A standard transformation 
converted the ketone 6.5 to the enol silane 6.6 which was subjected to epoxidation 
conditions. Dimethyl dioxirane generated in situ58 >59 under phase transfer conditions60  (as 
used during our synthesis of 18-0-methyl mycalamide, chapter 5, scheme 5.2) gave oxirane
6.7 as a 3:1 mixture of diastereoisomers as determined by *H NMR spectroscopic analysis. 
However, mCPBA epoxidation conditions returned the same oxirane 6.7 as a single 
diastereoisomer. A rationale for the excellent stereoselectivity achieved by the epoxidation of 
enol silane 6.6 is the same as that given for the epoxidation of enol silane 1.65 in Chapter 5 
(scheme 5.3 and 5.4). Assignment of the oxirane (6.7) stereochemistry was made after the 
next step (vide infra).
During a synthesis of the trioxadecalin nucleus of mycalamide A Roush4 4  reported the 
generation of the methylene acetal in 6.9 by adding phosphorous pentoxide (P2O5 ) to a 
solution of diol 6 .8  in dimethoxymethane101 as shown in scheme 6.3.
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>TBDPS)TBDPS
P2O5, dimethoxymethane
Scheme 6.3
Adopting similar conditions (scheme 6.4), we were pleased to find that the addition of 
oxirane 6.7 to a large excess of dimethoxymethane and P2O5 at 0°C caused ring closure to 
form the 2,4,7-trioxabicyclo[4.4.0]decane ring system in 77% yield after 3 steps and *H 
NMR spectroscopic analysis showed a favourable diastereomeric ratio of 15:1 at C-12 by 
integration of signals derived from C14-Me singlets f1!! NMR (360 MHz, CDCI3): 8  = 1.32 
ppm (minor) and 1.06 ppm (major)]. A notable observation is that if the phosphorous 
pentoxide is added to a stirred solution of oxirane 6.7 and dimethoxymethane at 0°C, the 
desired 2,4,7-trioxabicyclo[4.4.0]decane ring system is formed with a lower diastereomeric 
ratio of 8:1 at C-12 in 70% yield.
iMe
.OTBSPiv<
6.7
CH2CI2, 0 °C, 2 h
77% (3 steps) 
dr = 15:1
dr= 15:1
6.10 (mp = 88-89°C)
Assignment of relative stereochemistry by 1H NMR spectroscopic analysis
Piv< Piv<
6.10a 6.10b
5 = 4.91 d 
J = 7.6 Hz
5 = 4.27 dd 
J = 10.8, 7.6 Hz
5 = 4.27 dd 
J= 10.8, 7.6 Hz
5 = 3.86 ddd 
J= 10.8, 7.2 
1.2 Hz
Scheme 6.4
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A trans-diaxial relationship between the protons of C-10 and C -ll was determined by 
examination of the C10-H and C ll-H  vicinal coupling constants (10.8 Hz) in the *H NMR 
spectra of 6.10 thus proving the relative stereochemistry at C-10 (see 6.10a scheme 6.4). 
Examination of the vicinal coupling constants between C ll-H  and C12-H (7.6 Hz) showed 
the formation of a cw-declin ring as opposed to a trans-declin ring thus proving the relative 
stereochemistry at C-12 (see 6.10a in scheme 6.4). A tentative assignment of (12S) absolute 
stereochemistry was made which was confirmed later on during our synthesis {vide infra). A 
mechanism for the P2O5 reaction is proposed in scheme 6.5
-  o_f? fl_
M e C r ' "  OMe ° —  P— O— P—  O
it f?
M eO £ ( j ) —  O—  P =  O
Me O-
AMeO— ^— O— P— 0
0•Me
M OM l
PivO
MOM*
.OTBS
PivO
(Me
PivO
O
Cl
IMe
PivO
C l
IMe
OMe
PivO
PivO
Cl
6.10
Scheme 6.5
54
6.3 Formation of the C-13 Stereogenic Centre
Stereoselective reduction of ketone 6.10 proved problematic. The best diastereoselectivity 
obtained was 1:2 in favour of the undesired diastereoisomer 6.11b using an excess of KBH4 
and CeCl3*7 H2 0  in methanol at 0°C (scheme 6 .6 ). *H NMR analysis of crude product 
showed the 1:2 ratio of diastereoisomers at C-13 by integration of signals derived from C14- 
Me [!H NMR (360 MHz, CDCI3 ): 5 = 1.14 ppm (major) and 1.05 ppm (minor)]. A wide 
range of hydride reducing agents were investigated (NaBH4 , NaH(OAc)3 , Na(CN)BH3 , 
BH3#THF, L-selectride, UAIH4 , and KBH4 ) but they gave poor selectivity as did other 
methods involving single electron transfer. Na-EtOH and S m ^P rO H  caused destruction of 
the ketone 6.10 and Mg-MeOH gave a 1:1 mixture of alcohols with concomitant reduction of 
chloride at C-18. To overcome the problem of poor selectivity and make desired material we 
separated the diols 6.11a and 6.11b by column chromatography (easily separable) and 
oxidised the undesired diol 6.11b using Dess-Martin periodinane reagent98 back to ketone 
6.10. The ketone 6.10 was then reduced again as described and the whole cycle repeated. O- 
Methylation of 6.11a returned 6.12 in 92% yield.
Dess-Martin periodinane, CH2CI2, rt, 25 min, 100%
Piv< >OH
KBH4, CeCI3*7H20  
MeOH, 0°C, 1.5 h +
95%, dr = 1:2
Cl Cl
6.11a 6.11b
Piv<
6.10 (mp = 88-89°C)
(a) KHMDS, THF, -78°C , 5 min
(b) MeOTf, -78°C , 1 h, 92%
5 = 4.21, m
Piv< kOMe
6.12
6.12 Conformational 
analysis
6 = 3.49, d 
J = 10.4 Hz
5 = 3.90, dd 
J = 10.8, 6.8  Hz
5 = 4 .1 1 ,dd 
J = 10.4, 6.8  Hz
Scheme 6.6
Examination of the *H NMR spectroscopic vicinal coupling constants between C10-H and 
C ll-H  (10.8 Hz); C ll-H  and C12-H (6 .8  Hz); C12-H and C13-H (10.4 Hz) define the 
conformation of 6.12 (scheme 6 .6 ). The C-12 and C-13 protons adopt a frarcs-diaxial
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conformation as do the CIO and C ll  protons and the C ll  and C12 protons adopt an 
equatorial-axial relationship relative to one another. The absolute stereochemistry at C-10, C- 
11 and C-12 was tentatively assigned (10/?, 11/?, 125) from previous conformational analysis 
of 6.10 thus the absolute stereochemistry of 6.12 at C-13 was tentatively assigned as (13S).
It was striking that the diastereoselectivity observed in the reduction of ketone 6.10 using 
hydride reducing agents was so poor when compared to that of a similar ketone 5.8 using 
NaBH(OAc)3  and CeCl3*7 H2 0  during our synthesis of 18-O-methyl mycalamide B (dr = 
11:1, chapter 5, scheme 5.6). Comparison of the conformers of the two ketones 6.10 and 5.8 
in scheme 6.7 offers an explanation. Ketone 5.8 adopted a conformation with the C-15 side 
chain in an axial position which allowed intramolecular equatorial delivery of the hydride via 
a chelation between the boron and the axial a-alkoxy of the isopropylidene 5.9c. However, 
we have shown (scheme 6.4, 6.10a and 6.10b) that ketone 6.10 adopted a conformation with 
the C-15 side chain in an equatorial position and it was apparent that there were no proximate 
oxygens in the dioxane ring thereby preventing intramolecular delivery of hydride. 
Therefore, the hydride attacked ketone 6.10 from the equatorial direction in the conformer 
shown in scheme 6.7, being the least hindered direction of attack, resulting in the formation 
of the unnatural stereochemistry at C-13.
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18-O-Methyl mycalamide series Theopederin D series
dr= 11:1 )
O hydnde 
reduction
5.9a,b
Cl
5.8
C-15 side chain in 
an axial postion
OAc
5.9c Intramolecular delivery 
of hydride
f dr = 2:1
,OHPiv<Piv< hydride
reduction
Cl
6.11 a, b6.10 (mp = 88-89°C)
OPiv
6.10
C-15 side chain in 
an equatorial postion
OPiv
H-
Equatorial attack of hydride
Scheme 6.7
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6.4 Completion of the Right Fragment Synthesis
Conversion of 6.12 to 6.19 is presented in scheme 6 .8 .
o -^ o
yOMePiv(
6.12
Ph2S e 2, NaBH4 
EtOH, A, 5 min
98%
c r^o
>OMe
SePh
6.13
a) N al04, MeOH, HzO 
rt, 15 min
b) NEt3, PhMe, A, 3 min 
97% (2 steps)
Piv( >OMe
6.14
NaAIH2(OCH2CH2OMe) 2 
THF, -78-»0°C, 30 min
98%
kOMe
6.15
PDC
DMF, rt, 24 h
>0Me
HOO(
6.16
(PhO)2PON3, TMSCH2CH2OH 
('Pr)2NEt, 4A MS
PhMe, 65°C, 1 h 
58%
>OMe
6.17
M e02C-C0CI (5 eq) 
DMAP (5 eq)
CH2CI2, rt, 91 h 
66%
>OMeMe<
6.18
TBAF*3HzO 
THF, 0°C, 2 min
>OMeMel
83%
6.19 (mp = 169-170°C)
Scheme 6.8
Introduction of the C-10 stereogenic centre was preceded by installation of a terminal olefin 
in the C-15 side chain as a versatile synthetic handle. Chloride 6.12 was converted to olefin 
6.14 via selenide 6.13 using conditions previously described (chapter 5, scheme 5.9) in 95% 
yield over 3 steps. Reductive cleavage of pivalate 6.14 using Red-Al occurred in excellent 
yield (98%) to give the alcohol 6.15. Reductive cleavage of pivalate 6.14 using DIBAL 
suffered from poor yields probably due to the strong chelation of the aluminium to the 5 
oxygen atoms in 6.15. Oxidation of alcohol 6.15 to the carboxylic acid 6.16 required stirring 
with pyridium dichromate in DMF at room temperature for 24 hours. The carboxylic acid
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6.16 was used to create the C-10 aminal via a Curtius rearrangement using the conditions of 
Shioiri.53  Preparation of the acyl azide by reaction of carboxylic acid 6.16 with 
diphenylphosphoryl azide followed by thermolysis in the presence of 2 - 
(trimethylsilyl)ethanol to trap the intermediate isocyanate furnished the 2 - 
(trimethylsilyl)ethyl carbamate 6.17.44  One diastereoisomer was observed by *H NMR 
spectroscopy whose stereochemistry was assigned after a further two steps. Acylation of 
carbamate 6.17 occurred cleanly albeit slowly using methyl oxalyl chloride and DMAP to 
give the A-acyl oxalamide 6.18 in 6 6 % yield. Fluoride-induced cleavage of the 2- 
(trimethylsilyl) carbamate 6.18 released oxalamide ester 6.19, the right fragment, as a white 
solid27.
The stereochemistry at C-10 was assigned as (105) by comparison of the characteristic CIO- 
PI signals in the *11 NMR spectra of 6.17 with the C10-H signals of the reported oxalamides 
1.57 and 1.71.17 The natural (105) configuration has a characteristic C-10 triplet at 6  = 5.78 
(1H, t, J = 9.7 Hz), see scheme 6.9.
Comparison of published1 H NMR data (270 MHz, CDCI3, ref 7.27 ppm) for 1.57 and 1.71 
with 1H NMR data (360 MHz, CDCI3, ref 7.27 ppm) for theopederin D intermediate 6.19
Natural configuration at C-10 Unnatural configuration at C-10 Comparison to theopederin D intermediate
,OMeMel
OMe
OMe
OMe
1.57 1.71 6.19
5 = 7.58 (1H, br d, J = 9.1 Hz, NH) 
5 = 5.71 (1H, t, J = 9.8 Hz, C10-H)
5 = 8.19 (1H, brd, J  = 9.5 Hz, NH)
8 = 5.44 (1H, dd, J= 1.7, 9.8 Hz, C10-H)
8 = 7.53 (1H, br d, J = 9.2 Hz, NH)
8 = 5.73 (1H, t, J = 9.7 Hz, C10-H)
Scheme 6.9
6.5 Construction of the A-(l-alkoxy-l-alkyl)amide Bridge and Creation of C-7 
Stereogenic Centre
Prior to our synthesis of theopederin D the coupling of the left and right fragments of the 
mycalamides had proved capricious. However, a yield of >70% was obtained three times in 
succession demonstrating the coupling reaction to be reproducible (scheme 6.10). We believe 
the drying of both 1.56 and 6.19 by azeotropic distillation from toluene and the rigorous 
drying of all glassware and needles is the key to performing the coupling reaction in >70% 
yield.
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kOMekOMeMel
B
SePh
SePh
1.56 M = Li 6.20 (mp = 144-145°C)6.19 (m p= 169-170°C)
1.72 M = SnMe3
C.D.E
OMeOMe
kOMekOMe
OBzOBz
SePhSePh
6.21a dr = 5:1 6.21b
Scheme 6.10 Reagents and conditions:
A I stannane 1.72 (3 eq), nBuLi, TH F-hexanes,-78°C , 15 min 
B 78% TMEDA, ester 6.19, THF, -78°C , 2 h 
C I S-BU3 BHU, TH F,-95°C , 15 min 
D J, CSA, MeOH-CH 2CI2, rt, 40 min 
E 91% BzCI, DMAP, ('Pr)2NEt, CH2CI2, rt
71.0 % overall yield (5 steps)
Three equivalents of vinyl stannane 1.72 were transmetallated to the lithium derivative 1.56 
with nBuLi at -78°C in THF (scheme 6.10). To the mixture was added Nfl,N',N'- 
tetramethylethylenediamine (TMEDA) followed by a THF solution of oxalamide 6.19 at 
-78°C. The acylated dihydro-2//-pyran derivative 6.20 was formed in 78% yield as a 
colourless crystalline solid. Reduction of the ketone 6.20 with LiBH(s-Bu)3 at -95°C 
followed by acid-catalysed diastereoselective addition of MeOH to the dihydropyran and 
benzoylation gave benzoates 6.21a and 6.21b. A 5:1 ratio of diastereoisomers at C-7 was 
obtained as determined by *H NMR spectroscopic analysis by integration of doublets derived 
from the OCT/aHrO signal [*H NMR (360 MHz,C6D6 , referenced to 7.16 ppm): 8  = 4.53 
(major) and 4.71 (minor)]. The two diastereoisomers were assigned (6R,1S) for 6.21a and 
(6R,1R) 6.21b (scheme 6.11) based on a comparison of the *H NMR spectroscopic C10-H 
chemical shifts of 6.21a and 6.21b with the *H NMR spectroscopic C10-H chemical shifts 
for benzoates 1.74a and 1.74b, which were previously observed during our synthesis of 18- 
O-methyl mycalamide B 1.5.
60
Comparison of published 1H NMR data (360 MHz, C6D6, ref 7.16 ppm) for benzoates 1.74a 
and 1.74b with 1H NMR data (360 MHz, C6D6, ref 7.16 ppm) for benzoates 6.21a and 6.21b
OMeOMe
,OMe,OMe
OBzOBz
SePhSePh
OMeOMe
OMeOMe
1.74a
5 = 5.93 (1H, t, J = 9.7 Hz, C10-H)
1.74b
5 = 5.97 (1H, t, J = 9.7 Hz, C10-H)
OMe OMe
,OMe,OMe
OBzOBz
SePhSePh
6 .21a
5 = 5.94 (1H, t,J = 9.7 Hz, C10-H)
6.21b
8 = 6.02 (1H, t, J =  9.7 Hz, C10-H
Scheme 6.11
The acylated dihydro-2//-pyran derivative 6.20 was crystallised and its X-ray crystal 
structure determined. The presence of the selenium atom allowed the absolute 
stereochemistry of 6 .2 0  to be defined and we were pleased to confirm that all our tentative 
stereochemical assignments were correct; (2R,3R,4S, 105,11S, 12R, 135,15R) Figure 1. Bond 
lengths and bond angles are given in appendix A of this thesis.
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6.6 Synthesis of Theopederin D (l.ld ) and 17-epi-Theopederin D (6.27)
Asymmetric dihydroxylation converted olefin 6.21a (scheme 6.12) to an approximate 1:1 
mixture of diastereomeric diols 6.22a,b, as determined by TLC, using hydroquinine 9- 
phenanthryl ether 6.4 as ligand100 and we were pleased to observe no complications from the 
selenium atom. The diols 6.22a,b were separable by TLC (hexanes :EtOAc 3:7) but for our 
purposes separation of diastereoisomers was of no consequence as the diols 6.22a,b were 
cleaved to an aldehyde function using sodium metaperiodate. During diol cleavage the 
selenide function was oxidised to its corresponding selenoxide, which on refluxing in a 
mixture of toluene and triethylamine returned the exocyclic methylene to give aldehyde 6.23 
in 69% yield.
© M e O  c r ^ ^ o
.OM e
O B z
S e P h
O H
O H
6 .22 a,b  [ d r = 1 : 1
.OM e
O B z
S e P h
6.21 a (m p  =  72-76°C )
B, C
Schem e 6.12 Reagents and conditions:
A  1 6 .4  ( 1  m o l % ), K 2 0 s 0 4 *2 H 2 0  ( 1  m ol% )
K 2 C O 3 , K 3 F e(C N )6, 'B u O H , H 2 0 ,  0°C , 3  h 
B  I  N a l0 4, M e O H -H 2 0 ,  rt. 1 h
C  69% N E t3, PhM e, A, 2  m in
69 %  overa ll y ie ld  (3 s teps)
O M e O  O ^ ^ O
.OM e
O B z
6.23 (m p =  86-87°C )
At this stage it is worth noting that the 1:1 diastereomeric mixture of diols 6.22a,b could 
have been separated by column chromatography and converted to mycalamide A 1.3 and 17- 
epi-mycalamide A 6.24 (scheme 6.13). However, owing to the lack of time and material, 
these transformations were not performed.
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1:1 Mixture of 
diols TYa,b
SePh
OH
OH OH
t
1.3 Mycalamide A
t
6.24 17-Epi-mycalamide A
Scheme 6.13
The choice of methods for introducing a suitable 3 carbon fragment to form the butyrolactone 
were severely restricted due to the acid sensitivity of the homoallylic acetal. Attempts to
However, a Grignard reagent derived from unprotected 3-chloropropan-l-ol104 added to 
aldehyde 6.23 cleanly at -78°C to furnish the 1,4-diols 6.25 (scheme 6.15). Oxidation of a 
crude mixture of diols 6.25 with TPAP105,106 gave butyrolactones 6.26a,b in 85% yield and 
^  NMR spectroscopic analysis showed a 1:1 mixture of diastereoisomers at C-17 by 
integration of C7-H singlets [iH NMR (360 MHz, C^D^, referenced to 7.16 ppm): 8  = 5.94 
and 5.84 ppm]. The diastereoisomers were separated by preparative TLC. Finally, 
methanolysis of the benzoate ester 6.26a using potassium carbonate in methanol gave 
theopederin D as determined by comparison of the ^  and 13C NMR spectra (400 MHz and 
100 MHz respectively) with published data for the natural product (Table 1 and 2)1. 17-Epi-
introduce a propionate component directly by addition of 2 -carboethoxyethylzinc102 or 
samarium reagents103 gave complex mixtures and are summarised in scheme 6.14.
Sml2, MeOH, -78-»0°C
O
OMe O
O
Scheme 6.14
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theopederin D 6.27 was prepared using the same conditions as described above (scheme 
6.15) and was clearly distinguishable by *H and 13C NMR spectroscopy.
OMe O 0 ^ 0
OMe
O Bz
6.23 (mp = 72-76°C)
C I M g ^ ^ ^ O M g C I
THF, -78°C, 2 h
OMe O
,OMe
OBz
6.25
(dr 1:1)
OH
OH
TPAP, NMO 
4A MS
MeCN, CH2CI2 
rt, 30 min 
85% (2 steps)
OMe
OMe
OBz
6.26a
OMe
OMe
OBz
dr= 1:1 6.26 b
K2C 03 
MeOH, rt, 1 h
59%
K2CO3 
MeOH, rt, 1 h 
79%
OMe O 9rO ?
OMe
OH
6.27 17-Epi-theopederin D
OMe O O ^ O
OMe
OH
1.1d Theopederin D
Scheme 6.15
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Table 1. 1H NMR Data for Synthetic and Natural Theopederin D
Synthetic Natural
Position S h J( Hz) 5 h J( Hz)
2 4.03 (dq) 6.5, 2.7 4.01 (dq) 6 .6 , 2 .8
2-Me 1 .2 0  (d) 6.5 1.18(d) 6 .6
3 2.26 (dq) 7.1, 2.7 2.24 (dq) 7.1, 2.6
3-Me
4
1 .0 1  (d) 7.1 0.98 (d) 7.1
4=CH2 4.86 (br s) __ 4.84 (t) 1.7
4.74 (br s) --- 4.73 (t) 1.7
5 2.35 (d) 14.0 2.33 (d) 13.9
f i
2 .2 1  (bd) 14.0 2.18 (d) 14.1
o
6 -OMe 3.28 (s) __ 3.28 (s) —
7 4.27 (d) 3.1 4.25 (d) 3.2
7-OH 4.08 (d) 3.1 4.11 (d) 3.2
g
9-NH 7.52 (d) 9.4 7.51 (d) 10.3
1 0 5.81 (dd) 9.4, 9.4 5.80 (dd) 9.5, 9.5
io-o c h 2o 5.13 (app d) 7.0 5.11 (app d) 7.0
4.87 (app d) 7.0 4.86 (app d) 7.0
11 3.82 (dd) 9.4, 6.4 3.80 (dd) 9.2, 6.4
1 2 4.21 (dd) 10.2, 6.4 4.19 (dd) 9.7, 6.4
13 3.44 (d) 1 0 .2 3.42 (d) 9.5
13-OMe 3.56 (s) — 3.54 (s) —
14 __ __ — —
14-Me (ax) 1 .0 2  (s) — 1 .0 0  (s) —
14-Me (eq) 0 .8 8  (s) — 0 .8 6  (s) —
15 3.42 (d) 1 0 .2 3.40 (d) 9.0
16 1.59 (dd) 14,2, 8.3 1.58 (ddd) 14.3, 8.3, 1.3
1.94 (m) — 1.92 (m) —
17 4.45 (ddd) 14.2, 8.4, 6.0 4.42 (ddd) 14.1,8.2,5.9
18 1.75 (2H, m) — 1.76 (2H, m) —
19 2.51 (ddd) 17.6, 10.0, 3.8 2.50 (m) —
2.45 (dd) 17.6,11.1 2.45 (m) —
2 0
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Table 2. 13C NMR Data for Synthetic
and Natural Theopederin D
Synthetic Natural
Position 5c 8c
2 69.4 69.6
2-Me 17.4 18.0
3 41.1 41.3
3-Me 11.5 1 2 .0
4 144.6 145.0
4=CH2 1 1 1 .0 1 1 1 .0
5 32.9 33.3
6 99.7 99.8
6 -OMe 48.2 48.5
7 71.5 71.6
8 171.7 172.3
10 73.4 73.6
10-OCH2O 86.4 86.5
11 70.0 69.5
12 73.9 74.0
13 79.2 79.5
13-OMe 61.4 61.7
14 41.1 41.1
14-Me (ax) 13.5 14.1
14-Me (eq) 23.0 23.6
15 75.8 76.0
16 34.6 35.0
17 79.1 79.2
18 27.6 28.0
19 28.1 28.7
2 0 176.7 177.5
A copy of the *H and 13C NMR spectra of synthetic theopederin D is shown in appendix C. 
A comparison of the iff NMR spectra of synthetic theopederin D with a *11 NMR spectra of 
natural theopederin D is also shown in appendix C.
6.7 Conclusion
Advanced intermediates 1.72 and 6.19 were synthesised from cheap readily available starting 
materials in 14 steps (12.7% yield) and 20 steps (4.5% yield) respectively. 1.72 and 6.19 
were coupled together and converted to theopederin D in 10 steps (37.8% yield) installing the 
butyrolactone at the last stage of the synthesis.
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Chapter 7 
Closing Remarks
The aim of the study was to synthesise theopederin D l . ld  as efficiently as possible starting 
from readily available starting materials. From the outset we planned; 1) to include a 
metallated dihydropyran approach to couple the left and right fragments together; 2 ) to 
develop an efficient, highly enantioselective, large scale route to early intermediates of the 
right fragment 6.19 and 3) to develop a new and more efficient route towards the left 
fragment 1.72,
In order to conduct the study we chose 18-0-methyl mycalamide B 1.5 as our initial target, 
for 1.5 had already been synthesised within the Kocienski group and would help expedite our 
study towards theopederin D. A synthesis of 18-O-methyl mycalamide B was completed (see 
chapter 5) encompassing all we had planned from the outset. However, after evaluating the 
new route to 18-O-methyl mycalamide B we concluded the route towards the right fragment 
was too long, the diastereocontrol at the C-10 stereogenic centre was poor and the conditions 
employed to construct the c/5,-2 ,4 ,7 -trioxabicyclo[4 .4 .0 ]decalin ring were very harsh (HC1 
gas). Thus a new route to the right fragment of theopederin D was developed using 
dimethoxymethane/P2 0 5  in conjunction with the epoxide 6.7 to construct the cis-2,4,7- 
trioxabicyclo[4.4.0]decalin ring and a Curtius rearrangement to install the stereogenic centre 
at C-10. After coupling the left and right fragments 1.72 and 6.19 using a metallated 
dihydropyran approach, the butyrolactone functionality was installed by addition of a 
Grignard reagent, derived from unprotected 3-chloropropan-l-ol, to aldehyde 6.23 followed 
by TPAP oxidation. A schematic summary of the synthetic route to theopederin D is given in 
last page of this thesis.
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Chapter 8 
Experimental
7.1 General Experim ental Details
Reactions requiring anhydrous conditions were conducted in flame-dried apparatus under a static atmosphere of 
dry argon or nitrogen. Organic extracts were evaporated at electric pump (5-10 mm Hg) or water pump (20 mm 
Hg) using a Buchi rotary evaporator.
Where appropriate, solvents and reagents were dried by standard methods, 1 0 7  i.e. by distillation from the usual 
drying agent prior to use: diethyl ether and tetrahydrofuran were distilled from Na/benzophenone and used 
fresh. Acetonitrile, pentane, pyridine, dichloromethane, AjA-dimethylformamide, toluene and triethylamine 
were distilled from CaH2  and stored over 4 A molecular sieves under nitrogen. Methanol was distilled from the 
corresponding magnesium alkoxide. Hexanes (bp 40-60°C) for chromatography was distilled before use. 
Trimethylsilyl chloride was distilled freshly before use. Iodine was sublimed at 0.5 mg Hg and stored under 
nitrogen. For best results, copper (I) iodide was extracted with THF in a soxhlet apparatus and stored in the 
dark. The Dess-Martin periodinane reagent9 8 ,1 0 8  was prepared according to the literature and stored at -20°C 
under nitrogen. Commercial organometallics were used as supplied and alkyllithium reagents were titrated 
against 1,3-diphenylacetone p-tosylhydrazone . 1 0 9
All reactions were magnetically stirred and were monitored by Thin Layer Chromatography (TLC) using 
Macherey-Nagel Diiren Alugram Sil G/UV2 5 4  pre-coated aluminium foil sheets, layer thickness 0.25 mm. 
Compounds were visualised by UV (254 nm), 20 wt% phosphomolybdic acid (PMA) in ethanol with heating, 
anisaldehyde with heating, vanallin followed by H2 SO4  with heating, potassium permanganate with heating or 
Ceric sulphate with heating. Flash chromatography was performed on Merck silica gel 60 (0.04-0.063 mm, 230- 
400 mesh) and run under low pressure . 1 1 0
Optical rotations were recorded on an Optical Activity AA-100 polarimeter. Melting points were measured on a 
Griffin electrothermal apparatus and are uncorrected. IR spectra were recorded on a Perkin Elmer 1600 series 
FTIR spectrometer as thin films supported on sodium chloride plates. Absorptions are reported as values in 
cm- l and defined as either strong (s), medium (m). Broad absorptions are designated (br). Weak absorptions 
are not reported.
Proton NMR spectra were recorded in Fourier Transform mode on a Jeol JNX-GX 270 (270 MHz), Bruker AM 
300 (300 MHz), Bruker AM 360 (360 MHz) or Bruker DPX 400 (400 MHz) spectrometer in either chloroform­
ed or benzene-^. Chemical shifts are reported in ppm relative to residual CHCI3  (8 = 7.27) or benzene (5 =
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7.16). Multiplicities are described using the following abbreviations: (s) singlet, (d) doublet, (t) triplet, (q) 
quartet, (m) multiplet, (br) broad. The nomenclature used for the assignment of individual protons within a 
given spectra was based on the theopederin D numbering shown in scheme 1.1 of this thesis. Carbon-13 NMR 
spectra were recorded on a Jeol JNX-GX-270 ( 6 8  MHz), Bruker AM 300 (75 MHz), Bruker AM 360 (90 MHz) 
or Bruker DPX 400 (100 Hz) spectrometer in either chloroform-^ (5 = 77.2) or benzene-Jg (S  = 128.7). 
Chemical shifts are reported in ppm relative to the solvent. M ultiplicities were determined using the 
Distortionless Enhancement by Phase Transfer (DEPT) spectral editing technique, with secondary pulses at 90° 
and 135°. C-H coupling is indicated by an integer 0-3 in parenthesis following the 13c chemical shift value 
denoting the number of coupled protons. Mass spectra were run on a VG 70-250-SE or JEOL MStation JMS- 
700 spectrometer. Ion mass/charge (m/i) ratios are reported as values in atomic mass units followed, in 
parentheses, by the peak intensity relative to the base peak ( 1 0 0 %) and where shown, the proposed signal 
assignment. All compounds submitted for mass spectral analysis were purified by either distillation or column 
chromatography and estimated to be at least 95% pure by NMR and thin layer chromatography.
7.1 The Synthesis o f the Right Fragm ent
Ethyl (S)-0-(terf-butyldim ethylsilyl)lactate.
%  ^ O H  ....  ,OTBS
Y  TBSCI, Et3N, DMAP, CH2CI2
C 0 2Et C 0 2E1
3.4
C5H10O3 C nH 240 3Si
Mol. Wt.: 118.13 Mol. Wt.: 232.39
A solution of TBSCI (80 g, 530 mmol), ethyl (S)-lactate 3.4 (60.8 mL, 536 mmol), triethylamine (76.8 mL, 550 
mmol) and DMAP (2.6 g, 21.2 mmol) in CH2 CI2  (400 mL) was heated at reflux for 24 h. The mixture was 
filtered through a pad of celite and washed with hexanes (2 x 100 mL). The filtrate was washed with 2M H C l^ )  
(100 mL) and water (100 mL), dried (Na2 S0 4) and concentrated in vacuo at 30°C. The residue was vacuum 
distilled (98-100°C at 15 mm Hg) to give TBS ether (122 g, 525 mmol, 99 %) as a colourless liquid .
Observed [a ] D 2 2  -30.0 (c 2.5, CHC13); lit. [a ]D -30.5 (c 2.1, CHCI3 )111.
!H and 13C NMR spectra were in agreement with that reported in the literature111
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Ethyl (S)-4-(terf-butyldimethylsilyloxy)pent-2-enoate 3.3.
.OTBS
f •OTBS a) OIBAL, CH2CI2> -78°C
C 0 2Et b) (Et0)2P(0)CH2C 0 2Et, NaH, THF
COzEt
CnH24 0 3Si 
Mol. Wt.: 232.39
3.3Ci3H26C>3Si 
Mol. Wt.: 258.43
A solution of DIBAL (neat, 46 mL, 258 mmol) in CH2 CI2  (40 mL) was added dropwise to a stirred solution of 
TBS ethyl (S)-lactate (56.6 g, 244 mmol) in CH2 CI2  (640 mL) over 15 min at a rate sufficient to maintain a 
temperature between -78°C and -70°C. The reaction mixture was stirred at -78°C for 30 min before being 
quenched with acetone ( 6  mL) followed by saturated aqueous Na2 S0 4  (20 mL) and CH2 CI2  (400 mL). The 
mixture was stirred at ambient temperature for 1 h forming a milky suspension. Solid Na2 SC>4 (217 g) was 
added and the mixture stirred for a further 1 h. The mixture was filtered through a pad of Celite and the salt cake 
was washed with CH2 CI2  (3 x 70 mL). The filtrate was concentrated on the rotary evaporator at room 
temperature to give crude aldehyde (43.8 g) as a colourless liquid which was used immediately in the next step.
Triethyl phosphonoacetate (50 mL, 250 mmol) was added dropwise to a stirred suspension of sodium hydride 
(9.84 g, 60% dispersion in oil, 246 mmol, washed three times with hexanes) in THF (400 mL) between 0°C and 
-5°C over 20 min. The mixture was stirred for 15 min to form a homogeneous solution. A solution of crude 
aldehyde in THF (10 mL) was added dropwise over 35 min keeping the reaction temperature below 10°C. The 
cooling bath was removed and the reaction mixture was stirred at ambient temperature for 40 min. Acetone (20 
mL, dried over K2 CO3 ) was added and the mixture was stirred for a further 30 min before being quenched with 
saturated aqueous NH 4 CI (200 mL). The phases were separated and the aqueous phase was extracted with 
hexanes (2 x 300 mL). The combined organic extracts were washed with water (3 x 150 mL), brine (100 mL), 
dried (Na2 SC>4 ) and concentrated. The residue was distilled under reduced pressure and the fraction boiling 
between 102°C and 108°C at 0.2 mm Hg was collected to give enoate ester 3.3 (45.2 g, 77%) as a colourless oil.
JH and 13C NMR spectra were in agreement with that reported in the literature6 5
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Ethyl (3/J,4S)-4-(terf-butyldimethylsilyIoxy)-3-inethylpentanoate 3.2.
Ester 3.2 was synthesised according to literature procedure6 4
OTBS .OTBS
MezCuLi, TMSCI, HMPA 24:1
THF, Et20 ,  -90°C
COzEt COzEt
3.3Ci3H2603Si 
Mol. Wt.: 258.43
3.2
Ci4H3o03Si 
Mol. Wt.: 274.47
MeLi»LiBr complex (1.4 M in ether, 325 mL, 455 mmol) was added to a stirred suspension of Cul (43.3 g, 
227.5 mmol) in THF (390 mL) between -10°C and 0°C over 30 min to form a cloudy grey solution. The 
mixture was cooled to -80°C  whereupon HMPA (55.3 mL, 317.6 mmol) was added over 5 min. The mixture 
was further cooled to -95°C  and a solution of enoate 3.3 (23.4 g, 95.0 mmol) and chlorotrimethylsilane (33.2 
mL, 265.4 mmol) in THF (190 mL) was added dropwise between -95°C  and -90°C  over 40 min forming a 
green mixture. The reaction mixture was stirred at -95°C  for 2 h. Saturated aqueous NH4 CI (320 mL) was 
added carefully (gas evolution!) followed by water (300 mL) and concentrated aqueous ammonia (200 mL). The 
mixture was stirred at ambient temperature for 2 h. Hexanes (500 mL) were added and the phases separated. 
The aqueous layer was extracted with hexanes (2 x 150 mL) and the combined organic extracts were washed 
with brine (200 mL), dried (Na2 S(>4 ) and concentrated. The residue was treated with EtOH (75 mL) and water 
(3 mL) and stirred at 50°C for 45 min and then concentrated. The residue was purified by short path distillation 
to give ester 3 .2  (18.6 g, 70.8 mmol, 75%) as a colourless oil: bp 66-72°C at 0.2 mm Hg. 13C NMR 
spectroscopy (CDCI3 ) revealed a 24:1 mixture of diastereoisomers according to integration of the signals at S =
71.6 (major) and 70.7 (minor).
JH and 13C NMR spectra were in agreement with that reported in the literature6 4  
Ethyl (2/?,3/?,4S)-2-allyl-4-(lerl-butyldimethylsilyIoxy)-3-inethylpentanoate 3.5.
Ester 3 .2  (24.0 g, 91.6 mmol) was added dropwise via syringe to a stirred solution of potassium 
bis(trimethylsilyl)amide (-80% , 23.3 g, 93.0 mmol) in THF (350 mL) at -78°C . The reaction mixture was 
stirred at -78°C  for 30 min and then allyl bromide (40 mL, 456 mmol) was added dropwise. The reaction 
mixture was stirred at -78°C  for 3 h, quenched with saturated aqueous NH4 CI and extracted with hexanes (2 x 
100 mL). The combined organic extracts were washed with brine (100 mL), dried (Na2 SC>4 ) and concentrated. 
The residue was purified by short path distillation to give ester 3.5 (22.2 g, 73.4 mmol, 80%) as a colourless oil:
KHMDS, Allyl Bromide
22:1
3.2
CuHsoOaSi 
Mol. Wt.: 274.47
3.5
C i7H34 0 3Si 
Mol. Wt.: 314.54
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bp 84-88°C at 0.5 mm Hg as a 22:1 mixture of diastereoisomers according to integration of the doublets at 8 = 
0.06 (minor) and 0.04 (major) as revealed in the *H NMR spectrum (CDCI3 ).
[a]D22-2.9  (c 1.5, CHCI3 ).
umax film/cm - 1  2926 (s), 1740(s), 1261 (m), 838 (s).
lH NMR (360 MHz, CDCI3 ): 5=  5.74 (1H, ddt, J =  17.0, 1 0 . 1 , 7.0 Hz, =CH), 5.05 (1H, ddt, J  = 17.1, 3.3, 1.5 
Hz, =CHa Hb ), 4.99 (1H, dddd, J = 10.2, 3.0, 2.2, 1.1 Hz, =CT/AHB), 4.21-4.04 (2H, m, OCH2), 3.68 (1H, dq, J  
= 6.2, 5.4 Hz, C2-H), 2.47 (1H, ddd, J  = 8 .8 , 7.6, 3.7 Hz, C4-H), 2.29 (2H, m, C5-H2), 1.94-1.84 (1H, m, J = 
7.0, 5.3 Hz, C3-H), 1.25 (3H, t, J = 7.1 Hz, OCU2CH3), 1.07 (3H, d, J  = 6.2 Hz, C2-Me), 0.89 (3H, d, J  = 7.0 
Hz, C3-Me), 0.886 (9H, s, lBuSi), 0.043 and 0.036 (3H each, s, Me2 Si).
,3C NMR (90 MHz, CDCI3 ): 8=  175.5 (0), 136.2 (1), 116.5 (2), 69.8 (1), 60.2 (2), 47.5 (1), 42.5 (1), 32.9 (2),
26.0 (3, 3C), 19.2 (3), 18.2 (0), 14.5 (3), 11.1 (3), -4 .2  (3), -4 .7  (3).
LRMS m/z (Cl, NH3) 315 [(M+H)+, 6 %], 332 [(M+NH4)+, 1], 275 (1.5), 202 (1.2), 110 (1.2).
HRMS (Cl mode) Found: (M+H)+, 315.2354. C 1 7 H 3 5 0 3Si requires M, 315.2355.
(2/?,3/?,4S)-2-AlIyl-4-0-(terr-butyldimethylsilyl)-3-methyl-l,4-pentandiol 3.9.
OTBS
X'  DIBAL, CH2CI2, -5°C
C 0 2Et
3.5
Ci7H3403Si 
Mol. Wt.: 314.54
A solution of DIBAL (neat, 28 mL, 156 mmol) was added dropwise to a stirred solution of ester 3.5 (21.0 g, 
66.9 mmol) in CH2 C12  (30 mL) between 5°C and 10°C over 40 min. The reaction mixture was stirred at -5°C 
for 1 h. A mixture of water (4 mL) and acetone (40 mL) was added dropwise over 45 min. keeping the 
temperature of the reaction mixture below 20°C. The clear solution became a white solid. Aqueous 2M HCl(aq) 
(230 mL) was then added over 15 min. The phases were separated and the aqueous layer was extracted with 
CH2 C12  (2 x 100 mL). The combined organic extracts were dried (M gS04) and concentrated. Kugelrohr 
distillation afforded alcohol 3.9 (16.2 g, 59.6 mmol, 89%) as a colourless oil: bp 140-145°C at 0.02 mm Hg.
[a ]D2 2 + l.l  (c 1.6, CHCI3 ).
umax film/cm - 1 3374 (br), 1261 (s), 838 (s).
3.9
C i5H32 0 2Si 
Mol. Wt.: 272.50
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!H NMR (360 MHz, CDC13): 8=  5.84 (1H, dddd, 7 = 17.1, 10.1, 7.8, 5.8 Hz, =CH), 5.06 (1H, dm, 7 =  17.1 Hz, 
=CHa / / b ), 5.01 (1H, dm, 7 = 10.0 Hz, = C //AHB), 3.78 (1H, dq, 7 = 6.2 Hz, C2-H), 3.68 (1H, dd, 7 = 11.0, 4.4 
Hz, CHa / /bOH), 3.49 (1H, dd, 7 =  11.0, 6.3 Hz, C tfAHBOH), 2.30-2.10 (1H, m), 1.95-1.50 (4H, m), 1.16 (3H, 
d, 7 = 6.2 Hz, C2-Me), 0.90 (9H, s, lBuSi), 0.85 (3H, d, 7 = 7.0 Hz, C3-Me), 0.08 and 0.06 (3H each, s, Me2 Si).
13C NMR (90 MHz, CDCI3 ): 8=  138.3 (1), 116.1 (2), 71.0 (1), 64.1 (2), 41.1 (1), 40.8 (1), 32.6 (2), 26.1 (3, 
3C), 21.5 (3), 18.2 (0), 12.5 (3), -4 .0  (3), -4 .7  (3).
LRMS m/z (Cl, NH3) 273 [(M+H)+, 100%], 290 [(M+NH4)+, 50]
HRMS (Cl mode) Found: (M+H)+, 273.2247. C 15H3 3 0 2Si requires M, 273.2250
(2/?,3/?,4S)-2-Allyl-4-0-(terf-butyldim ethyIsilyl)-3-m ethyl-l-0-triphenylm ethyl-l,4-pentandiol 3.10.
.OTBS.OTBS
TrCI, Et3N, DMAP
OH OTr
3.9 3.10
C is H 3 2 0 2 S i  C 3 4 H 4 e 0 2 S i
Mol. Wt.: 272.50 Mol. Wt.: 514.81
A solution of alcohol 3.9 (15.0 g, 55.0 mmol), trityl chloride (17.3 g, 62.0 mmol), triethylamine (22 mL, 157 
mmol) and DMAP (610 mg, 5.0 mmol) was stirred at room temperature for 12 h. The mixture was then poured 
onto aqueous saturated NaHCC>3 and extracted with CH2 C12  (3 x 100 mL) and concentrated. The oily residue 
was dissolved in Et20  (100 mL) treated with hexanes (200 mL) and washed with water (500 mL). The organic 
layer was dried (Na2 S 0 4) and concentrated. The residue was filtered through a pad of silica gel (75 g, 
hexanes:Et20  5%) to give trityl ether 3.10  (26.6 g, 51.7 mmol, 94%) as a colourless oil : [a ]p 2 2  +9-8 (c 1.0, 
CHC13).
umax film/cm - 1  2935 (m), 1452 (m), 829 (s).
]H NMR (360 MHz, CDCI3 ): 8=  7.50-7.15 (15H, m), 5.65 (1H, dddd, 7 =  17.1, 10.1, 7.8, 5.8 Hz, =CH), 4.95- 
4.82 (2H, m, =CH2), 3.73 (1H, dq, 7 = 6.2 Hz, C2-H), 3.10 (1H, dd, J = 9.2, 4.8 Hz, CHa/7bO), 2.90 (1H, dd, 7 
= 9.0, 7.6 Hz, C/7a HbO), 2.30-2.20 (1H, m), 2.13-2.03 (1H, m), 1.89-1.76 (2H, m), 1.09 (3H, d, J=  6.1 Hz, C2- 
Me), 0.91 (9H, s, lBuSi), 0.72 (3H, d, 7 = 7.1 Hz, C3-Me), 0.04 and 0.02 (3H each, s, Me2 Si).
13C NMR (90 MHz, CDC13): 8=  144.7 (0, 2C), 144.7 (0), 137.9 (1), 129.0 (1, 3C), 128.8 (1, 2C), 127.9 (1, 3C),
127.8 (1, 2C), 127.0 (1, 3C), 126.9 (1, 2C), 115.6 (2), 8 6 . 6  (0), 70.6 (1), 64.6 (2), 41.0 (1), 38.8 (1), 31.8 (2),
26.1 (3, 3C), 21.0 (3), 18.2 (0), 11.2 (3), -3 .8  (3), -4 .7  (3).
LRMS m/z (Cl, NH3) 532 [(M+NH4)+, 7%], 243 (100).
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HRMS (Cl mode) Found: (M+NH4)+, 532.3610. C3 4 H5o0 2NSi requires M, 532.3611.
(2/?,3/?,4S)-2-Allyl-3-m ethyI-l-0-triphenyIm ethyI-l,4-pentandiol 3.11.
.OH.OTBS
TBAF, THF, A
OTrOTr
3.113.10
C 3 4 H 4 6 0 2 S i C 2 8 H 3 2 O 2
Mol. Wt.: 514.81 Mol. Wt.: 400.55
A solution of TBS ether 3.10 (53.6 g, 104.0 mmol) and TBAF trihydrate (53.0 g, 168.0 mmol) in THF (200 mL) 
was stirred at reflux for 5 h. After cooling to room temperature, the mixture was poured onto water (1 L) and 
extracted with Et20  (3 x 150 mL). The combined organic extracts were dried (Na2 S 0 4) and concentrated to 
give crude alcohol 3.11 (40.4 g, 100.9 mmol, 97%) as a colourless oil which was immediately used in the next 
step. For analysis a sample purified by column chromatography (S i02, haxanes:Et20  5-10%) gave: [oc]^22 
+12.3 (c 1.6, CHCI3 ).
umax film/cm - 1  3409 (br), 1449 (s), 706 (s).
lH NMR (360 MHz, CDCI3 ): 8= 7.50-7.15 (15H, m), 5.71 (1H, ddt, 7 = 17.1, 10.1, 7.2 Hz, =CH), 4.96 (1H, 
dm, 7 = 17.2 Hz, =CHA/ / B ), 4.91 (1H, dm, 7 =  10.1 Hz, =C//AHB), 3.61 (1H, quintet, 7 = 6.7 Hz, C2-H), 3.15 
(1H, dd, 7 = 9.3, 4.8 Hz, CHAtfB0 ), 3.00 (1H, dd, 7 = 9.3, 7.1 Hz, C //a HbO), 2.30-2.28 (1H, m), 2.10-1.87 
(2H, m), 1.78 (1H, ddq, 7 =  7.1, 4.1 Hz, C3-H), 1.68 (1H, br, OH), 1.11 (3H, d, 7 =  6.2 Hz, C2-Me), 0.67 (3H, 
d, 7 = 7.0 Hz, C3-Me).
l3C NMR (90 MHz, CDCI3 ): 8=  144.4 (0, 3C), 137.9 (1), 128.8 (1, 4C), 127.8 (1, 8 C), 126.9 (1, 3C), 115.8 (2),
86.7 (0), 69.6 (1), 64.3 (2), 41.1 (1), 39.4 (1), 32.0 (2), 21.0 (3), 11.6 (3).
LRMS m/z (Cl, NH3) 418 [(M+NH4)+, 0.4%], 243 (32).
Microanalysis: Anal. Calcd for C2 8 H 3 2 0 2: C, 84.00; H, 8.00. Found: C, 84.07; H, 8.00.
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(2R,3R,4R)-2-Allyl-4-0-(4-chlorobenzoyI)-3-methyl-l-0-triphenylmethyl-l,4-pentanediol 3.1.
—  .OH
J  ^  p-C IC e^C O ^, Ph3P, DIAD
THF, 0°C
OTr
3.11
C28H32O2 
Mol. Wt.: 400.55
A solution of DIAD (16.05 mL, 81.5 mmol) in THF (10 mL) was added dropwise to a stirred solution of crude 
alcohol 3.11 (18.5 g, 46.3 mmol) as prepared in the previous step, triphenylphosphine ( 21.4 g, 81.6 mmol) and 
p-chlorobenzoic acid (12.8 g, 81.7 mmol) in THF (150 mL). During addition the temperature was maintained 
between -7°C  and 0°C. The reaction mixture was stirred for 3 h between — 10°C and 0°C. Water (1 mL) was 
added and the mixture was stirred at ambient temperature for 15 min then concentrated. The residual oil was 
treated with Et2 0  (50 mL) and hexanes (100 mL) were added dropwise to cause formation of white crystals. 
The crystals were filtered off and washed with hexanes (3 x 50 mL). The filtrate was extracted with 2M 
NaOH(aq) (2 x 30 mL), water (50 mL) and brine (50 mL), dried (Na2 SC>4 ) and concentrated. The residue was 
purified by column chromatography (SiC> 2 150 g, hexanesrether 0 -4 %) to give ester 3.1 (19.0 g, 35.2 mmol, 
76%) as a colourless oil which solidified on standing in the refrigerator to give a white solid: mp 102-102.5 °C 
(MeOH:H2 0 ).
[a]D22 -25.7 (c 1.25, CHC13).
vmax film/cm - 1 2972 (m), 1719 (s), 1273 (s), 762 (s).
*H NMR (360 MHz, CDCI3 ): 8=  7.91 (2H, dm, J  = 8 . 6  Hz), 7.50-7.35 (7H, m), 7.30-7.15 (10H, m), 5.63 (1H, 
ddt, J  = 17.1, 10.1, 7.0 Hz, =CH), 5.09 (1H, dq 7 =  6.3 Hz, C2-H), 4.92 (1H, dm, 7 = 17.1 Hz, =CHA/ / B), 4.90 
(1H, dm, 7 =  10.1 Hz, =CHAHB), 3.11 (1H, 4 lines of ABX system, /  = 9.4, 7.2 Hz, CHaH bO), 3.08 (1H, 4 
lines of ABX system, 7 = 9.4, 5.7 Hz, C //a HbO), 2.25-2.12 (1H, m), 2.10-1.95 (2H, m), 1.90-1.80 (1H, m),
1.32 (3H, d, 7 =  6.3 Hz, C2-Me), 0.92 (3H, d, 7=  7.0 Hz, C3-Me).
13C NMR (90 MHz, CDCI3 ): <5= 165.2 (0), 144.4 (0, 3C), 139.3 (0), 137.1 (1), 131.1 (1, 2C), 129.9 (0, 3C),
128.9 (1, 3C), 128.8 (1, 3C), 127.9 (1, 6 C), 127.0 (1, 3C), 116.3 (2), 86.7 (0), 73.8 (1), 63.6 (2), 41.0 (1), 38.1 
(1), 32.2 (2), 18.7 (3), 11.1(3).
LRMS m/z (Cl, NH3) 556 [(M+NR0+, 0.24], 539 [(M+H)+, 0.01%], 316 (4), 263 (2), 243 (100).
Microanalysis: Anal. Calcd for C 3 5 H 3 5 C1 0 3: C, 77.99; H, 6.49. Found: C, 77.92; H, 6.60.
OTr
3.1
C35H35CIO3 
Mol. Wt.: 539.10
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(3R,4/?,5/?)-5-(4-Chlorobenzoyloxy)-4-methyl-3-(triphenyImethoxymethyl) hexanoic acid 3.13.
Cleavage of an olefin and oxidation to a carboxylic acid is described in the literature .
ci
ecu, MeCN, H20
OTr OTr
3.133.1
C35H35CIO3 C34H33CIO5
Mol. Wt.: 539.10 Mol. Wt.: 557.08
Sodium metaperiodate (11.1 g, 51.9 mmol) was added to a stirred mixture of olefin 3.1 (6.4 g, 11-9 mmol), CCI4  
(60 mL), acetonitrile (60 mL) and water (50 mL). After 15 min R u C ^ ^ ^ O  (190 mg, 0.75 mmol) was added 
and the reaction mixture was stirred vigorously for 5 h. The mixture was poured onto water (300 mL) the 
organic layer removed and the aqueous phase extracted with CH2 CI2  (3 x 50 mL). The combined organic 
extracts were dried (MgS0 4 ) and concentrated. The residue was purified by column chromatography (Si0 2  100 
g, hexanes:Et2 0  20-40%) to give acid 3.13 (3.47 g, 6.25 mmol, 53%) as a white foam: mp 55-58°C.
[a]d 2 2  -44.4 (c 0.9, CHCI3).
vmax KBr/cm" 1 3422 (br), 1716 (s), 1273 (s).
]H NMR (360 MHz, CDCI3 ): 5 =  7.87 (2H, dm, J  = 7.2 Hz), 7.48-7.5 (7H, m), 7.32-7.15 (10H, m), 5.09 (1H, 
dq, J  = 6.0, 0.9 Hz, C2-H), 3.24 (1H, dm, J  = 4.4 Hz), 3.09 (1H, dm, J  = 6.2 Hz), 2.49-2.32 (3H, m), 2.04-1.94 
(1H, m), 1.33 (3H, d , J  = 6.3 Hz, C2-Me), 0.94 (3H, d, J  = 7.0 Hz, C3-Me).
13C NMR (50 MHz, CDCI3 ): 8 = 179.5 (0), 165.1 (0), 144.1 (0, 3C), 139.4 (0), 131.1 (1, 3C), 129.2 (0), 128.8 
(1, 3C), 128.8 (1, 3C), 128.8 (1, 3C), 127.9 (1, 5C), 127.1 (1, 2C), 86.9 (0), 73.2 (1), 64.3 (2), 38.4 (1), 37.9 (1), 
33.8(2), 18.4 (3), 11.3 (3).
LRMS m/z (EI+) 556 [(M+H)+, 0.03%], 479 (0.15), 400 (3), 324 (7), 243 (100), 165 (46), 139 (70).
HRMS (FAB mode) Found: (M+Na)+, 579.1913. C3 4 H3 3 0 5 ClNa requires M, 579.1914.
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(4/?)-4-[(lR,2R)-2-(4-Chlorobenzoyloxy)-l-methylpropyll-dihydrofuran-2(3//)-one 3.14.
■Cl ci
PTSA, MeOH, rt
OTr O
3.13
C34H33CIO5 
Mol. Wt.: 557.08
3.14
C15H17CIO4 
Mol. Wt.: 296.75
A solution of acid 3.13 (3.47 g, 6.25 mmol) and p-toluenesulfonic acid (160 mg, 0.84 mmol) in MeOH (60 mL) 
was stirred at room temperature for 3 h before being concentrated. The residue was purified by column 
chromatography (Si0 2  30 g, hexanes:Et2 0  10-50%) to give lactone 3.14 (1.32 g, 4.45 mmol, 71%) as a white 
solid. All minor diastereomeric impurities were removed by recrystallisation from hexanes:Et2 0  to give pure 
lactone 3.14 (1.08g, 3.63 mmol, 58%) as colourless rock crystals: mp 69.5-70°C (hexanes:Et2 0 ).
[cc]d22-0.4  (c 1.9, CHCI3 ).
umax film/cm- 1  = 1785 (s), 1716 (s), 1595 (m), 1275 (s).
lH NMR (360 MHz, CDC13): 8=  7.93 (2H, dd, 7 = 6.7, 2.0 Hz), 7.43 (2H, dd, 7 = 6 .8 , 2.0 Hz), 5.17 (1H, dq 7 = 
6.5, 2.7 Hz, C2-H), 4.55 (1H, dd, 7  = 9.0, 8.1 Hz, CHa / /bO), 4.03 (1H, t, 7 = 9.1 Hz, C //a HbO), 2.67-2.52 (2H, 
m), 2.33-2.21 (1H, m), 1.90-1.80 (1H, m), 1.34 (3H, d, 7 = 6.5 Hz, C2-Me), 1.10 (3H, d, 7 =  6.9 Hz, C3-Me).
13C NMR (90 MHz, CDCI3 ): 8 = 176.4 (0), 165.0 (0), 139.7 (0), 130.9 (1, 2C), 128.9 (1, 2C), 128.6 (0), 72.6
(1), 72.4 (2), 41.0 (1), 38.5 (1), 33.0 (2), 16.7 (3), 13.0 (3).
LRMS m/z (CI, /sobutane) 297 [(M+H)+, 5%], 265 (1.7), 139 (100), 111 (20), 82 (12).
Microanalysis: Anal. Calcd for C i5 H 1 7C104: C, 60.71; H, 5.73. Found: C, 60.84; H, 5.74.
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(3S,4/?,5/?)-5-(4-Chlorobenzoyloxy)-4-methyl-3-(phenylseIenylmethyl) hexanoic acid 3.15.
Alkoxy bond cleavage of six membered lactones using Ph2 Se2 , NaBIfy and 18-crown-6 is described in the 
literature74.
3.14
SePh
3.15
Ph2S e 2, NaBH4 
EtOH, A
C15H 17CI04 C2i H23CI04Se
Mol. Wt.: 296.75 Mol. Wt.: 453.82
Sodium borohydride (348 mg) was added in several portions to a stirred yellow suspension of diphenyl
diselenide (1.6 g, 5.15 mmol) in anhydrous EtOH (5.8 mL) to cause exothermic reaction and gas evolution.
Lactone 3.14  (991 mg, 3.34 mmol) was then added to the pale yellow homogeneous solution of sodium 
phenylselenide. The resulting mixture was stirred at reflux for 11 h. After cooling to room temperature the 
reaction mixture was diluted with Et2 0  ( 8  mL) and treated with 2M HCl(aq) (5 mL). The layers were separated 
and the aqueous phase was extracted with Et2 0  (3 x 20 mL). The combined organic extracts were washed with 
diluted aqueous NaHC0 3  (2 x 1 0  mL), dried (MgSC>4 ) and concentrated. The residue was purified by column 
chromatography (S i0 2  20 g, hexanes:Et2 0  10-30%) to give acid 3.15 (1.33 g, 2.93 mmol, 8 8 %) as a yellow oil.
[a ]D2 2 -3.5 (c 1.5, CHC13).
vmax film/cm - 1  1719 (s), 1595 (s), 1281 (s), 1100 (s).
NMR (360 MHz, CDC13): 8=  7.97-7.90 (2H, dm, J  = 8.5), 7.50-7.45 (2H, m), 7.44-7.38 (2H, dm, J  = 8.5), 
7.23-7.16 (3H, m), 5.18 (1H, quintet, J = 6.2, Hz, C2-H), 3.06 (1H, dd, J  = 5.8, 3.0 Hz, C-5 HA/ / B), 3.02 (1H, 
dd, J  = 5.6, 3.0 Hz, C-5HAH B), 2.61 (1H, dd, J  = 11.5, 4.9 Hz, CHAHBSe), 2.48 (1H, dd, J  = 16.4, 8.0 Hz, 
CHA//BSe), 2.34-2.24 (1H, m, C4-H), 2.15-2.05 (1H, m, ,C3-H), 1.28 (3H, d, J=  6.3 Hz, C2-Me),1.01 (3H, d, J  
= 7.0 Hz, C3-Me).
13C NMR (90 MHz, CDC13): 8=  179.2 (0), 165.3 (0), 139.5 (0), 133.0 (1), 131.1 (1, 2C), 129.8 (0), 129.2 (1, 
2C), 129.0 (0), 128.8 (1, 2C), 127.2 (1, 2C), 73.2 (1), 40.0 (1), 37.2 (1), 35.5 (2), 31.5 (2), 18.5 (3), 10.8 (3).
LRMS m/z (EI+) 454 [(M+H)+, 8 %], 298 (24), 156 (45), 139 (100), 111 (29).
Microanalysis: Anal. Calcd for C2 ]H2 3ClC>4 Se: C, 55.56; H, 5.07. Found: C, 55.53; H, 5.23.
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(2/?,3/?,4/?)-5,6-DimethyI-4-phenylseIenylmethyl-tetrahydro-2//-pyran-2-one 3.17.
The reduction of an ester using an 'ate' complex is described in the literature . 7 5 ,1 1 2
SePh
3.15C2iH23CI04Se 
Mol. Wt.: 453.82
a) nBuLi, DIBAL 
THF, -7 8 —>0 °C
b) HCIaq, Et20 ,  rt
SePh
3.17
C14H isC^Se 
Mol. Wt.: 297.25
nBuLi (2.32 M in hexanes, 3.75 mL, 8.7 mmol) was added dropwise to a solution of DIBAL (neat, 1.55 mL, 8.7 
mmol) in CH2 CI2  (16 mL) at -5°C. THF (32 mL) was then added. The mixture was cooled to -78°C and ester 
3.15 (1.31 g, 2.90 mmol) in THF (24 mL + 8  mL) was added via cannula. The mixture was left to warm to 
-20°C over 2 min. and stirred at -20°C for 3 h. The mixture was then treated with 2M HCl(aq) (50 mL, 30 eq), 
and Et2 0  (50 mL) and stirred vigorously for 24 h. The organic layer was removed and the aqueous phase 
extracted with Et2 0  (2 x 40 mL). The combined organic extracts were dried (MgSO,*) and concentrated. The 
residue was purified by column chromatography (SiC>2 40 g, hexanes:ether 10-30%) to give lactone 3.17 (619 
mg, 2.08 mmol, 72%) as a clear colourless oil.
]H and 13C NMR spectra were in agreement with that reported in the literature3 6
(2/?3/?,4/?)-3,4-Dihydro-2,3-dim ethyl-4-phenylselenylm ethyl-6-trim ethylstannyl-2//-pyran 1.72.
SePh
3.17
C14H i 80 2 S e  
Mol. Wt.: 297.25
XTa) KHMDS, HMPA, THFb) PhN(Tf)z
C) Me6Sn2, LiCI, Pd[Ph3P]4. THF I
SePh
1.72Ci7H260SeSn 
Mol. Wt.: 444.06
As previously reported in the literature with 70% yield3 6
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7.2 The Synthesis of 18-0-M ethyl Mycalamide B.
Ethyl -6-chIoro-3-carbonyl-2,2-dimethyIhexanoate 4.3.
4.1 4.3
C6H12O 2 C10H i7CIO3
Mol. Wt.: 116.16 Mol. Wt.: 220.69
"BuLi (2.5 M in THF, 120 mL, 0.30 moles) was added dropwise to a solution of diisopropylamine (42.0 mL, 
0.30 moles) in THF (100 mL) at 0°C over 15 min. After 1 h at 0°C the mixture was cooled to -78°C to which a 
solution of ethyl isobutyrate 4.1 (40.1 mL, 0.30 moles) in THF (100 mL) was added over 30 min keeping the 
temperature of the reaction mixture below -70°C. After 1 h a solution of 4-chlorobutyryl chloride 4.2 (33.6 mL, 
0.30 moles) in THF (50 mL) was added over 20 min keeping the temperature of the reaction mixture below 
- 6 8 °C. The mixture was left to stir for 1 h at -78°C before the reaction was quenched by the addition of 
aqueous saturated NH4 CI (200 mL). The organic phase was removed and washed successively with H 2 O (3 x 
200 mL) and brine before being dried (MgSCXO and concentrated. The orange residue was filtered through a pad 
of silica eluting with hexanes:Et2 0  (5:1), concentrated and purified by short path distillation (ob 110°C, head 
78-84°C at 0.1 mm Hg) to return (3-keto ester 4.3 (61.6 g, 280 mmol, 93%) as a pale yellow oil.
vmax film/cm- 1  1714 (s).
*H NMR (300 MHz, CDCI3 ): 8 = 4.19 (2H, q, J  = 7.1 Hz, CH3CH20),  3.56 (2H, t, J  = 6.0 Hz, C18-H2), 2.66 
(2H, t, J =  6 . 8  Hz, C16-H2), 2.06 (2H, dt, /  = 6 .6 , 6 . 8  Hz, C17-H2), 1.37 (6 H, s, C14-Me2), 1.26 (3H, t, J = 7.1 
Hz, C //3 CH2 O).
13C NMR (67.5 MHz, CDCI3 ): 8=  207.3 (0), 173.7 (0), 61.6 (2), 55.7 (0), 44.4 (2), 34.8 (2), 26.7 (2), 22.0 (3, 
2C), 14.2 (3).
LRMS m/z (CI) 221 [(M+H)+, 100%], 185 (45).
HRMS (CI) Found: (M+H)+, 221.0946. C 1 0H 1 8ClO3 requires M, 221.0944.
8 0
(S)-AK4-Methylbenzenesulfonyl)valine 4.9.
V cp-TosCI, NaOH |
T n h 2 d . . .  a* PhMe, A T  |I Tos
4.8 4.9
C5H11NO2 C i2H17N0 4S
Mol. Wt.: 117.15 Mol. Wt.: 271.33
4.9 Was synthesised according to literature procedure1 1 3  in 72% yield. 
Observed mp 147-148°C; literature mp 147°C114.
l-Ethoxy-2-m ethyl-l-(trim ethylsilyloxy)-l-propene 4.6.
Enol silane 4.6 was synthesised according to literature procedure115.
a) LDA, THF, 0°C v   P Et
b) Me3SiCI, 0°C /  'OTMS
4.6
CgH2o 0 2Si 
Mol. Wt.: 188.34
nBuLi (2.37 M in hexanes, 192 mL, 455 mmol) was added to a mechanically stirred solution of 
diisopropylamine (67 mL, 473 mmol) in THF (350 mL) at 0°C over 30 min. After stirring at 0°C for 20 min 
ethyl isobutyrate (60 mL, 450 mmol) was added over 10 min maintaining a temperature of 0°C. After a further 
30 min chlorotrimethylsilane (140 mL) was added at 0°C over 15 min. After 10 min the cooling bath was 
removed and the reaction mixture was stirred at room temperature for 1 h. After such time the mixture was 
filtered (under N2 ) and concentrated in vacuo using a 50 cm Vigreux distillation column. The residue was 
filtered again (under N 2 ) and purified by short path distillation to give enol silane 4.6 (81 g, 430 mmol, 95%) as 
a clear colourless oil: bp 80-90°C at 10.0 mm Hg.
]H NMR spectroscopic data was in agreement with literature1 15
4.1CeHi202 
Mol. Wt.: 116.16
4-Chlorobutanal 4.7.
The TEMPO oxidation was performed according to a literature procedure
TEMPO, KBr 
NaOCUq, NaHCOs
116
CH2CI2, H20 , 0°C 4 7
C4H9CIO C4H7CIO
Mol. Wt.: 108.57 Mol. Wt.: 106.55
A mixture of 4-chlorobutanol (50 mL, 475-450 mmol), TEMPO (780 mg, 5 mmol), CH 2 CI2  (170 mL) and a 
solution of KBr ( 6  g, 50 mmol) in water (25 mL) was vigorously stirred and cooled to -10°C. A pre-cooled 
solution of sodium hypochlorite (272 mL, 13%), NaHC0 3  (9.34 g) and water (280 mL) was added over 20 min
8 1
keeping the temperature of the reaction mixture between 5°C and 10°C. The reaction mixture was stirred for 15 
min and then the phases were separated. The aqueous phase was extracted with CH2 CI2  (50 mL) and the 
combined organic extracts were washed successively with 2M HCl(aq) (100 mL) containing KI (3 g), 10% 
aqueous Na2 S2 C>3 (100 mL) and 5% aqueous NaHC 0 3 . The organic phase was dried (Na2 SC>4 ) and 
concentrated in vacuo at room temperature. The residue was purified by short path distillation to give aldehyde
4.7 (34.2 g, 318-321.0 mmol, 67-71%) as a clear colourless oil: bp 62-65°C at 10.0 mm Hg.
JH NMR spectroscopic data was in agreement with literature1 17
Ethyl (R)-6-chloro-3-hydroxy-2,2-dim ethylhexanoate 4.4.
M ethod 1: Reduction o f (3-keto ester 4.3.
0 1
The enantioselective reduction of (3-keto esters without the gem-dimethyl group is described in the literature
[(R)-BINAP][p-cymene]RuCI2
H2, (120 psi), HCI, MeOH
4.3 4.4
C10H17CIO3 C10H19CIO3
Mol. Wt.: 220.69 Mol. Wt.: 222.71
A Parr high pressure hydrogenator was charged with a solution of the |3—ketoester 4.3 (11.0 g, 50.0 mmol) in 
methanol (100 mL). Methanolic HCI (2M, 0.1 mL) was added followed by [(R)-BINAP][p-cymene]RuCl2  (0.2 
mol %, 93 mg). The apparatus was evacuated and filled with hydrogen three times and the mixture allowed to 
stir at 120 psi and 40°C for three days under an atmosphere of hydrogen. After such time the mixture was 
concentrated in vacuo and the residue purified by filtration through a pad of silica (30 g) eluting with 
hexanes:Et2 0  (5:1). Hydroxy ester 4.4 (10.4 g, 46.7 mmol, 93%) was obtained as a pale yellow oil. !H NMR 
integration of the C 14-Me singlets from the derived (/?)-MTPA ester determined enantiomeric ratio of hydroxy 
ester as 97:3 [(270 MHz, CgD6 , referenced to 7.16 ppm): S=  1.16 (major), 1 . 1 1  (minor)].
Method 2: M ukiyam a Directed Aldol Reaction
V OTMS 
/  OEt
4.6
C9H2o02Si 
Mol. Wt.: 188.34
Cl
4.7
C4H7CIO 
Mol. Wt.: 106.55
BH
TOS
Cl
4.4
C10H19CIO3 
Mol. Wt.: 222.71
A solution ofB H 3«THF complex (1 M in THF, 10 mL, 10 mmol) was added dropwise to a stirred suspension of 
(^-A-tosylvaline 4.9 (2.71 g, 10 mmol) in CH2 CI2  (50 mL) at room temperature over 25 min. After 10 min the
8 2
reaction mixture was cooled to -78°C and aldehyde 4.7 (1.06 g, 10 mmol) was added followed by silyl ketene 
acetal 4.6 (2.03 g, 10.8 mmol). After 1.5 h at -78°C the reaction mixture was quenched with saturated aqueous 
NaHCC>3 , diluted with hexanes (100 mL) and washed with water (3 x 50 mL). The combined organic extracts
were dried (Na2 S 0 4 ) and concentrated. The residue was purified by column chromatography (SiC>2 30 g,
hexanes:AcOEt 0-20%) to give hydroxy ester 4 .4  (1.74 g, 7.8 mmol, 78%) as a colourless oil. NMR 
integration of the C 14-Me singlets from the derived (/?)-MTPA ester determined enantiomeric ratio of hydroxy 
ester as 97:3 [(270 MHz, CgDg, referenced to 7.16 ppm): 8 = 1.16 (major), 1.11 (minor)].
[a]D27+18.7 (c 0.9, CHCI3 ).
vmax film/cm- 1  3490 (br), 1718 (s).
lH NMR (360 MHz, CDC13): 8=  4.13 (2H, q, J  = 7.1 Hz, CH3 C//2 0), 3.64-3.50 (3H, m, C15-H and C18-H2), 
2.75 (1H, br s, OH), 2.15-2.00 (1H, m, C17-H), 1.82 (1H, ddq, J  = 14.5, 9.2, 6.2 Hz, C17-H), 1.65 (1H, dddd, J  
= 13.5, 9.3, 6.0, 1.9 Hz, C16-HA/ / B), 1.35 (1H, dddd, / =  13.9, 10.8, 9.3, 4.8 Hz, C \6-H AUB), 1.24 (3H, t, J  =
7.1 Hz, C //3 CH2 O), 1.17 (3H, s, C 14-Me), 1.15 (3H, s, C14-Me).
13C NMR (90 MHz, CDCI3 ): 8=  177.8 (0), 76.1 (1), 60.9 (2), 47.1 (0), 45.2 (2), 29.8 (2), 28.9 (2), 22.4 (3),
20.4 (3), 14.2 (3).
LRMS m/z (CI, NH3) 223 [(M+H)+, 100%], 205 (25), 187 (45), 116 (20).
Microanalysis: Anal. Calcd for C 10H 1 9O3 CI: C, 53.93; H, 8.54. Found: C, 53.67; H, 8.29.
Ethyl (R)-3-acetoxy-6-chloro-2,2-dim ethylhexanoate 4.11.
An ice cold solution of the (3-hydroxyester 4.4 (20.7 g, 93. 0 mmol) in CH2 CI2  (160 mL) was treated with 
triethylamine (11.3 g, 15.6 mL, 112.0 mmol), acetic anhydride (11.4 g, 10.5 mL, 112.0 mmol) and DMAP (40 
mg). After 5 min the ice bath was removed and the mixture was left to warm up to room temperature. After 
stirring overnight at room temperature the mixture was diluted with hexanes (400 mL), washed with water (3 x 
100 mL), brine (50 mL), dried (MgS0 4 ) and concentrated in vacuo. The residue was purified by short path 
vacuum distillation to give the acetate ester 4.11 (20.1 g, 76.0 mmol, 82%) as a pale yellow oil: bp 86-92°C at 
0.1 mm Hg.
Ac20 ,  EtgN, DMAP
CH2CI2, 0°C
4.4
C10H19CIO3 
Mol. Wt.: 222.71
4.11
C12H21CIO4 
Mol. Wt.: 264.75
8 3
Aldol reaction followed bv acetate formation.
H/ niOEt)TMS + Cl CH2CI2, —78°C}Tos,BH Ac Cl
4.6 4.7
C4 H7CIO 
Mol. Wt.: 106.55
b) Ac20 ,  EfeN, DMAP 
CH2CI2, 0°C 4.11C12H21CIO4 
Mol. Wt.: 264.75
C 9 H2o 0 2Si 
Mol. Wt.: 188.34
A solution of BH 3 *THF complex (1 M in THF, 153 mL, 153 mmol) was added dropwise to a stirred suspension 
of (S)-N-tosylvaline 4.9 (41.9 g, 154 mmol) in CH2 C12  (780 mL) at 25°C over 1 h. After 30 min the clear 
solution was cooled to -74°C  and a solution of aldehyde 4.7 (16.3 g, 153.3 mmol) in CH2 C12  (10 + 5 mL) was 
added over 5 min. Then silyl ketene acetal 4.6 (31.7 g, 169 mmol) was added over 10 min at a rate sufficient to 
maintain the temperature of the reaction mixture below - 6 8 °C. After 2 h at -74°C  the reaction mixture was 
quenched with saturated aqueous NaHCC>3 (250 mL), warmed up to room temperature and stirred vigorously for 
30 min before being treated with water (250 mL). The phases were separated and the aqueous phase was 
extracted with CH2 C12  (50 mL). The combined organic extracts were dried (Na2 SC>4 ) and concentrated. The 
residue was diluted with hexanes (300 mL) and washed with aqueous NaHC0 3 - The organic phase was dried 
(Na2 SC>4 ) and concentrated to a pale yellow oil (32 g) which was used immediately in the next step.
An ice cooled solution of the crude product from above (32 g) in CH2 C12  (100 mL) was treated with 
triethylamine (25 mL, 180 mmol), acetic anhydride (16 mL, 168 mmol) and DMAP (76 mg, 0.6 mmol). After 5 
min the ice bath was removed and the reaction mixture was stirred at room temperature for 3 h. The mixture 
was diluted with hexanes (300 mL), washed with water (3 x 100 mL), brine (50 mL), dried (Na2 SC>4 ) and 
concentrated. The residue was filtered through a pad of silica (15 g, hexanes:Et2 0 )  and purified by short path 
vacuum distillation (88-98°C at 0.1 mm Hg) to give acetate 4.11 (30 g, 113 mmol, 74% over 2 steps) as a clear 
colourless oil: bp 88-98°C at 0.1 mm Hg.
[a]D22 + 9.4 (c 1.6, CHCI3). 
vmax film/cm - 1  1718 (s), 1236 (s).
lU NMR (270 MHz, CDC13): 8=  5.24 (1H, dd, J = 9.3, 3.9 Hz, C15-H), 4.14 (2H, q, /  = 7.1 Hz, CH2 0 ), 3.63-
3.49 (2H, m, C18-H2), 2.06 (3H, s, C12-H3), 1.83-1.57 (4H, m, C16-H2 and C17-H2), 1.26 (3H, t, /  = 7.1 Hz, 
CH3CH2 0 ), 1.18 (6 H, s, C 14-Me).
13C NMR (90 MHz, CDC13): 8=  175.6 (0), 170.7 (0), 76.2 (1), 60.9 (2), 46.5 (0), 44.6 (2), 29.2 (2), 27.7 (2),
21.8 (3), 21.0 (3), 20.3 (3), 14.2 (3).
LRMS m/z (CI, NH3) 223 [(M+H)+, 100%], 205 (25), 187 (45), 116 (20).
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Microanalysis: Anal. Calcd for C i2 H2 iC104: C, 54.44; H, 7.93. Found: C, 54.67; H, 7.96. 
(/?)-6-(3-Chloropropyl)-5,5-dimethyI-tetrahydro-2/7-pyran-2,4-dione 4.12.
Ac
Cl
LDA (2 eq), THF, -78°C
Cl
4.11
C12H 21CIO4 
Mol. Wt.: 264.75
4.12
C10H15CIO3 
Mol. Wt.: 218.68
nBuLi (2.3 M in hexanes, 100 mL, 230 mmol) was added to a stirred solution of diisopropylamine (34 mL, 240 
mmol) in THF (330 mL) at 0°C over 15 min. After 20 min the mixture was cooled to -74°C  and a solution of 
ester acetate 4.11  (29 g, 110 mmol) in THF (40+5 mL) was added dropwise over 15 min keeping the
quenched with 2M H C l^ )  (280 mL). The phases were separated and the aqueous phase was extracted with 
CH2 C12 (3 x 120 mL). The combined organic extracts were washed with brine (100 mL), dried (Na2 S 04) and 
concentrated. The residue was crystallised from CH2 C12:hexanes to give |3-ketolactone 4.12 (16.2 g, 74.0 mmol, 
67%) as pale yellow heavy rock crystals. The mother liquor was concentrated and purified by column 
chromatography (S i0 2  35 g, hexanes:AcOEt 10-50%) to give a further portion of (3-ketolactone 4.12 (2.1 g, 6 . 6  
mmol, 9%). Double recrystallisation from CH2 Cl2:hexanes afforded P-ketolactone 4.12  (14.7g, 67.1 mmol, 
61%) as white heavy rock crystals: mp 103-105°C (CH2 Cl2 :hexanes). The enantiomeric excess was determined 
as >99% by chiral HPLC after a further two steps.
[a\D20 +10.8 (c 1.0, CHCI3 ).
vmax film/cm- 1  1679 (s), 1605 (s), 1464 (s).
NMR assignments made using 2D H-H and C-H correlation spectra.
>H NMR (400 MHz, CDC13): 8=  4.35 (1H, dd, 7 = 10.8, 4.5 Hz, C15-H), 3.69 (1H, ddd, 7 =  11.1, 7.1, 4.8 Hz, 
C18-//AHB), 3.61 (1H, ddd, 7 =  11.1,7.1,5.1 Hz, C18-HA/ / B)> 3.61 (1H, d ,7 =  19.0 Hz, C12-HA/ / B), 3.39 (1H, 
d, 7 =  18.9 Hz, C 12-//a Hb), 2.30-2.12 (1H, m), 2.04-1.64 (3H, m), 1.18 (3H, s, C14-Me), 1.10 (3H, s, C14-Me).
13C NMR (100 MHz, CDC13): 8=  205.4 (0), 167.3 (0), 82.5 (1), 46.9 (0), 45.0 (2), 44.5 (2), 28.8 (2), 26.1 (2),
20.5 (3), 17.6 (3).
LRMS m/z (CI, NH3) 219 [(M+H)+, 25%], 236 [(M+NH4)+, 30%], 112 (70), 70 (100).
Microanalysis: Anal. Calcd for C 1oH1 5C103: C, 54.92; H, 6 .8 6 . Found: C, 54.93; H, 6.71.
temperature of the reaction mixture below - 6 8 °C. The yellow solution was stirred at -74°C  for 1.5 h and
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(/?)-6-(3-Chloropropyl)-4-methoxy-5,5-dim ethyI-5,6-dihydro-2//-pyran-2-one 4.13.
c
Me2S 0 4, K2C O 3 , 18-C-6
CH2CI2l rt
Cl Cl
4.12
C10H15CIO3 
Mol. Wt.: 218.68
4.13
C 1 1 H 17CIO3 
Mol. Wt.: 232.70
A solution of (i-ketolactone 4.12 (20.9 g, 95.5 mmol) and dimethyl sulphate (10.9 mL, 115.0 mmol) in CH2 CI2  
(100 mL) was treated with K2 C O 3 (18.6 g, 134.5 mmol) and 18-crown-6 (250 mg, 1.0 mmol) at room
concentrated in vacuo. The residue was purified by Kugelrohr distillation (200°C at 0.1 mm Hg) to give enol 
ether 4.13 (22.3 g, 95.5 mmol, 100%) as a colourless oil which formed a white solid on cooling: mp 56-57°C.
[a ] D 2 2  - 6 8 . 8  (c 1.7, CHC13). 
vmax film/cm - 1  1673 (s), 1603 (s).
]H NMR (300 MHz, CDCI3 ): 5=  5.06 (1H, s, C12-H), 4.03 (1H, dd, J = 11.0, 2.2 Hz, C15-H), 3.72 (3H, s, 
OMe), 3.70-3.53 (2H, m, C18-H2), 2.30-2.11 (1H, m), 1.97-1.62 (3H, m), 1.13 (3H, s, C14-Me), 1.10 (3H, s, 
C 14-Me).
13C NMR (90 MHz, CDCI3 ): <5 = 180.0 (0), 166.8 (0), 88.9 (1), 83.0 (1), 56.5 (3), 45.0 (2), 38.9 (0), 28.9 (2),
25.7 (2), 20.7 (3), 19.1 (3).
LRMS m/z (CI, NH3) 233 [(M+H)+, 100%], 126 (85), 112 (45), 70 (70).
Microanalysis: Anal. Calcd for C n H 1 7C1 0 3 : C, 56.77; H, 7.31. Found: C, 56.74; H, 7.45. 
(R)-6-(3-Chloropropyl)-5,5-dim ethyl-5,6-dihydro-4//-pyran-4-one 2.2 .
A solution of enol ether 4.13 (10.3 g, 44.2 mmol) in CH2 CI2  (80 mL) was cooled to -78°C  to which DIBAL 
(neat, 8.7 mL, 48.6 mmol) was added in a dropwise fashion at a rate sufficient to keep the temperature below 
-70°C. When the addition was complete, the mixture was stirred for 40 min before the reaction was quenched 
by the careful addition of 2M H C l^ )  (250 mL). The mixture was stirred for a further 2 h at room temperature
temperature. The mixture was stirred vigorously for 15 h before being filtered through a pad of celite and
a) DIBAL, CH2 CI2 ,-7 8 °C
b) HCI(aq)
4.13
C11H17CIO3 
Mol. Wt.: 232.70
2.2
C10H15CIO2 
Mol. Wt.: 202.68
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then extracted with CH2 CI2  (3 x 50 mL). The combined organic extracts were washed with saturated aqueous 
NaHCC>3 (50 mL), brine (50 mL), dried (MgSC^) and concentrated in vacuo. The residue was purified by 
Kugelrohr distillation (150°C at 0.1 mm Hg) to give dihydropyranone 2.2 (7.6 g, 37.4 mmol, 85%) as a pale 
yellow oil: [a)D22 +135.1 (c 2.2, CHC13).
v max film/cm - 1  1674 (s), 1603 (s).
NMR assignments made using 2D H-H and C-H correlation spectra.
lU NMR (400 MHz, CDC13): 5=  7.29 (1H, d, J  = 5.8 Hz, C ll-H ), 5.36 (1H, d , J  = 5.8 Hz, C12-H), 4.02 (1H, 
dd, / =  10.2, 2.5 Hz, C15-H), 3.67-3.55 (2H, m, C18-H2), 2.20-2.05 (1H, m, C17-HAHB), 1.96-1.75 (3H, m, 
C18-H2 and C17-HA//g), 1.13 (3H, s, C14-Me), 1.04 (3H, s, C14-Me).
13C NMR (75 MHz, CDC13): 8=  198.4 (0), 161.4 (1), 105.2 (1), 85.7 (1), 44.6 (2), 44.3 (0), 28.9 (2), 25.4 (2), 
19.6 (3), 17.8 (3).
LRMS m/z (CI, NH3) 203 [(M+H)+, 100%], 167 (8 ), 112 (45), 132 (8 ), 98 (7), 69 (6 ), 41 (4).
HRMS (CI mode) [Found: (M+H)+, 203.0840. C i0 H 15C1O2 requires M, 203.0839.
Microanalysis: Anal. Calcd for C 1 0H 1 5CIO2 : C, 59.26; H, 7.41. Found: C, 58.47; H, 7.24.
HPLC on Chiralcel OD 2 (4.6 x 250 mm), cyclohexane:isopropanol 98:2, major isomer 13.24 min, minor 
isomer 14.63 min established an ee of >99%.
Chlorom ethyldim ethylisopropoxysilane.
Chloro-(chloromethyl)-dimethylsilane (50.0 mL, 54.3 g, 380.0 mmol) was added carefully to a solution of 
istfpropanol (32.8 mL, 25.0 g, 415.0 mmol) and imidazole (28.3 g, 415.0 mmol) in CH2 CI2  (200 mL) at 0°C. 
The ice bath was removed and after stirring for 2 h the CH2 CI2  was removed in vacuo. The mixture was diluted 
with pentane (300 mL), filtered and concentrated in vacuo. The residue was vacuum distilled using short path 
apparatus (15 cm, ob 110°C, head 35°C at 50 mm Hg) to give a cloudy oil which was filtered through a cotton 
wool plug to give silane (50.2 g, 351.0 mmol, 92%) as a clear colourless oil.
Literature bp 64-66°C at 54 mm H g118.
Imidazole, 'PrOHCl-
CaHaCbSi 
Mol. Wt.: 143.09
C6H15CIOSi 
Mol. Wt.: 166.72
8 7
lH NMR (270 MHz, CDCI3 ): 8=  4.08 (1H, septet, 7 =  6.2 Hz, CH(CH3)2), 2.79 (2H, s, CH2 C1), 1.18 (6 H, d, J  
= 6.2 Hz, CH(CH3)2), 0.25 (6 H, s, SiMe2).
13C NMR (67.5 MHz, CDC13): 8=  78.7 (1), 42.9 (2), 38.7 (3, 2C), 9.9 (3, 2C).
(2S,6R)-6-(3-Chloropropyl)-2-[(isopropyIoxydim ethyIsilyI)m ethyl]-5,5-dimethyl-tetrahydro-2//-pyran-4-
one 5.2.
The 1,4-addition of an isopropoxymethyldimethylsilane Grignard to 2-cyclohexenone is described in the 
literature90. The author also reported that any attempt to add an isopropoxymethyldimethylsilane Grignard 
reagent to any other a,j8 -enones failed under a variety of conditions.
Magnesium turnings (5.60 g, 0.23 mol) were dried with a heat gun before a solution of THF (80 mL), 1,2- 
dibromoethane (250 p.L) and chloromethylisopropoxydimethylsilane (2.0 mL, 11.1 mmol) were added. The 
mixture was heated gently until a strong exotherm indicated the reaction had begun. The remaining portion of 
chloromethylisopropoxydimethylsilane (18.6 mL, 103.2 mmol) was added carefully maintaining a temperature 
range of 50-60°C over a period of 20 min. After the addition was complete the mixture was left to cool to room 
temperature and stirred for 24 h.
To a mixture of CuBr*SMe2  (694 mg) and SMe2  (10.4 mL) at -78°C and was added the Grignard reagent over 
30 min whilst maintaining a temperature below -60  °C. The mixture was diluted with THF (20 mL) and stirred 
at -70  °C for 10 min after which time enone 2.2 (9.0 g, 44.3 mmol) was added. After a further 1 h the mixture 
was left to warm to -30  °C and quenched by the addition of saturated aqueous NH4 CI (200 mL), 10% aqueous 
ammonia solution (10 mL) and hexanes (200 mL). After stirring for 15 min the organic layer was removed and 
the aqueous layer extracted with hexanes (100 mL). The combined organic extracts were dried (MgSC^) and 
concentrated in vacuo to give the crude silane 5.2 (100%) which was used immediately in the next step. A 
sample was purified by column chromatography (S i0 2, hexanes:Et20  10-20% and Et3N 1%) to give the 
following analytical data: [ « ] d 2 2  +8.7 (c 2.2, CHCI3 ).
Vmax film/cm - 1  1712 (s).
C uBr»SM e2 
S M e2, TH F, -7 0 ° C
2.2
C 1 0 H 1 5 CIO 2 
Mol. W t.: 202 .68
5.2C16H31 ClOaSi 
M ol. W t.: 334 .95
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lH NMR (270 MHz, CDC13): 5 =  4.19 (1H, dddd, J  = 13.7 7.9, 6.2, 5.0 Hz, C l 1-H), 3.99 (1H, 7 lines, J = 6.2 
Hz, CHMe2), 3.67 (1H, dd, J  = 10.6, 3.9 Hz, C15-H), 3.58 (2H, t, J=  6.2 Hz, C18-H2), 2.55 (1H, 4 lines of 
ABX system, J = 14.3, 4.4 Hz, C12-HA/ / B), 2.48 (1H, 4 lines of ABX system, J  = 14.3, 8.3 Hz, C12-//AHB), 
2.10-1.50 (4H, m), 1.23 (3H, s, C 14-Me), 1.14 [6 H, d, 6.2 Hz, CH(CH3)2\, 1.03 (3H, s, C14-Me), 1.05-0.98 
(2H, m, C10-H2), 0.16 (6 H, s, SiMe2).
13C NMR (75.0 MHz, CDCI3 ): 8 = 212.7 (0), 80.2 (1), 69.4 (1), 65.2 (1), 49.6 (0), 45.9 (2), 45.0 (2), 29.2 (2),
25.9 (3, 2C), 25.7 (2), 25.3 (2), 24.0 (3), 19.5 (3), -0.2 (3), -0.4 (3).
LRMS m/z (CI, NH3) 335 [(M+H)+, 15%], 275 (60), 229 (100), 170 (50).
Microanalysis: Anal. Calcd for C i6 H3 1 C103 Si: C, 57.19; H, 9.16. Found: C, 57.40; H, 9.27.
(2S,6/?)-6-(3-Chloropropyl)-2-hydroxym ethyl-5,5-dim ethyI-tetrahydro-2/7-pyran-4-one 5.3.
Oxidation of a isopropoxydimethylsilyl group to a hydroxyl is described in the literature9 1
O -S h
ci
5.2
KHCO3, MeOH 
THF, rt
5.3
C i6H 3iC I03Si C11H19CIO3
Mol. Wt.: 334.95 Mol. Wt.: 234.72
Crude silane 5.2 (43.3 mmol) was dissolved in an ice cold mixture of KF»2H20  (6.28 g, 66.7 mmol), KHCO3 
(8.2 g, 82.0 mmol), THF (80 mL) and MeOH (80 mL). Aqueous hydrogen peroxide (30% wt. solution, 45.0 
mL) was added in several portions. The mixture was stirred for 6  h at 0°C then saturated aqueous Na2 S2 0 3  (200 
mL) was added carefully over 15 min whereupon the solution turned bright yellow (strong exotherm!). Water 
(200 mL) was added and the mixture extracted with CH 2 C12  (4 x 100 mL). The combined organic extracts were 
dried (MgSC>4 ) and concentrated in vacuo. The residue was purified by column chromatography (S i0 2  60 g, 
hexanes:EtOAc 20-50%) to give the alcohol 5.3 (9.1 g, 38.7 mmol, 87% yield over 2 steps) as a clear colourless 
oil: [a ] D 2 2  -8 .7  (c 1.2, CHC13).
vmax film/cm - 1  3436 (br), 1701 (s).
]H NMR (270 MHz, CDC13): 8=  4.07-3.96 (1H, m, C l 1-H), 3.78 (1H, dd, / =  11.6, 3.7 Hz, C15-H), 3.71 (1H, 
4 lines of ABX system, J=  11.8, 3.6 Hz, C10-Ha //b), 3.62 (1H, 4 lines of ABX system, J=  11.8, 6.0 Hz, C10- 
/ / AHB), 3.57 (2H, t, J =  6 . 6  Hz, C18-H2), 2.72 (1H, dd, / =  14.7, 10.0 Hz, C12-HA/ / B), 2.28 (1H, dd, / =  14.7, 
4.2 Hz, C12-HAHB), 2.20-1.50 (5H, m), 1.28 (3H, s, C14-Me), 1.02 (3H, s, C14-Me).
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13C NMR (67.5 MHz, CDC13): 8 = 211.8 (0), 81.8 (1), 71.5 (1), 65.1 (2), 49.7 (0), 44.8 (2), 39.2 (2), 28.8 (2),
25.3 (2), 24.7 (3), 19.5 (3).
LRMS m/z (Cl, NH3) 235 [(M+H)+, 30%], 252 [(M+NH4)+, 45%], 217 (10), 128 (100).
Microanalysis: Anal. Calcd for C 11H 1 9CIO3 : C, 56.29; H, 8.10. Found: C, 56.02; H, 7.98.
(2S,6/?)-2-[(terf-Butyldimethylsilyloxy)methyl]-6-(3-chloropropyI)-5,5-dimethyl-tetrahydro-2ff-pyran-4- 
one 5.4.
To a solution of the alcohol 5.3 (12.15 g, 51.7 mmol), triethylamine (93.0 mmol, 13.0 mL) and DMAP (230 mg) 
in CH2 CI2  (120 mL) was added terr-butyldimethylsilyl chloride (62.04 mmol, 9.35 g). The mixture was stirred 
at room temperature for 36 h whereupon saturated aqueous N aH C03  (200 mL), water (300 mL) and hexanes 
(200 mL) were added in succession. The organic layer was removed and the aqueous layer was extracted with 
hexanes (100 mL). The combined organic extracts were dried (M gS04) and concentrated in vacuo. The residue 
was filtered through a pad of silica eluting with hexanes:EtOAc 5:1 to give the TBS ether 5.4 (17.0 g, 48.8 
mmol, 94%) as a pale yellow oil: [a]o 2 2  +0.1 (c 2.4, CHCI3 ).
v max film/cm - 1  1714 (s), 838 (s).
!H NMR (270 MHz, CDC13): 8=  4.05-3.94 (1H, m, C ll-H ), 3.82 (1H, dd, J =  11.2, 3.3 Hz, C15-H), 3.72 (1H, 
4 lines of ABX system, J  = 10.8, 3.5 Hz, C10-HA/ /B), 3.69 (1H, 4 lines of ABX system, J -  10.8, 5.0 Hz, C10- 
HAHB), 3.59 (2H, t, J  = 6 . 6  Hz, C18-H2), 2.65 (1H, dd, J  = 14.7, 8.7 Hz, C12-HAHB), 2.38 (1H, dd, J = 14.7, 
5.0 Hz, C 12-//a Hb), 2.10-1.40 (4H, m), 1.23 (3H, s, C14-Me), 1.03 (3H, s, C14-Me), 0.90 (9H, s, ^u S i), 0.08 
and 0.07 (3H each, s, Me2 Si).
13C NMR (67.5 MHz, CDC13): 8=  212.3 (0), 81.0 (1), 72.0 (1), 66.0 (2), 49.3 (0), 44.7 (2), 39.2 (2), 28.9 (2),
25.9 (3, 3C), 25.4 (2), 23.6 (3), 19.2 (3), 18.3 (0), -5 .4  (3), -5.5 (3).
LRMS m/z (Cl, NH3) 366 [(M+N1L0+ 15%], 349 [(M+H)+, 50%], 291 (35), 185 (100), 117 (80).
HRMS (Cl mode) [Found: (M+H)+, 349.1966. C i7 H3 4 C103Si requires M, 349.1966.
TBSCI, NEta DMAP
C H 2 C I2 , rt
5.3
C11H19CIO3 
Mol. Wt.: 234.72
5.4Ci7H33CIOaSi
Mol. Wt.: 348.98
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(2S,6/?)-4-(te/?-Butyldimethylsilyloxy)-2-[(te/f-butyldimethylsilyIoxy)methyl]-6-(3-chloropropyl)-5,5- 
dim ethyl-5,6-dihydro-2f/-pyran 5.5.
>TBS
.OTBS
TBSOTf, NEt3
5.5
)TBS
Cl
5.4
C 17H33CI03Si C23H47CI03Si2
Mol. Wt.: 348.98 Mol. Wt.: 463.24
To a solution of the ketone 5.4 (16.8 g, 48.2 mmol) and triethylamine (11.0 mL, 78.9 mmol) in CH2 CI2  (100 
mL) was added dropwise re/t-butyldimethylsilyl trifluoromethanesulfonate (13.3 mL, 57. 9 mmol) over 5 min. 
The yellow solution turned orange with a slight exotherm which was controlled by cooling with a water bath. 
After stirring at ambient temperature for 1.5 h the reaction was quenched by adding the reaction mixture to a 
mixture of saturated aqueous NaHC0 3  (200 mL) and hexanes (200 mL). The organic phase was removed, dried 
(MgSC>4 ) and concentrated in vacuo to give enol silane 5.5 as a pale yellow oil (100%) which was used 
immediately in the next step. A sample (200 mg) purified by column chromatography (Si(>2 , hexanes:Et2 0  2%) 
gave: [a]D22 -24.8 (c 2.0, CHC13).
vmax film/cm- 1 1664 (s), 1471 (s), 1256 (s), 1126, 838 (s).
lU NMR (270 MHz, CDC13): 8 = 4.62 (1H, d, J  = 3.3 Hz, C12-H), 4.22 (1H, ddd, J  = 6 .8 , 5.2, 3.3, C l 1-H), 
3.73-3.53 (3H, m), 3.52-3.42 (2H, m), 2.2-2.0 (1H, m), 1.9-1.4 (3H, m), 0.99 (3H, s, C14-Me), 0.97 (3H, s, C14- 
Me), 0.95 (9H, s, lBuSi), 0.90 (9H, s, lBuSi), 0.172 (3H, s, MeSi), 0.170 (3H, s, MeSi), 0.06 (6 H, s, Me2 Si).
13C NMR (67.5 MHz, CDC13): 8=  156.7 (0), 99.0 (1), 77.6 (1), 72.9 (1), 65.2 (2), 45.4 (2), 38.9 (0), 30.2 (2),
26.5 (2), 26.1 (3, 3C), 25.9 (3, 3C), 22.3 (3), 19.6 (3), 18.4 (0, 2C), -4.2 (3), -4 .7  (3), -5 .2  (3, 2C).
LRMS m/z (Cl, NH3) 463 [(M+H)+, 35%], 347 (45), 317 (100), 157 (70).
HRMS (Cl mode) [Found: (M+H)+, 463.2827. C2 3 H4 8 C1 0 3 Si2  requires M, 463.2831.
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(2/?,3S,4S,6/?)-4-(terf-Butyldimethylsilyloxy)-2-[(terf-butyldimethyIsilyloxy)methyl]-6-(3-chloropropyl)- 
3,4-epoxy-5,5-dim ethyl-tetrahydro-2//-pyran 5.6.
)TBS
.OTBS
5.5
)TBS
.OTBS
Oxone, 18-C-6 
PhMe, H20
Acetone, rt
5.6
C23H47CI03Si2 C23H47C I04Si2
Mol. Wt.: 463.24 Mol. Wt.: 479.24
To a mechanically stirred solution of enol silane 5.5 (22.2 g, 48 mmol), KHCO3  (121.0 g, 120.0 mmol), 18- 
crown- 6  (1.11 g, 4.21 mmol), toluene (600 mL), acetone(120 mL) and water (1.20 L) was added oxone (200 g, 
300 mmol) in portions over a period of 0.5 h. Beware gas evolution! After the addition was complete the 
mixture was stirred at room temperature for 30 min before the organic layer was removed. The aqueous phase 
was extracted with hexanes (2 x 100 mL) and the combined organic extracts were dried (M gS04) and 
concentrated in vacuo to give oxirane 5.6 (22.7 g, 47.3 mmol, 99%) as a pale yellow oil which was used 
immediately in the next step. A sample (200 mg) purified by column chromatography (SiC>2 , with hexanes:Et2 0  
1%) gave: [a]D22 - 8 . 6  (c 1.0, CHCI3 ).
vmax film/cm- 1  1664 (s), 1471 (s), 1256 (s), 1126, 838 (s).
*H NMR (270 MHz, CDC13): S=  4.10 (1H, dt, /  = 7.0, 3.3, C ll-H ), 3.69 (1H, dd, / =  9.7, 7.5 Hz, C10-HA/ / B), 
3.61 (1H, dd, J = 9.7, 6 . 8  Hz, C10-tfAHB), 3.60-3.45 (2H, m, C18-H2), 3.41 (1H, d, J = 3.3 Hz, C12-H), 3.24 
(1H, dd, J=  10.4, 1.0 Hz, C15-H), 2.1-1.9 (1H, m), 1.8-1.5 (2H, m), 1.4-1.2 (1H, m) 1.04 (3H, s, C14-Me), 0.96 
(3H, s, C14-Me), 0.91 and 0.90 (9H each, s, ‘BuSi), 0.14, 0.09, 0.08 and 0.07 (3H each, s, Me2 Si).
13C NMR (67.5 MHz, CDC13): 5=  86.1 (0) 75.6 (1), 71.0 (1), 60.7 (1), 60.2 (2), 45.3 (2), 39.1 (0), 30.3 (2),
26.9 (2), 26.0 (3, 3C), 25.9 (3, 3C), 18.6 (3), 18.4 (0), 18.0 (0), 16.9 (3), -3 .2  (3), -3 .4  (3), -5 .3  (3), -5.2 (3).
LRMS m/z (Cl, NH3) 479 [(M+H)+, 65%], 443 [(M+H-HC1)+, 20], 347 [(M+H-TBSOH)+, 100].
HRMS (Cl mode) [Found: (M+NH4)+, 496.3058. C 2 3 H 5 1 C1 0 4 NSi2  requires M, 496.3045, [Found: (M+H)+, 
479.2748. C2 3 H4 gC1 0 4 Si2  requires M, 479.2780.
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(2/?,3S,6/?)-6-(3-ChloropropyI)-3-hydroxy-2-hydroxymethyI-5,5-diinethyl-tetrahydro-2H-pyran-4-one 
5.7a and (2/?,3/?,6/?)-6-(3-Ch]oropropyl)-3-hydroxy-2-hydroxymethyl-5,5-diinethyl-tetrahydro-2/2r-pyran- 
4-one 5.7b.
MeOH, A
5.7a
+
>TBS
.OTBS
5.6
C23H47CI04Si2 C ,iH 19CI04 C11H 19CIO4
Mol. Wt.: 479.24 Mol. Wt.: 250.72 Mol. Wt.: 250.72
A crude mixture of oxiranes 5.6 (1.19 g, 2.48 mmol), pyridinium p-toluenesulfonate (62 mg, 0.248 mmol), 
MeOH (5 mL) and water (0.25 mL) was heated at reflux for 18 h. After such time the reaction mixture was 
poured onto saturated aqueous NaHC0 3  and extracted with CH2 CI2  (3 x 20 mL). The combined organic extracts 
were dried (Na2 S 0 4 ) and concentrated. The residue was purified by column chromatography (Si0 2  20 g, 
hexanes:AcOEt 20-70%) and NMR spectroscopic analysis (CgDg) of the mixture revealed doublets at 8 = 
4.29 (major) and 4.34 (minor) attributed to the methine proton adjacent to the carbonyl corresponding to a 15:1 
mixture of diastereoisomeric diols 5 .7 a  and 5 .7b  (537 mg, 2.14 mmol, 8 6 %) as a colourless oil. The 
diastereoisomers were separated by recrystallisation (hexanes:Et2 0 ) to give pure desired diastereoisomer 5.7a 
(335 mg, 1.34 mmol, 54%) as clear colourless crystals. The mother liquor was purified by column 
chromatography (S i0 2  15 g, hexanes:AcOEt 20-70%) to give another portion of the desired diastereoisomer 
5.7a (137 mg, 0.55 mmol, 22%) as a white solid and pure undesired diastereoisomer 5.7b (30 mg, 0.12 mmol, 
5%) as a white solid.
Desired diastereoisomer 5.7a:
mp 60-60.5°C (hexanes:Et2 0 )
[a]D22= +90.0 (c 1.5, CHC13).
vmax film/cm- 1  3417 (br), 1714 (s), 1463 (s), 1376 (m).
lH NMR (270 MHz, CDCI3 ): 8=  4.61 (1H, d, J  = 7.9 Hz, C12-H), 4.43 (1H, ddd, J  = 8.1, 5.2, 3.8, C ll-H ), 
3.91 (1H, dd, J  = 12.6, 5.2 Hz, C10-HAHB), 3.80 (1H, dd, / =  12.6, 3.5 Hz, C 10-//AHB), 3.86-3.77 (2H, m), 
3.70-3.58 (2H, m, C18-H2), 2.20-1.75 (3H, m), 1.70-1.50 (2H, m), 1.18 (3H, s, C14-Me), 1.07 (3H, s, C14-Me).
13C NMR (90 MHz, CDC13): 8=  213.3 (0), 79.0 (1) 78.1 (1), 70.7 (1), 62.4 (2), 49.0 (0), 45.1 (2), 30.0 (2), 27.0
(2), 20.3 (3), 19.4 (3).
LRMS m/z (Cl, NH3) 268 [(M+NH4 )+, 65%], 251 [(M+H)+, 50], 233 [(M+H-H 2 0 )+, 25], 144 (100).
93
Microanalysis: Anal. Calcd for C 11H 1 9CIO4 : C, 52.69; H, 7.58. Found: C, 52.66; H, 7.45.
Undesired diastereoisomer 5.7b: 
mp 63-63.5°C (hexanes:Et2 0 ).
[a]D22 +9.7 (c 1.8, CHCI3 ).
vmax film/cm- 1 3443 (br), 1714 (s), 1048 (s).
NMR assignments made using 2D C-H correlation spectra.
*H NMR (270 MHz, CDCI3 ): 8 = 4.49 (1H, dm, J  = 9.7 Hz, C15-H), 3.94 (1H, dd, J  = 11.3, 3.0 Hz, C10- 
HA/ /B), 3.86 (1H, dd, / =  11.2, 4.6 Hz, C10-//AHB), 3.83 (1H, dd, 7 =  8.5 , 3.3 Hz, C12-H), 3.69 ( 1H, d ,J  = 3.2 
Hz, C12-OH), 3.55 (2H, t, J  = 6.2 Hz, C18-H2), 3.46 (1H, ddd, / =  8.1, 4.6, 3.0 Hz, C ll-H ), 2.44 (1H, br s, 
CH2 -Otf), 1.95-1.40 (4H, m), 1.41 (3H, s, C14-Me), 1.05 (3H, s, C14-Me).
I3C NMR (90 MHz, CDCI3 ): <5 = 212.7 (0), 83.6 (1) 76.8 (1), 70.0 (1), 63.2 (2), 49.7 (0), 44.6 (2), 28.1 (2), 26.0 
(3), 24.5 (2), 19.5 (3).
LRMS m/z (Cl, NH3) 268 [(M+NH4 )+, 100%].
Microanalysis: Anal. Calcd for C 11H 1 9CIO4 : C, 52.69; H, 7.58. Found: C, 52.61; H, 7.56. 
(lS,6R,8/?)-8-(3-ChIoropropyl)-3,3,9,9-tetram ethyl-2,4,7-trioxabicyclo[4,4,0]decan-10-one 5.8.
A solution of diol 5 .7 a  (4.2 g, 16.6 mmol), 2-methoxypropene (3.2 mL, 33.0 mmol) and pyridinium p- 
toluenesulfonate (420 mg, 1.7 mmol) in CH2 C12  (65 mL) was stirred at room temperature for 4.25 h. The 
reaction mixture was then poured onto saturated aqueous NaHCC>3 (300 mL) and extracted with CH 2C12 (3 x 70 
mL). The combined organic extracts were dried (MgS0 4 ) and concentrated in vacuo. The residue was purified 
by column chromatography (S i0 2  120 g, hexanes:Et20  20-50%) to give the acetonide 5.8 (4.2 g, 14.3 mmol, 
8 6 %) as a colourless oil: [«]d 2 2  -1.5 (c 1.4, CHCI3 ).
PPTS. CH2CI2, rt
X ,
5.7a
C11H19CIO4 
Mol. Wt.: 250.72
5.8
C14H23CIO4 
Mol. Wt.: 290.78
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Vmax film/cm - 1  1726 (s), 1090 (S).
NMR assignments made using 2D C-H correlation spectra.
]H NMR (360 MHz, CDC13): 8=  4.25 (1H, dd, J  = 11.5, 2.5 Hz, C ll-H ), 4.21 (1H, d, J  = 3.2 Hz, C12-H), 4.09 
( 1H, dd, J = 13.0, 3.6 Hz, C10-HA/ / B), 3.90 (1H, dd, J  = 13.0, 2.8 Hz, C 1 0 - //AHB), 3.77 (1H, dd, /  = 6.1, 3.2 
Hz, C15-H), 3.62 (2H, t, J  = 6.1 Hz, C18-H2), 2.05-1.78 (2H, m), 1.70-1.60 (1H, m), 1.55-1.45 (1H, m) 1.45
,3C NMR (90 MHz, CDCI3 ): 8=  208.3 (0), 99.1 (0), 80.4 (1), 72.8 (1), 65.7 (1), 62.8 (2), 49.2 (0), 44.8 (2),
29.1 (2), 28.6 (3), 25.5 (2), 24.5 (3), 19.8 (3), 19.5 (3).
LRMS m/z (Cl, NH3) 291 [(M+H)+, 100%], 275 (15), 203 (25), 132 (30), 101 (20), 73 (30).
Microanalysis: Anal. Calcd for C 14H2 3 CIO4 : C, 57.83; H, 7.91. Found: C, 57.79; H, 7.84.
(lR ,6/?,8S',10S)-8-(3-ChIoropropyI)-3,3,9,9-tetram ethyl-2,4,7-trioxabicyclo[4,4,0]decan-10-ol 5.9a and  
(lR,6R,8S,10R)-8-(3-ChIoropropyI)-3,3,9,9-tetramethyl-2,4,7-trioxabicyclo[4,4,0]decan-10-ol 5.9b.
00
Reduction of a ketone to alcohol using NaBH4  and CeCl3 #7 H 2 0  is described in the literature
To a solution of ketone 5.8 (4.2 g, 14.3 mmol) in MeOH (218 mL) at 0°C was added CeCl3 *7 H2 0  (6.4 g, 17.1 
mmol). After stirring for 30 min, sodium triacetoxyborohydride (10.0 g, 47.5 mmol) was added. The reaction 
was stirred at 0°C for 4.25 h before saturated aqueous N aH C03 (500 mL) was carefully added and the MeOH 
was removed in vacuo. The resulting mixture was extracted with CH2 C12  (3 x 100 mL), dried (MgS0 4 ) and 
concentrated in vacuo. Purification by column chromatography (S i0 2  120 g, hexanes:Et20  50-70%) gave a 
mixture of diastereoisomeric alcohols 5.9a,b (3.01 g, 10.3 mmol, 72%) as a white solid. JH NMR spectroscopic 
analysis of the mixture (CgDg) revealed singlets at 8=  0.78 (major) and 0.88 (minor) corresponding to 5.9a:5.9b 
= 11:1. Crystallisation from hexanes:Et20  gave diastereoisomerically pure alcohol 5.9a (2.1 g, 7.3 mmol, 51%) 
as colourless needles. The mother liquor was purified by column chromatography (S i0 2  100 g, hexanes:Et20
(3H, s, CMe2), 1.43 (3H, s, CMe2), 1.33 (3H, s, C14-Me), 1.03 (3H, s, C14-Me).
CeCl3*7 H20 , NaB(OAc)3H
MeOH. 0°C
5.8
C14H 23CIO4 
Mol. Wt.: 290.78
5.9a
C14H 25CIO4 
Mol. Wt.: 292.80
5.9b
C14H25CIO4 
Mol. Wt.: 292.80
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20-70%) to give another portion of 5.9a (310 mg, 1.06 mmol, 7%) and pure undesired diastereoisomer 5.9b  
(206 mg, 0.70 mmol, 5%) as a white solid. Recrystallisation from hexanes:Et2 0  gave white crystals for analysis.
Desired diastereoisomer 5.9a:
mp 96-97°C (hexanes:Et2 0 )
[ct] D 2 2  +30.4 (c 1.2, CHCI3 ).
vmax film/cm - 1  3437 (br), 1462 (s), 1377 (s).
lH NMR (270 MHz, C6 D6): 5=  3.77 (1H, dd, J  = 12.4, 3.3 Hz, C10-HAtf B), 3.67 (1H, dd, /  = 12.4, 3.7 Hz, 
C10-//a Hb), 3.60 (1H, d d , / =  3.7, 3.1 Hz, C12-H), 3.44 (1H, q, J  = 3.5 Hz, C ll-H ), 3.35 (1H, d, J  = 3.9 Hz, 
OH), 3.34 (1H, dd, / =  3.8, 2.9 Hz, C13-H), 3.25 (3H, t , / =  6 . 8  Hz, C18-H2,C15-H), 2.10-1.90 (1H, m), 1.85- 
1.80 (1H, m), 1.60-1.40 (1H, m), 1.45 (3H, s, CMe2), 1.40-1.25 (1H, m), 1.24 and 1.23 (3H each, s, CMe2 and 
C14-Me), 0.80 (3H, s, C14-Me).
13C NMR (67.5 MHz, CDC13): <5 = 98.5 (0), 80.3 (1), 75.0 (1), 70.5 (1), 62.9 (2), 60.3 (1), 45.2 (2), 36.4 (0),
29.8 (2), 28.9 (3), 27.1 (3), 24.6 (2), 21.2 (3), 19.8 (3).
LRMS m/z (Cl, NH3) 293 [(M+H)+, 100%], 277 (20), 217 (20).
Microanalysis: Anal. Calcd for C 14H25C104: C, 57.43; H, 8.55. Found: C, 57.42; H, 8.55.
Undesired diastereoisomer 5.9b: 
mp 89-90°C (hexanes:Et2 0 ).
[a]D22 +47.0 (c 1.0, CHCI3 ).
vmax film/cm - 1 3516 (m), 1461 (s), 1377 (S).
]H NMR (270 MHz, C6 D6): S=  3.66 (1H, dd, J=  12.7, 1.9 Hz, C10-HA/ / B), 3.59 (1H, dd, J  = 4.2, 2.1 Hz, C12- 
H), 3.53 (1H, dd, J  = 12.6, 2.9 Hz, C10-//AHB), 3.39 (1H, d d , /=  11.5, 3.1 Hz, C15-H), 3.37-3.30 (1H, m, C13- 
H), 3.28-3.10 (2H, m, C18-H2), 2.72 (1H, q, J  = 2.1 Hz, C ll-H ), 2.31 (1H, d, J  = 10.6 Hz, OH), 1.65-1.15 (4H, 
m), 1.37 and 1.27 (3H each, s, CMe2), 1.13 (3H, s, C14-Me), 0.88 (3H, s, C14-Me).
13C NMR (90 MHz, CHC13): <5= 98.9 (0), 81.8 (1), 71.6 (1), 67.5 (1), 63.2 (2), 62.7 (1), 45.1 (2), 37.7 (0), 29.4
(3), 29.1 (2), 24.6 (3), 22.6 (3), 22.6 (2), 18.7 (3).
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LRMS m/z (Cl, NH3) 310 [(M+NH4 )+, 60%], 293 [(M+H)+, 55],
Microanalysis: Anal. Calcd for CJ4 H2 5 CIO4 : C, 57.43; H, 8.55. Found: C, 57.36; H, 8.47.
(LR,6/?,8/?,105)-8-(3-Chloropropyl)-10-methoxy-3,3,9,9-tetramethyl-2,4,7-trioxabicyclo[4,4,0]decan 5.11.
(Me0)2S 0 2, 50% NaOHaq 
Bu4N+H S04-, PhMe, rl
5.9a
c 14h 25c io 4
Mol. Wt.: 292.80
Dimethyl sulfate (3.0 mL, 4.0 g, 32.0 mmol) was added to a vigorously stirred mixture of alcohol 5.9a (2.42 g, 
8.27 mmol), tetrabutylammonium hydrogen sulphate (573 mg, 1.70 mmol), toluene (32 mL) and 50% aqueous 
solution of NaOH (21 mL). The reaction mixture was stirred vigorously for 14 h whereupon MeOH (9 mL) was 
added and after a further 15 min the mixture was treated with H2 O (220 mL). The mixture was extracted with 
CH2 CI2  (3 x 80 mL), and the combined organic extracts were dried (MgSOa) and concentrated in vacuo. The 
residue was purified by column chromatography (Si0 2  80 g, hexanes:Et2 0  10-25%) to give methyl ether 5.11 
(2.47 g, 8.06 mmol, 97%) as a colourless oil which solidified on standing: mp 49-50 °C (MeOH:H2 0 )
[«]d 2 2 -1 .9  ( c  1.2, CHCI3 ).
vmax film/cm - 1  1454 (s), 1381 (s), 1276 (s), 1094 (s).
lH NMR (270 MHz, CDC13): 8 = 4.08 (1H, dd, J  = 12.7, 2.5 Hz, C10-HAHB), 3.90 (1H, t, J  = 2.3 Hz, C12-H),
3.86 (1H, dd, J  = 12.7, 1.7 Hz, C 10-//AHB), 3.59 (2H, t, / =  6 . 6  Hz, C18-H2), 3.55-3.45 (2H, m, C ll-H  and 
C15-H), 3.39 (3H, s, OMe), 2.84 (1H, d, /  = 2.7 Hz, C13-H), 2.20-2.05 (1H, m), 1.95-1.45 (3H, m), 1.47 and
1.45 (3H each, s, CMe2), 1.25 (3H, s, C14-Me), 0.93 (3H, s, C14-Me).
13C NMR (67.5 MHz, CDCI3 ): 8=  98.6 (0), 85.8 (1), 80.5 (1), 67.3 (1), 63.6 (2), 60.7 (1), 59.3 (3), 45.6 (2),
36.9 (0), 30.5 (2), 29.6 (3), 28.3 (3), 25.1 (2), 22.3 (3), 19.6 (3).
LRMS m/z (Cl, NH3) 307 [(M+H)+, 100%].
Microanalysis: Anal. Calcd for Q 5 H2 7 CIO4 : C, 58.73; H, 8.81. Found: C, 57.80; H, 8.74.
I J l ^ O M e
5.11
CisH27CI04 
Mol. Wt.: 306.83
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(U?,6/?,8/J,10S)-10-Methoxy-3,3,9,9-tetramethyl-8-(3-phenylselenylpropyl)-2,4,7-trioxabicyclo[4,4,0]decan
5.12.
Substitution of a halide with sodium phenylselenide is described in the literature1 1 9
X o  < X o
>OMe kOMe
EtOH, A
Cl SePh
5.125.11
C 1 5 H 2 7 C I O 4  C 2 1 H  3 2 0 4 S e
Mol. Wt.: 306.83 Mol. Wt.: 427.44
Sodium borohydride (208 mg, 5.50 mmol) was added in batches into a stirred yellow suspension of diphenyl 
diselenide (773 mg, 2.47 mmol) in anhydrous EtOH (11.5 mL) to cause exothermic reaction and gas evolution. 
A solution of chloride 5.11 (990 mg, 3.23 mmol) in anhydrous EtOH (3 x 2.5 mL) was transferred via cannula 
to the solution of sodium phenyl selenide and the resulting mixture was heated at reflux for 40 min. After 
cooling to room temperature the reaction mixture was diluted with Et2 0  (160 mL) and extracted with 2 M 
NaOH(gq) (2 x 35 mL) and brine. The organic layer was dried (MgSO,*) and concentrated. The residue was 
purified by column chromatography (Si0 2  10 g, hexanes:Et2 0  0-30%) to give selenide 5.12 (1.40 g, 100%) as a 
colourless oil: [a ] D 2 2  +17.9 (c 1.4, CHCI3 ).
Vmax film/crrr1 1579 (s).
>H NMR (270 MHz, CDC13): S=  7.52-7.45 (2H, m), 7.29-7.21 (3H, m),.4.01 (1H, dd, J = 12.7, 2.5 Hz, C10- 
HA/ / B), 3.87 (1H, t , / =  2.3 Hz, C12-H), 3.76 (1H, dd, J = 12.7, 1.7 Hz, C10-//AHB), 3.46 (1H, d d ,/  = 12.2, 2.9 
Hz, C15-H), 3.42 (1H, q, /  = 2.3 Hz, C l 1-H), 3.38 (3H, s, OMe), 3.01 (1H, ddd, J  = 11.8, 7.9, 6.0 Hz, C18- 
Ha / / b), 2.88 (1H, ddd, / =  12.0, 7.9, 7.1 Hz, C18-T/AHB), 2.81 (1H, d, / =  2.7 Hz, C13-H), 2.11 (1H, dddd, /  =
14.1, 12.2, 9.1, 4.6 Hz, C16-H), 1.90-1.60 (3H, m), 1.46 and 1.44 (3H each, s, CMe2), 1.22 (3H, s, C14-Me), 
0.88 (3H, s, C14-Me).
13C NMR (67.5 MHz, CDC13): 8=  132.7 (1, 2C), 130.5 (0), 129 (1, 2C), 126.7 (1), 98.3 (0), 84.9 (1), 80.6 (1),
66.5 (1), 63.4 (2), 59.4 (3), 59.3 (1), 36.3 (0), 29.4 (3), 27.9 (3), 27.8 (2), 27.0 (2), 26.9 (2), 22.4 (3), 18.8 (3).
LRMS m/z (Cl, NH3) 446 [(M+NH4 )+, 17%], 429 [(M+H)+, 9].
Microanalysis: Anal. Calcd for C2 iH 3 2 0 4 Se: C, 59.02; H, 7.49. Found: C, 59.27; H, 7.61.
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(l/?,6/?,8/?,10S)-10-Methoxy-3,3,9,9-tetramethyl-8-(prop-2-enyl)-2,4,7-trioxabicyclo[4,4,0]decan 5.13.
Oxidation of a selenide to a selenoxide and elimination of a selenoxide are described in the literature1 3 , 14
,X o ,X o
a) Nal04, MeOH, H20
b) PhMe, NEt3, A
SePh
5.12C21H 3204Se 
Mol. Wt.: 427.44
5.13Ci5H2604
Mol. Wt.: 270.36
Sodium metaperiodate (1.01 g, 4.70 mmol) was added in several portions to a stirred mixture of selenide 5.12 
(1.31 mg, 3.23 mmol), water (18 mL) and MeOH (45 mL) at room temperature. The reaction mixture was 
stirred for 15 min and then diluted with water (55 mL) and extracted with CH2 CI2  (3 x 40 mL). The combined 
organic extracts were dried (M gSO ^ and concentrated. The residue was treated with toluene (4.5 mL) and 
triethylamine (4.5 mL) and heated at reflux for 10 min. The yellow reaction mixture was cooled to room 
temperature, poured onto saturated aqueous NaHC0 3  and extracted with CH2 CI2  (3 x 40 mL). The combined 
organic extracts were dried (MgSC^) and concentrated. The residue was purified by column chromatography 
(SiC>2 30 g, hexanes:ether 0-20%) to give alkene 5.13 (780 mg, 3.20 mmol, 99%) as a colourless oil which 
solidified on storage in the refrigerator: mp 33-33.5 °C (M eO H ^O ).
[«]d 2 2 -H -2  (c 1.1,CHC13).
vmax film/cm- 1  1651 (m) 1463 (m), 1390 (s).
NMR assignments made using 2D C-H correlation spectra.
]H NMR (270 MHz, CDC13): 8 = 5.82 (1H, dddd, J  = 17.6, 10.2, 7.5, 6.0 Hz, C17-H), 5.03 (1H, dq, J  = 16.9,
I.7 Hz, C18-Htrans), 4.98 (1H, dm, J  = 10.2 Hz, C18-Hcis), 4.05 (1H, dd, J  = U . l ,  2.7 Hz, C10-HA/ / B), 3.90 
(1H, t, J = 2.5 Hz, C12-H), 3.82 (1H, dd, J  = 12.7, 2.1 Hz, C10-tfAHB), 3.59 (1H, dd, J  = 12.0, 3.7 Hz, C15-H), 
3.53 (1H, q, J  = 2.3 Hz, C ll-H ), 3.40 (3H, s, OMe), 2.84 (1H, d, /  = 2.7 Hz, C13-H), 2.79 (1H, dddt, J  = 15.0,
II.4, 7.3, 1.1 Hz, C16-HA/ / B), 2.17 (1H, dddt, 7 =  15.5, 5.4, 3.5, 1.5 Hz, C 16-//AHB), 1.47 and 1.44 (3H each, 
s, CMe2), 1.25 (3H, s, C14-Me), 0.93 (3H, s, C14-Me).
13C NMR (67.5 MHz, CDC13): 8=  136.7 (1), 115.2 (2), 98.1 (0), 84.8 (1), 80.7 (1), 66.3 (1), 63.2 (2), 59.3 (3),
59.1 (1), 36.2 (0), 32.2 (2), 29.2 (3), 27.6 (3), 22.4 (3), 18.7 (3).
LRMS m/z (Cl, NH3) 271 [(M+H)+, 30%], 229 (80), 171 (70), 101 (55), 85 (80), 71 (100).
Microanalysis: Anal. Calcd for C 15H2 6 O4 : C, 6 6 .6 6 ; H, 9.62. Found: C, 66.64; H, 9.61.
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(l/?,6/?,8/?,10S)-8-[(2S)-2,3-Dihydroxypropyl]-10-methoxy-3,3,9,9-tetramethyl-2,4,7- 
trioxabicyclo[4,4,0]decan 5.14a and (l/?,6/?,8/?,105)-8-[(2R)-2,3-dihydroxypropyl]-10-methoxy-3,3,9,9- 
tetram ethyl-2,4,7-trioxabicyclo[4,4,0]decan 5.14b.
The asymmetric dihyroxylation was performed according to literature procedure 120
OMe (DHQ)2PYR, K20 s0 4*2H20  
KaFe(CN)6, K2CQ3
'BuOH, H20 ,  0°C 
dr = 6.6:1
,OMe
OH
OH
kOMe
+
OH
OH
5.13
CisH2804 
Mol. Wt.: 270.36
5.14a
Ci5H2806 
Mol. Wt.: 304.38
5.14b
Ci5H2806 
Mol. Wt.: 304.38
Alkene 5.13 (918 mg, 3.4 mmol) and (DHQ^PYR (34 mg, 0.039 mmol) were stirred in warm lBuOH (21 mL) 
until the ligand dissolved (ca 30 min). After cooling to room temperature water (21 mL), K3Fe(CN ) 6  (3.4 g,
10.32 mmol) and K2 CO3 (1.43 g, 10.36 mmol) were added and the mixture was cooled to 0°C. Potassium 
osmate dihydrate (12.5 mg, 0.034 mmol) was then added. The reaction mixture was stirred for 3 h at 0°C, 
treated with saturated aqueous Na2 SC>3 (42 mL) and stirred for 15 min then extracted with CH2 CI2  (3 x 100 
mL). The combined organic extracts were washed with brine, dried (Na2 SC>4 ) and concentrated to give a 6 .6 :1 
mixture of diols 5.14a,b according to integration of the singlets at 8=  0.86 (major) and 0.92 (minor) revealed in 
the !H NMR spectrum (CgDg) of the mixture. The diastereoisomers were separated by column chromatography 
(SiC>2 20 g, CH2 Cl2 :methanol 0-4%) to afford pure major diol 5.14a (860 mg, 83%) and a mixture of diols 
5.14a,b (165 mg, 16%). The desired isomer 5 .1 4 a  was recrystallised from hexanes:Et2 0  to form thick 
colourless needles: mp 102-103°C (Et2 0 :hexanes).
[«]d 17-19.1 ( c  1.0, CHCI3 ). 
vmax CCl^cm - 1  3441 (br).
NMR assignments made using 2D H-H and C-H correlation spectra.
]H NMR (270 MHz, CDCI3 ): 8=  4.09 (1H, dd, J  = 12.9, 2.5 Hz, C10-HA/ /B), 3.93 (1H, t, J  = 2.5 Hz, C12-H), 
3.95-3.85 (1H, m, C17-H), 3.86-3.73 (3H, m), 3.64 [1H, m ( in presence of D2 O appears as dd, J  = 11.2, 3.7 
Hz), C18-HA/ / B], 3.50 [1H, m ( in presence of D2 O appears as dd, / =  11.2, 6.0 Hz), C18-HaHb], 3 40 (3H, s, 
OMe), 2.86 (1H, d, J  = 2.9 Hz, C13-H), 2.20 (1H, br, OH), 2.19 (1H, ddd, J  = 15.1, 12.0, 8.9 Hz, C16-HAtfB), 
1.67 (1H, br, OH), 1.56 (1H, ddd, J = 3.5, 2.1 Hz, signal collapses with gem-Me groups, C16-HAHB), 1.47 and
1.45 (3H each, s, CMe2), 1.23 (3H, s, C14-Me), 0.93 (3H, s, C14-Me).
1 0 0
13C NMR (67.5 MHz, CDC13): S=  98.4 (0), 84.5 (1), 81.1 (1), 72.5 (1), 66.5 (1), 66.0 (2), 63.2 (2), 60.3 (1),
59.3 (3), 36.5 (0), 30.0 (2), 29.2 (3), 27.4 (3), 21.9 (3), 18.8 (3).
LRMS m/z (Cl, NH3) 305 [(M+H)+, 50%], 289 (25), 273 (15), 247 (55), 87 (100).
Microanalysis: Anal. Calcd for C 15H2 8 O6 : C, 59.21; H, 9.21. Found: C, 59.31; H, 9.11.
A sample of undesired diastereoisomer 5.14b obtained by further column chromatography of a mixture of 
5.14a,b gave: mp 104-104.5°C (Et2 0 :hexanes).
[a ] D 17 +6.9 (c 0.9, CHCI3 ).
vmax CCl^cm - 1  3441 (br).
NMR assignments made using 2D H-H and C-H correlation spectra.
lH NMR (400 MHz, CDCI3 ): 8=  4.08 (1H, dd, J  = 12.8, 2.0 Hz, C10-HA/ / B), 3.91 (1H, t, J  = 2.0 Hz, C12-H), 
3.90-3.80 (3H, m), 3.57 [1H, m ( in presence of D2 O appears as dd, J  = 11.2, 3.2 Hz), C18-HAi /B], 3.52 (1H, 
m), 3.50 [1H, m ( in presence of D 2 O appears as dd, J  -  11.2, 7.6 Hz, C18-HAHB], 3.39 (3H, s, OMe), 2.92 
(1H, d, J  = 4.8 Hz, C17-OH), 2.85 (1H, d, J  = 2.4 Hz, C13-H), 2.39 (1H, d d ,7 =  8.0, 4.0 Hz, C18-OH), 2.29 
(1H, dd, J  = 8.1, 4.1 Hz, OH), 2.12 (1H, ddd, J  = 14.8, 12.4, 2.8 Hz, C16-//AHB), 1.50 (3H, s, OC(Me)O), 1.46 
(3H, s, OC(Me)O), 1.43 (1H, ddd, / =  14.8, 10.0, 3.2 Hz, C16-HA/ /B), 1.26 (3H, s, C14-Me), 0.92 (3H, s, C14- 
Me).
13C NMR (67.5 MHz, CDC13): 8=  98.5 (0), 84.5 (1), 77.7 (1), 68.9 (1), 67.7 (2), 66.4 (1), 63.3 (2), 59.5 (1, 2, 
2C), 36.0 (0), 30.3 (2), 29.3 (3), 27.8 (3), 22.5 (3), 18.6 (3).
LRMS m/z (Cl, NH3) 305 [(M+H)+, 5%], 289 (20), 273 (10), 231 (15), 87 (100).
Microanalysis: Anal. Calcd for Q 5 H2 8 O6 : C, 59.21; H, 9.21. Found: C, 59.23; H, 9.29.
1 0 1
(l/?,6/?,8/f,105)-10-Methoxy-8-[(2S)-2,3-dimethoxypropyl]-3,3>9,9-tetramethyl-2,4,7-
trioxabicyclo[4,4,0]decan 5.15.
kOMe
NaH, Mel
THF, rt
OMe
OMe
kOMe
OH
OH
5.14a 5.15
C 1 5 H 2 8 O 6  C 1 7 H 3 2 O 6
Mol. Wt.: 304.38 Mol. Wt.: 332.43
Sodium hydride (500 mg, 60% in oil, 12.5 mmol) was added to a stirred solution of diol 5.14a (1.65 g, 4.96 
mmol) and methyl iodide (1.0 mL, 16.7 mmol) in THF (18 mL) at 0°C. After 5 min the cooling bath was 
removed and the reaction mixture was stirred at room temperature for 7 h and then poured onto brine and 
extracted with CH2 CI2  (3 x 40 mL). The combined organic extracts were dried (Na2 SC>4 ) and concentrated. The 
residue was purified by column chromatography (SiC>2 20 g, hexanes:AcOEt 10-50%) to give methyl ether 5.15 
(1.55 g, 4.68 mmol, 94%) as a colourless oil: [oJd2 3  +7.6 (c 1.1, CHCI3).
vmax film/cm - 1 2878 (s), 2821 (s), 1455 (s), 1380 (s), 1094 (s), 850 (s).
*H NMR (270 MHz, CDC13): 8=  4.09 (1H, dd, J = 12.6, 2.5 Hz, C10-HAtfB), 3.93 (1H, t, J  = 2.1 Hz, C12-H),
3.85 (1H, dd, J  = 12.7, 1.7 Hz, C 10-//AHB), 3.63 (1H, q, J=  1.9 Hz, C ll-H ), 3.57 (1H, dd, J  = 12.3, 3.0 Hz, 
C15-H), 3.51 (1H, 4 lines of ABX system, / =  10.2, 3.5 Hz, C18-H AHB), 3.46 (1H, 4 lines of ABX system ,/  =
10.2, 5.0 Hz, C12-//a Hb), 3.42-3.32 (1H, m, C17-H), 3.37 (6 H, s, OMe), 3.36 (3H, s, OMe), 2.83 (1H, d, J =
2.5 Hz, C13-H), 2.35 (1H, ddd, J  = 14.8, 12.4, 4.6 Hz, C16-HA/ / B), 1.57 (1H, ddd, / =  14.9, 7.9, 3.1 Hz, C16- 
/ / a Hb), 1.47 and 1.44 (3H each, s, CMe2), 1.23 (3H, s, C14-Me), 0.91 (3H, s, C14-Me).
13C NMR (67.5 MHz, CDC13): 8=  98.3 (0), 84.8 (1), 78.7 (1), 78.6 (1), 73.2 (2), 66.5 (1), 63.5 (2), 59.7 (1),
59.4 (3), 59.2 (3), 57.2 (3), 36.3 (0), 29.4 (3), 28.2 (2), 27.7 (3), 22.3 (3), 18.7 (3).
LRMS m/z (Cl, NH3) 350 [(M+NH4 )+, 55%], 333 [(M+H)+, 100].
HRMS (Cl mode) Found: (M+H)+, 333.2270. C 1 7H3 3 0 6  requires M, 333.2277.
1 0 2
(2R,3R,4S,6/?)-2-Hydroxymethyl-4-methoxy-6-[(S)-2,3-dimethoxypropyl]-5,5-dimethyl-tetrahydro-2Zf- 
pyran-3-ol 2.1.
X
kOMe
OMe
OMe
kOMe
PTSA, MeOH, rt
OMe
OMe
5.15 2.1
C 1 7 H 3 2 O 6  C 1 4 H 2 8 O 6
Mol. Wt.: 332.43 Mol. Wt.: 292.37
A solution of acetal 5.15 (1.38g, 4.15 mmol) and /7-toluenesulfonic acid (16 mg, 0.083 mmol) in MeOH (14 
mL) was stirred at room temperature for 45 min. NaHC0 3  (0.4 g, 9.76 mmol) was then added and the mixture 
concentrated. The residue was taken up in CH2 CI2 , filtered through a pad of celite and concentrated to give 
crude diol 2.1 (100%) whose and ,3C NMR spectroscopic data were in agreement with that reported in the
17literature . The mixture was used in the next step without further purification.
(2R,3/?,4S,6/?)-2-[(terf-Butylcarbonyloxy)methyl]-4-methoxy-6-[(2S)-2,3-dimethoxypropyl]-5,5-dimethyl- 
tetrahydro-2//-pyran-3-ol 5.17.
kOMe
OMe
OMe
Pi OH
kOMe
OMe
OMe
2.1 5.17
C 1 4 H 2 8 O 6  C 1 9 H 3 6 O 7
Mol. Wt.: 292.37 Mol. Wt.: 376.48
As previously described on a 4.21 mmol scale with a quantitative yield over two steps17
(2/? ,3R,4S,6R)-2-[(terf-Butylcarbonyloxy)m ethyl]-4-m ethoxy-6-[(2S)-2,3-dimethoxypropyl]-5,5-dimethyl- 
3-(triethylsilyloxy)-tetrahydro-27/-pyran 5.18.
TESCI, Imidazole
OHPiv<
kOMe
OMe
OMe
DMF, 2h
5.17 5.18
C19H36O7 C25H5o07Si
Mol. Wt.: 376.48 Mol. Wt.: 490.75
Piv( OTES
kOMe
OMe
OMe
A solution of alcohol 5.17 (1.58 g, 4.21 mmol), imidazole (331 mg, 5.0 mmol) and chlorotriethylsilane (0.81 
mL, 4.72 mmol) in anhydrous DMF ( 6  mL) was stirred at room temperature for 2 h. The reaction mixture was 
then poured onto water (60 mL) and extracted with hexanes (3 x 40 mL). The combined organic extracts were
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dried (Na2 S 0 4 ) and concentrated. The residue was purified by column chromatography (S i0 2  15 g, 
hexanes:AcOEt 0-10%) to give silyl ether 5.18 (1.96 g, 4.17 mmol, 99%) as colourless rock crystals: mp 41- 
42°C (MeOH:H2 0).
[ « ] D 2 3  +70.9 (c 1.2, CHC13).
Vmax CClVcm - 1  1730 (s).
*H NMR (270 MHz, CDCI3 ): 8=  4.52 (1H, dd, J = 12.4, 9.5 Hz, C10-HAHB), 4.27 (1H, dd, J  = 12.4, 2.3 Hz, 
C10-//a Hb), 4.12 (1H, ddd, J  = 9.5, 6.9, 4.3 Hz, C ll-H ), 3.93 (1H, dd, J  = 9.5, 6 . 8  Hz, C12-H), 3.50 (3H, s, 
OMe), 3.50-3.30 (4H, m), 3.361 (3H, s, OMe), 3.359 (3H, s, OMe), 2.78 (1H, d, J =  9.6 Hz, C13-H), 1.72-1.63 
(2H, m, C16-H2), 1.23 (9H, s, lBu), 0.973 (3H, t, J =  8.1 Hz, CH3CH2), 0.971 (6 H, t, J =  8.1 Hz, C //3CH2), 0.94 
(3H, s, C14-Me), 0.87 (3H, s, C14-Me), 0.633 (4H, q, /  = 7.9 Hz, CH3C H 2\  0.629 (2H, q, J  = 7.9 Hz, 
CH3 C //2 ).
13C NMR (67.5 MHz, CDC13): 8=  178.6 (0), 86.5 (1), 77.9 (1), 75.3 (1), 73.8 (1), 73.4 (2), 70.2 (1), 62.3 (3),
60.1 (2), 59.3 (3), 56.9 (3), 41.1 (0), 38.8 (0), 29.8 (2), 27.3 (3, 3C), 23.4 (3), 14.0 (3), 6 . 8  (3, 2C), 6.7 (3), 5.9
(2), 4.9 (2, 2C).
LRMS m/z (Cl, NH3) 508 [(M + N H ^, 30%], 491 [(M+H)+, 20].
Microanalysis: Anal. Calcd for C2 5 H5 o0 7 Si: C, 61.22; H, 10.20. Found: C, 61.08; H, 10.10.
(2R,3/?,4S,6/?)-2-Hydroxym ethyl-4-methoxy-6-[(2S)-2,3-dim ethoxypropyl]-5,5-dim ethyl-3- 
t(triethylsilyl)oxy]-tetrahydro-2//-pyran 5.19.
DIBAL, CH2CI2, -78°C
5.18 5.19
C 2 5 H 5 o 0 7 S i  C 2 o H 4 2 0 e S i
Mol. Wt.: 490.75 Mol. Wt.: 406.63
DIBAL (neat, 2 mL, 11.2 mmol) was added dropwise to a stirred solution of ester 5.18 (3.03 g, 6.17 mmol) in 
CH2 CI2  (25 mL) at -78  °C. The reaction mixture was stirred for 30 min before being treated with saturated 
aqueous Na2 S0 4  (2 mL) and CH2 CI2  (50 mL). After stirring for a further 1 h at room temperature the resulting 
milky suspension was filtered through a pad of celite and concentrated to give alcohol 5.19 (2.47 g, 98%) as a 
colourless oil: [a ]o 2 0  +57.8° (c 1.0, CHCI3 ).
Pi QTES
,OMe
OMe
OMe
•H QTES
kOMe
OMe
OMe
Vmax film/cm - 1  3476 (br).
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NMR (270 MHz, CDCI3 ): 8=  4.02-3.88 (3H, m), 3.69 (1H, br, C10-H), 3.62 (1H, dd, / =  9.5, 4.6 Hz, C12- 
H), 3.58-3.32 (3H, m, C17-H and C18-H2), 3.51 (3H, s, OMe), 3.41 (3H, s, OMe), 3.38 (3H, s, OMe), 2.79 (1H, 
d, J  = 9.3 Hz, C13-H), 1.70-1.50 (1H, br, OH), 1.68 (2H, t, J  = 6.4 Hz, C16-H2), 0.972 (3H, t, /  = 8.3 Hz, 
CH3CH2), 0.970 (6 H, t, /  = 8.0 Hz, C tf3 CH2), 0.92 (3H, s, C14-Me), 0.87 (3H, s, C14-Me), 0.626 (4H, q, /  =
7.9 Hz, CH3CH2), 0.623 (2H, q, / =  8.0 Hz, CH3 CH2).
13C NMR (67.5 MHz, CDC13): 8=  86.7 (1), 78.3 (1), 76.7 (1), 75.8 (2), 72.3 (1), 71.0 (1), 62.5 (3), 59.1 (3),
57.3 (3), 57.1 (2), 41.3 (0), 31.2 (2), 23.2 (3), 13.7 (3), 6 . 8  (3, 3C), 6.0 (2), 4.9 (2, 2C).
LRMS m/z (Cl, NH3) 407 [(M+H)+, 80], 377 (50), 345 (30), 213 (100).
Microanalysis: Anal. Calcd for C2 oH4 2 0 6 Si: C, 59.11; H, 10.34. Found: C, 59.06; H, 10.17.
(2S,3R,4S,6/?)-2-Form yl-4-m ethoxy-6-[(2S)-2,3-dimethoxypropyl]-5,5-diinethyl-3-(triethylsilyloxy)- 
tetrahydro-2//-pyran 5.20.
Dess-Martin Oxidation
IH QTES
,OMe
OMe
OMe
QTES
,OMe
OMe
OMe
5.19 5.20
C20H42O6Si C2oH4o06Si
Mol. Wt.: 406.63 Mol. Wt.: 404.63
Dess-Martin periodinane was added in one portion to a solution of the alcohol 5.19 (200 mg, 0.49 mmol) in 
CH2 C12  ( 8  mL) at room temperature. After 40 min the reaction was quenched by the addition of saturated 
aqueous N aH C 0 3 (20 mL). After stirring for 10 min the organic layer was removed and the aqueous layer 
extracted with CH2 C12  (3 x 20 mL). The combined organic extracts were dried (MgSCLt) and concentrated to 
give crude aldehyde 5 .20  as a colourless oil (100%). Due to its instability, the aldehyde 5 .2 0  was used 
immediately in next step. Analytical data was collected without further purification.
[ « ] D 2 0  +29.2 (c 1.7, CHC13).
Vmax film/cm - 1  1729 (s), 1604 (s).
lH NMR (270 MHz, CDC13): 8=  10.1 (1H, s, C10-H), 4.31 (1H, d, / =  7.3 Hz, C ll-H ), 4.14 (1H, dd, J = 9.7,
7.1 Hz, C12-H), 3.72-3.56 (3H, m, C17-H, C18-H2), 3.52 (3H, s, OMe), 3.51 (1H, dd, J  = 9.6, 2.7 Hz, C15-H),
3.43 (3H, s, OMe), 3.40 (3H, s, OMe), 2.64 (1H, d, J  = 9.7 Hz, C13-H), 1.70-1.50 (2H, m, C16-H2), 1.00 (9H, t, 
J = 8.3 Hz, CH3CH2), 0.89 (3H, s, C14-Me), 0.85 (3H, s, C14-Me), 0.696 (4H, q, J  = 7.9 Hz, CH 3 CH2), 0.692 
(2H, q, 7=7.9  Hz, CH3  CH2).
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13C NMR (67.5 MHz, CDCI3 ): <5= 202.8 (1), 88.1 (1), 80.7 (1), 77.8 (1), 77.0 (1), 72.6 (2), 71.1 (1), 62.3 (3),
59.1 (3), 57.8 (3), 41.4 (0), 29.7 (2), 22.9 (3), 13.6 (3), 6.7 (3, 3C), 4.8 (2 , 3C).
LRMS m/z (Cl) 405 [(M+H)+, 100].
HRMS (Cl mode) Found: (M+H)+, 405.2668. C2 oH4 i 0 6Si requires M, 405.2672.
Benzyl orthoformate
121
Benzyl orthoformate was synthesised according to literature procedure .
OH CHCI3, KOH, 18-C-6
C6H6, 60°C, 24 h
(BnO)3CH
C7HeO 
Mol. Wt.: 108.14
C22H22O3
Mol. Wt.: 334.41
Powdered KOH (13 g) was added to an ice cooled solution of benzyl alcohol (24 mL), chloroform ( 6  mL), 18- 
crown- 6  (300 mg) in benzene (100 mL). The mixture was heated at 60°C (temp, of oil bath) over 24 h, filtered 
through a pad of celite and concentrated then again filtered and excess benzyl alcohol was removed by 
Kugelrohr distillation (150°C 0.01 mm Hg). The residue was filtered through a pad of silica (2 g, toluene:NEt3 
5%) and heated on high vacuum to give yellow-brown residue of benzyl orthoformate (3.77 g, 16.6%).
13C NMR Spectroscopic data was in agreement with that reported in the literature"
(25,3/?,4S,6/?)-2-Dibenzyloxym ethyI-4-methoxy-6-[(2S)-2,3-dim ethoxypropyl]-5,5-dimethyI-tetrahydro- 
2//-pyran-3-ol 5.21.
A solution of aldehyde 5.20 (891 mg, 2.19 mmol), benzyl orthoformate (2.22 g, 6 . 6  mmol) and camphorsulfonic 
acid (109 mg, 0.43 mmol) in CH 2 CI2  (10 mL) was stirred at room temperature for 5 h. Solid potassium 
carbonate (138 mg) was added and the solvent removed in vacuo. The residue was taken up in THF (20 mL) to 
which TBAF (3.15 g, 10 mmol) was added and the mixture was stirred at room temperature. After 11 h the 
reaction mixture was concentrated and the residue was taken up in Et20  (150 mL), washed with water (2 x 50 
mL) and brine. The organic phase was dried (Na2 S 0 4) and concentrated. The residue was purified by column
a) (BnO)3CH, CSA 
CH2CI21 rt
b) TBAF, THF, rt
II
OMeOMe
5.20
C2oH4oOeSi 
Mol. Wt.: 404.63
5.21
C2BH40O7
Mol. Wt.: 488.61
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chromatography (SiC>2 30 g, hexanes:Et2 0  10-80%) to give hydroxy acetal 5.21 (908 mg, 90%) as a yellow oil: 
[a]D20 +89.6 (c 1.6, CHC13).
vmax film/cm - 1  3452 (br).
NMR (360 MHz, CDC13, 333K): S=  7.45-7.25 (10H, m), 5.11 (1H, d, J  = 5.3 Hz, C10-H), 4.78 (1H, d, J  =
11.6 Hz), 4.77 (1H, d, J  = 11.6 Hz), 4.72 (1H, d, /  = 11.6 Hz), 4.65 (1H, d, J  = 11.6 Hz), 4.16 (1H, t , J  = 5.5 Hz, 
C ll-H ), 4.04-3.95 (1H, m, C12-H), 3.57 (1H, dd, J  = 10.5, 2.2 Hz, C15-H) 3.52-3.36 (3H, m, C17-H, C18-H2), 
3.50 (3H, s, OMe), 3.31 (3H, s, OMe), 3.29 (3H, s, OMe), 2.99 (1H, d, /  = 8.1 Hz, C13-H), 2.80 (1H, d, / =  4.6 
Hz, OH), 1.76 (1H, ddd, J  = 14.5, 10.5, 3.1 Hz, C ^ H ^H b ), 1.66 (1H, ddd, 7 =  14.3, 8 .8 , 2.2 Hz, C16HAHfi), 
0.97 (3H, s, C14-Me), 0.90 (3H, s, C14-Me).
13C NMR (90 MHz, CDC13> 333K): <5= 138.2 (0), 137.5 (0), 128.8 (1), 128.6 (1), 128.3 (1, 2C), 128.2 (1, 2C),
127.9 (1, 4C), 101.4 (1), 87.3 (1), 78.3 (1), 77.5 (1), 73.6 (2), 72.6 (1), 70.4 (2), 69.8 (1), 68.3 (2), 61.7 (3), 59.3
(3), 57.0 (3), 40.1 (0), 30.1 (2), 24.8 (3), 16.0 (3).
LRMS m/z (Cl, NH3) 506 [(M+NH4 )+, 2%], 489 [(M+H)+, 0.4], 398 (0.8), 381 (0.8).
HRMS (Cl mode) [Found: (M+H)+, 489.2859. C2 8 H4 1 0 7  requires M, 489.2852.
(l/?,55,65',8/?,10S)-5-Benzyloxy-8-[(25)-2,3-dim ethoxypropyl]-9,9-dim ethyl-10-m ethoxy-2,4,6- 
trioxabicyclo[4,4,0]decane 5.22a and (l/?,5/?,6S,8/?,10S)-5-Benzyloxy-8-[(2S)-2,3-dimethoxypropyl]-9,9- 
dimethyl-10 m ethoxy-2,4,6-trioxabicycIo[4,4,0]decane 5.22b.
(CH20 )n. HCI
(Bn O H
>OMe
Bn<
OMe
OMe
CH2CI2, 0°C 
d r  =  6.5:1
,OMe
OMe
OMe
,OMe
BnO*
+
OMe
OMe
5.21 5.22a 5.22b
C28H40O7 C22H34O7 C22H34O7
Mol. Wt.: 488.61 Mol. Wt.: 410.50 Mol. Wt.: 410.50
HCI gas was passed through a stirred mixture of hydroxy acetal 5 .2 1  (908 mg, 1.97 mmol) and 
paraformaldehyde (635 mg, 21.2 mmol) in CH 2 CI2  (80 mL) at 0°C for 30 min. The white suspension of 
paraformaldehyde disappeared to give a colourless solution. A stream of nitrogen was then passed through the 
reaction mixture for 1 h to form a white suspension. The mixture was poured onto saturated aqueous NaHC03, 
the organic layer was separated and the aqueous phase was extracted with CH 2 CI2  (3 x 25 mL). The combined 
extracts were dried (Na2 S0 4) and concentrated. The residue was purified by column chromatography (SiC>2 
13g, hexanes:Et2 0  5-40%) to give the acetals 5.22a,b  (740 mg, 93%) as a 6.5:1 mixture of diastereoisomers 
according to integration of the C-10 methine doublets at 8=  5.15 (major) and 5.25 (minor) revealed in the !H
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NMR spectrum  (CDCI3 ). For analysis a sample of the acetals 5 .2 2 a ,b  were separated by column 
chromatography (Si0 2 , hexanes:Et2 0  5-30%).
Major diastereoisomer 5.22a:
[a ] D 2 0  +32.3 (c0.7, CHCI3).
vmax film/cm - 1  2879 (s), 1455 (s), 1178 (s), 1101 (s), 1044 (s), 981 (s), 821 (s), 735 (s), 700 (s).
NMR (270 MHz, CDC13): 8 = 7.40-7.:27 (5H, m), 5.15 (1H, d, 7  = 6.0 Hz, OCHa / / bO), 4.86 (1H, d, J=  6.0 
Hz, O C //a HbO), 4.85 (1H, s, C10-H), 4.81 (1H, d, 7 = 12.0 Hz, PhCH2), 4.58 (1H, d, 7 = 11.8 Hz, PhCH2),
3.94 (1H, t, 7 = 2.7 Hz, C12-H), 3.71 (1H, t, 7 = 1.7 Hz, C l 1-H), 3.57 (1H, dd, 7  = 12.2, 3.1 Hz, C15-H), 3.56-
3.40 (2H, m, C18-H2), 3.40-3.30 (1H, m, C17-H), 3.38 (3H, s, OMe), 3.33 (3H, s, OMe), 3.30 (3H, s, OMe), 
2.89 (1H, d, 7  = 3.1 Hz, C13-H), 2.28 (1H, ddd, 7 = 15.3, 12.4, 4.6 Hz, C16-Ha / / b ), 1.59 (1H, ddd, 7 =  14.9,
7.7, 3.1 Hz, C16-/7AHB), 1.22 (3H, s, C14-Me), 0.91 (3H, s, C14-Me).
13C NMR (67.5 MHz, CDC13): 8= 137.2 (0), 128.6 (1, 2C), 128.2 (1, 2C), 128.0 (1), 96.7 (1), 85.3 (2), 83.8 (1),
78.7 (1), 78.5 (1), 73.5 (2), 70.1 (1), 69.1 (2), 63.1 (1), 59.6 (3), 59.3 (3), 57.2 (3), 37.0 (0), 28.4 (2), 27.4 (3),
21.8 (3).
LRMS m/z (Cl, NH3) 411 [(M+H)+, 45], 307 (50), 345 (25), 277 (65), 126 (100).
Microanalysis: Anal. Calcd for C2 2 H3 4 O7 : C, 64.39; H, 8.29. Found: C, 64.16; H, 8.47.
Minor diastereoisomer 5.22b:
[a ]D2 0 +11.4° (c 0.8, CHCI3 ).
vmax film/cm- 1 2879 (s), 1455 (s), 1178 (s), 1101 (s), 1044 (s), 981 (s), 821 (s), 735 (s), 700 (s).
*H NMR (360 MHz, CDC13j 333 K): 8= 7.40-7.27 (5H, m), 5.24 (1H, d, 7 =  6.3 Hz, OCHa/ /bO), 5.00 (1H, d,7 
= 3.6 Hz, C10-H), 4.89 (1H, d, 7 =  11.8 Hz, PhCH2), 4.63 (1H, d, 7 =  6.3 Hz, O C //a HbO), 4.60 (1H, d, 7=  11.8 
Hz, PhCH2), 4.11 (1H, dd, 7 = 6.1, 3.6 Hz, C12-H), 4.03 (1H, dd, 7 = 10.2, 2.5 Hz), 3.98 (1H, dd, 7 = 18.8, 6.1 
Hz), 3.50-3.20 (3H, m), 3.50 (3H, s, OMe), 3.39 (1H, d, 7 = 2.4 Hz, C13-H), 3.34 (3H, s, OMe), 3.20 (3H, s, 
OMe), 1.74-1.56 (2H, m, C16-H2), 0.99 (3H, s, C14-Me), 0.87 (3H, s, C14-Me).
13C NMR (90 MHz, CDC135333 K): 8=  137.5 (0), 128.7 (1, 2C), 128.1 (1, 2C), 128.0(1), 99.0 (1), 82.2 (2),
81.9 (1), 78.5 (1), 76.8 (1), 74.2 (2), 73.6 (1), 70.4 (2), 67.3 (1), 61.2 (3), 59.2 (3), 57.1 (3), 40.2 (0), 30.4 (2),
24.5 (3), 15.2 (3).
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LRMS m/z (Cl, NH3) 411 [(M+H)+, 45], 307 (15), 294 (20), 277 (35), 126 (100), 91 (70).
Microanalysis: Anal. Calcd for C2 2 H3 4 O7 : C, 64.39; H, 8.29. Found: C, 64.22; H, 8.41.
(li?,5/?S,6/?,8/?,10S)-10-M ethoxy-8-[(2S)-2,3-dimethoxy-propyl]-9,9-dimethyl-2,4,7- 
trioxabicyclo[4.4.0]decan-5-ol 5.23.
H2 (g),5% Pd/C
,OMeBnOJ
6.5:1
OMe
OMe
EtOAc, rt
kOMe
OMe
OMe
5.22a,b
C22H34O7 
Mol. Wt.: 410.50
5.23
C15H28O7 
Mol. Wt.: 320.38
To a solution of acetals 5.22a,b (400 mg, 0.97 mmol) in EtOAc (30 mL) was added Pd/C 5% (760 mg). The 
argon atmosphere was replaced with hydrogen and the mixture was stirred vigorously for 17 h. The hydrogen 
gas was removed and the mixture filtered through a pad of celite and concentrated. The residue was passed 
through a pad of silica (7 g, hexanes:EtOAc 50%) to give a 3:1 mixture hemiacetals 5.23 (271 mg, 0.844 mmol, 
87%) according to integration of the C14-Me singlets at 8=  0.91 (major) and 0.94 (minor) revealed in the *H 
NMR spectrum (CDCI3 ) of the mixture.
]H and 13C NMR spectroscopic data were in agreement with that reported in the literature17
Form ation o f azides 5.24.
cr^\)
.OMe
OMe
OMe
5.23
C15H28O7 
Mol. Wt.: 320.38
a) MsCI, DMAP, NEt3 
CH2C2,-7 0 -+ -1 0 °C , 1 h
b) TMSN3, TASF 
CH2CI2, -80°C-»rt, 16 h
,OMe
OMe
OMe
5.24
Cl5H27N306
Mol. Wt.: 345.39
As previously reported in 74% yield17
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Formation of oxalamides 1.57a and 1.57b.
b) methyloxalyl chloride, DMAP 
CH2CI2, -20°C , 15 min 
dr= 1:2
OMe
5.24
C15H27N3O6 
Mol. Wt.: 345.39
1.71
C18H31 NOg 
Mol. Wt.: 405.44
1.57
C18H31NO9 
Mol. Wt.: 405.44
As previously reported in 57% yield17.
(lS,5S,6S,8S,10/?)-5{[(2/?,3/?,4/?)-3,4-dihydro-2,3-dimethyl-4-phenylselenylmethyl-2ff-pyran-6-yl]-
oxoethanam ido}-8-[(2S)-2,3-dim ethoxypropyl]-9,9-dim ethyl-10-m ethoxy-2,4,7-trioxabicyclo[4.4.0]decane
1.73.
Prepared according to literature procedure17.
SePh
1.72
Ci7H2eOSeSn 
Mol. Wt.: 444.06
SnM$3 nguLj
'V . . .THF, -78°C SePh
1.56
C14H17UOS6  
Mol. Wt.: 287.19
o < y ^ (
,OMeMel
OMe
OMe
1.57
C18H31 NOg 
Mol. Wt.: 405.44
TMEDA
THF
-78°C
,OMe
OMe
Phi
OMe
1.73
C31 H 45NOgSe
Mol. Wt.: 654.65
nBuLi (1.5 M in hexanes, 0.375 mL, 0.562 mmol) was added dropwise to a stirred solution of vinyl stannane
1.72 (256 mg, 0.576 mmol) in THF (2.7 mL) at -80°C. The solution was stirred for 15 min and TMEDA (0.1 
mL, 0.66 mmol) was added. After 10 min a cold (-80°C) solution of ester 1.57 (72 mg, 0.18 mmol) in THF (1 + 
0.5 + 0.5 mL) was quickly added via cannula. The reaction mixture was stirred for 30 min, treated with brine 
and extracted with CH 2 CI2  (3 x 20 mL). The combined extracts were dried (Na2 SC>4 ) and concentrated. The
1 1 0
residue was purified by column chromatography (Si0 2  4 g, hexanes:EtOAc) to give enone 1.73 (87 mg, 74%) 
as a colourless oil. and 13C NMR data were in agreement with literature36.
Formation o f  benzoates 1.74a and 1.74b
,OMe
OMe
OMe
a) /-Selectride, THF, -95°C
b) MeOH, CSA, CH2CI2> rt
c) BzCI, ('Pr)2EtN, DMAP, CH2CI2, rt
1.73
C31 H^NOgSe 
Mol. Wt.: 654.65
OMe OMe
>OMeiOMe
OBz OBz
Ph! Phi
OMeOMe
OMe OMe
1.74a
C39 H 55 NO11 Se  
Mol. Wt.: 792.81
As previously reported in 55% overall yield . 17  
18-0-M ethyl M ycalam ide B 1.5
dr = 3:1 1.74b
C39H 55 NO nSe 
Mol. Wt.: 792.81
OMe
PhSeT
kOMe
OMe
OMe
a) Nal04, H20, MeOH, rt
b) NEt3, PhMe, A
c) 1M LiOH(aq), MeOH
OMe O 9 ^ ? ^ ?
kOMe
OH
OMe
OMe
1.74a
C39 H 55 NO11 Se  
Mol. Wt.: 792.81
1.5 18-O-methyl mycalamide B 
C26H45NO10 
Mol. Wt.: 531.64
As previously reported in 6 8 % yield 17
1 1 1
7.3 Synthesis o f Theopederin D 
(2S,6R)-6-(3-Chloropropyl)-tetrahydro-5,5-dim ethyl-2-vinyl-2//-pyran-4-one 6.1.
CH2=CH2 MgCI, Cul 
THF, -90^-30°C , 2.5 h
Cl
2.2
Mol. Wt.: 202.68
To a stirred solution of enone 2.2 (14.2 g, 70.1 mmol) and copper(I) iodide (700 mg, 3.7 mmol) in THF (120 
mL) at -95°C was added a solution of vinyl magnesium chloride (1.7 M in THF, 60 mL, 102 mmol) over 30 
min. The reaction mixture was stirred for 1.5 h at -90°C and then allowed to warm up to -30°C over 1.5 h. After 
such time saturated aqueous NH4 CI (200 mL) was added followed by concentrated ammonia solution (40 mL). 
The resulting mixture was stirred for 30 min at room temperature before being extracted with Et2 0  (3 x 60 mL). 
The combined organic extracts were dried (Na2 SC>4 ) and concentrated. The residue was purified by Kugelrohr 
distillation to give vinyl ketone 6.1 (12.69 g, 55.3 mmol, 79%) as a colourless oil: bp 160-180°C at 0.07 mm 
Hg. The diastereomeric ratio was found to be 15:1 from the JH NMR spectrum by integration of the two doublet 
of doublet signals derived from C 1 2 -H2 [!H NMR (360 MHz, CDCI3 ): 8 = 2.85 and 2.81 (minor) and 2.55 and 
2.67 ppm (major) ppm],
[a]D20 +46.5 (c 1.1,CHC13).
vmax film/cm - 1  1712 (s), 1128 (s).
JH NMR (400 MHz, CDC13): 5 =  5.85 (1H, ddd, 7 = 17.2, 11.2, 4.8 Hz, C10-H), 5.25 (1H, t, 7 = 1.2, C9- 
Ha / / b ), 5.21 (1H, dt, 7 = 8 .8 , 1.2 Hz, C9-tfAHB), 4.56 (1H, qt, 7 = 4 .8 , 1.6 Hz, C ll-H ), 3.61 (1H, dd ,7  = 10.0,
3.6 Hz, C15-H), 3.55 (2H, t, 7 = 6.4 Hz, C18-H2), 2.67 (1H, dd, 7 =  14.4, 6.0 Hz, C12-HAHB), 2.55 (1H, dd, 7 =
14.4, 6.0 Hz, C12- //aHb), 2.02-1.92 (1H, m), 1.81-1.70 (1H, m), 1.70-1.50 (2H, m), 1.11 (3H, s, C14-Me), 1.06 
(3H, s, C14-Me).
13C NMR (100 MHz, CDCI3 ): 8=  211.5 (0), 137.3 (1), 117.9 (2), 79.3 (1), 72.6 (1), 49.8 (0), 45.0 (2), 41.5 (2),
29.3 (2), 25.9 (2), 22.0 (3), 19.4 (3).
LRMS m/z (Cl) 248 [(M+NH4)+, 100%].
HRMS (Cl) Found: (M+H)+, 230.1071. C i2 H i9 C102  requires M, 230.1074.
Microanalysis: Anal. Calcd for C]2 H 1 9C102: C,62.47; H, 8.24. Found: C, 62.48; H, 8.18.
6.1
Ci2Hi9CI0 2 
Mol. Wt.: 230.73
1 1 2
(2S,6/?)-6-(3-Chloropropyl)-5,5-dimethyl-2-[(l/?)-l,2-dihydroxyethyl]-tetrahydro-2/7-pyran-4-one 6.2.
1 0 0The asymmetric dihydroxylation was performed according to literature procedure.
dihydroquinine 9-phenantryl ether 
K3Fe(CN)6, K2C 03> K0s04*2H20
P
H20 , *BuOH, 0°C, 3 h
Cl
6.1
.CIO;
Mol. Wt.: 230.73 Mol. Wt.: 264.75
Olefin 6.1 (10.0 g, 43.5 mmol) and hydroqinine 9-phenanthryl ether 6.4 (439 mg, 0.88 mmol) were stirred in 
lBuOH (260 mL) until the ligand dissolved before water (260 mL), K3 Fe(CN)g (43.3 g, 131.3 mmol) and 
K2 CO3 (18.3 g, 132.6 mmol) were added and the mixture was cooled to 0°C. Potassium osmate dihydrate (267 
mg, 0.72 mmol) was added. The reaction mixture was stirred for 3 h at 0°C then treated with saturated aqueous 
Na2 S0 3  (400 mL) and water (100 mL). After stirring at ambient temperature for 0.5 h the mixture was extracted 
with CH2 CI2  (400 mL + 2 x 200 mL). The combined organic extracts were dried (Na2 S04) and concentrated to 
give the crude diol. Filtration through silica gel (100 g, Et2 0 :EtOAc 10-40%) afforded diol 6.2 (8.63 g, 32.7 
mmol, 75%) as a 13:1 mixture of diastereoisomers as determined from the XH NMR spectrum by integration of 
signals derived from the C14-Me group f1 H NMR (360 MHz, CDCI3 ): 8 = 1.26 ppm (major) and 1.28 ppm 
(minor)].
[a]D1 9 -8 .0  (c I.L C H C I3 ).
Vmax film/cm - 1  3412 (br), 1712 (s).
*H NMR (360 MHz, CDC13): 8=  3.94 (1H, dt, J  = 9.7, 4.6 Hz, C ll-H ), 3.81 (1H, ddd, J  = 9.8, 6.2, 3.7 Hz, 
C10-H), 3.77 (1H, dd, J  = 11.9, 3.5 Hz, C15-H), 3.73 (1H, dd, J  = 11.4, 3.6 Hz, C9-HAtf B), 3.65 (1H, d d ,/  =
11.3, 6.4 Hz, C9-tfAHB), 3.57 (2H, t, / =  6.0 Hz, C18-H2), 3.00-2.60 (2H, br, OH), 2.78 (1H, dd, / =  14.6, 9.7 
Hz, C12-HA/ / B), 2.40 (1H, dd, J=  14.6, 4.3 Hz, C12-//AHB), 2.00-1.95 (1H, m), 1.80-1.45 (3H, m), 1.27 (3H, 
s, C14-Me), 1.01 (3H, s, C14-Me).
13C NMR (90 MHz, CDC13): 8=  212.9 (0), 81.6 (1), 73.6 (1), 71.7 (1), 63.2 (2), 49.6 (0), 44.5 (2), 38.8 (2),
28.7 (2), 25.3 (2), 24.2 (3), 19.3 (3).
LRMS m/z (Cl) 248 [(M+NH4)+, 100%].
Microanalysis: Anal. Calcd for C 1 2H2 iC104: C, 54.44; H, 7.94; Cl, 13.42. Found: C, 54.50; H, 7.74; Cl, 13.72.
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The following additional experiments were performed on a 20 mg scale:
AD-mix-a
a /p  ca 1:2 (TLC) reaction slow abandoned
AD-mix-p
a /p  ca 2 :1  (TLC) reaction slow abandoned
DHQ 2,5-diphenyl-4,6-pyrimidinediyl diether [(DHQ^PYR] 
a /p  ca 1:3.5
DHQD 2,5-diphenyl-4,6-pyrimidinediyl diether[(DHQD)2 PYR] 
a /p  ca 2 .6 : 1
DHQ 4-methyl-2-quinoyl ether
a /p  ca 1:7.5
DHQ 9-phenantryl ether
a /p  ca 1 :8 . 1
DHQD-PYDZ
a/p  ca 1.3:1
without chiral ligand
a /p  ca 1:1.5 (TLC) reaction slow abandoned
(2S,6/?)-6-(3-Chloropropyl)-5,5-dimethyl-2-[(ljR)-2-(tert-butylcarbonyIoxy)-l-hydroxyethyl]-tetrahydro- 
27/-pyran-4-one 6.3.
PivCI, Py
c h 2ci2, o°c, 1 h ° y \
6.3
Ci2H2iC I04 Ci7H2gCI05
Mol. Wt.: 264.75 Mol. Wt.: 348.86
To a solution of diols 6.2 (dr = 13:1, 11.3 g, 43.0 mmol) and pyridine (10.4 mL, 128.9 mmol) in CH2 CI2  (70 
mL) at 0°C was added pivaloyl chloride (10.8 mL, 87.5 mmol). The reaction mixture was stirred at 0°C for 1 h, 
treated with saturated aqueous NaHC0 3  and extracted with Et2 0  (3 x 70 mL). The combined extracts were 
washed with 2M H C l^ )  (50 mL), brine (70 mL), dried (Na2 SC>4 ) and concentrated. The residue was filtered
ci
6.2
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through a pad of silica (100 g, hexanes:Et2 0  20-50%) and concentrated. Diastereoisomerically pure ester 6.3 
(11.6 g, 33.5 mmol, 78%) was obtained as colourless needles by recrystallisation from hexanes:Et2 0 ; mp 69- 
70°C (hexanes:Et2 0 )
[a]D1 9 -2 .0  (c 1.0, CHC13).
Vmax CCV cm - 1 3599 (br), 1716 (s).
lH NMR (400 MHz, CDCI3 ): S=  4.27 (1H, dd, 7 = 11.6, 3.6 Hz, C9-HA/ /B), 4.12 (1H, dd,7 = 11.6, 6.4 Hz, C9- 
Ha Hb), 3.96 (1H, dddd, 7 = 14.8, 6.4, 5.6, 4.0 Hz, C10-H), 3.92 (1H, dt, 7 = 9.8, 5.3 Hz, C l 1-H), 3.80 (1H, dd, 
7 = 12.0, 3.2 Hz, C15-H), 3.60-3.54 (2H, m, C18-H2), 2.82 (1H, dd, 7 = 14.8, 9.6 Hz, C 1 2 -HA/ /B), 2.70-2.20 
(1H, d, 7 = 4.4 Hz, OH), 2.42 (1H, dd, 7 =  14.8, 4.0 Hz, C12-HAHB), 2.00-1.85 (1H, m), 1.84-1.50 (3H, m),
1.29 (3H, s, C14-Me), 1.22 (9H, s, lBu), 1.03 (3H, s, C14-Me).
13C NMR (100 MHz, CDC13): 5=  211.9 (0), 179.1 (0), 82.1 (1), 72.3 (1), 71.2 (1), 64.9 (2), 49.7 (0), 44.8 (2),
39.1 (0), 38.6 (2), 28.8 (2), 27.4 (3, 3C), 25.4 (2), 24.8 (3), 19.5 (3).
LRMS m/z (Cl) 349 [(M+H)+, 20%].
Microanalysis: Anal. Calcd for C 1 7H2 9 CIO5 : C, 58.54; H, 8.32; Cl, 10.19. Found: C, 58.71; H, 8.02; Cl, 10.37.
(25,6/?)-6-(3-Chloropropyl)-5,5-diniethyl-2-[(lR)-2-(tert-butylcarbonyloxy)-l-(m ethoxym ethoxy)ethyl]- 
tetrahydro-2//-pyran-4-one 6.5.
Piv(
6.3
MOMCI, (PrfeNEt 
Bu4NI 
PhMe, 90°C, 2 hT
•Me
Cl
6.5
C17H2 9CIO5 CigH33CIOg
Mol. Wt.: 348.86 Mol. Wt.: 392.91
A mixture of alcohol 6.3 (2.4 g, 6.9 mmol), A-ethyldiisopropylamine (3.7 mL, 21.1 mmol), tetabutylammonium
iodide (128 mg, 0.35 mmol), chloromethyl methyl ether (1.6 mL, 21.1 mmol) and anhydrous toluene (20 mL)
were stirred at 90°C for 2 hours. The reaction mixture was cooled to room temperature and treated with
saturated aqueous NaHCC>3 (30 mL). The layers were separated and the aqueous layer was extracted with Et2 0
(2 x 30 mL). The combined organic extracts were washed with brine (30 mL), dried (Na2 S0 4 ) and concentrated.
The residue was purified by column chromatography (SiC>2 25g, hexanes:Et2 0  10-40%) to give MOM ether 6.5
(2.63 g, 6.7 mmol, 97%) as a white solid; mp 42-43°C (hexanes:Et2 0 )
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[a ]D21 +3.4 (c 1.4, CHCI3).
vmax CCVcm - 1 1732 (s), 1716 (s), 1154 (s).
*H NMR (400 MHz, CDCI3 ): 8 = 4.73 (1H, d, 7 =  6 . 8  Hz, OCHAtfB0 ), 4.64 (1H, d, 7 = 6 . 8  Hz, 0 C //AHB0), 
4.32 (1H, dd, 7 = 12.0, 4.4 Hz, C9-HAH B), 4.02 (1H, dd, 7 =  12.0, 5.2 Hz, C9-HAHB), 3.95 (1H, dt, 7 = 10.0,
4.4 Hz, C ll-H ), 3.82 (1H, q, 7  = 4.8 Hz, C10-H), 3.72 (1H, dd, 7 =  11.6, 3.2 Hz, C15-H), 3.51 (2H, t, 7 =  6.0 
Hz, C I 8 -H2 ), 3.34 (3H, s, OMe), 2.75 (1H, dd, 7 = 14.4, 9.6 Hz, C12-HAtfB), 2.38 (1H, dd, 7 =  14.4, 4.4 Hz, 
C12-Ha Hb), 1.95-1.83 (1H, m), 1.78-1.43 (3H, m), 1.23 (3H, s, C14-Me), 1.15 (9H, s, *6 1 1 ), 0.97 (3H, s, C14- 
Me).
13C NMR (100 MHz, CDC13): 8=  211.7 (0), 178.1 (0), 96.5 (2), 81.8 (1), 76.7 (1), 70.6 (1), 62.7 (2), 56.1 (3),
49.6 (0), 44.7 (2 ), 39.0 (2), 38.8 (0), 28.6 (2 ), 27.2 (3, 3C), 25.2 (2), 24.6 (3), 19.4 (3).
LRMS m/z (Cl) 393 [(M+H)+, 7%].
Microanalysis: Anal. Calcd for C 1 9H3 3 C106: C, 58.09; H, 8.41; Cl, 9.04. Found: C, 58.36; H, 8.12; Cl, 8.94.
(2S,6R)-4-[(terf-Butyldimethylsilyl)oxy]-2-[(LR)-2-(tert-butyIcarbonyloxy)-l-(methoxymethoxy)ethyI]-6-(3- 
chloropropyI)-5,6-dihydro-5,5-dimethyI-27/-pyran 6 .6.
^J)M e ^<j)Me
OTBSPiv< Piv<TBSOTf, NEt-
Cl
6.5 6.6
^ 1 9 ^ 3 3 ^ 1 0 6  C 25H 47C I 0 6Si
Mol. Wt.: 392.91 Mol. Wt.: 507.18
To a mixture of ketone 6.5 (6.81 g, 17.4 mmol) and triethylamine (4.7 mL, 3.41 g, 33.7 mmol) in CH2 CI2  (26 
mL) at 0°C was added TBSOTf (4.7 mL, 5.41 g, 20.5 mmol) in a dropwise fashion over 5 min. After the 
addition was complete the cool bath was removed and the reaction mixture stirred for 1.5 h at ambient 
temperature. After such time saturated aqueous NaHC0 3  (100 mL) was added and the mixture extracted with 
hexanes (3 x 50 mL). The combined extracts were dried (Na2 S0 4 ) and concentrated to give crude silyl enol 
ether 6 .6 . TBSOH was removed under vacuum at 50°C, 1 mm Hg overnight to give silyl enol ether 6 . 6  (8.58 g,
17.0 mmol, 98%) as a clear colourless oil.
For analysis a sample (200 mg) was removed and purified by column chromatography (SiC>2 , hexanes:Et2 0  
2%).
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[a]D17 +10.3 (c 1.1,CHC13).
vmax film/cm- 1  1732 (s), 1664 (s), 1154 (s).
JH NMR (400 MHz, CDCI3 ): 5 =  4.77 (1H, d, / =  3.2 Hz, C12-H), 4. 75 (1H, d, 7 =  6.4 Hz, OCHa HbO), 4.69 
(1H, d, 7 = 6 . 8  Hz, OCHa R bO), 4.50 (1H, dd, 7 = 12.0, 2.4 Hz, C9-HAHB), 4.23 (1H, dd, 7  = 7.6, 2.8 Hz, C l 1- 
H), 4.11 (1H, dd, 7 = 12.0, 5.6 Hz, C9-HAUB), 3.73 (1H, d d d ,7 =  8.0, 6.0, 2.8 Hz, C10-H), 3.65-3.53 (2H, m, 
C18-H2), 3.42 (1H, dd, 7 = 10.8, 2.4 Hz, C15-H), 3.40 (3H, s, OMe), 2.10-2.00 (1H, m), 1.84-1.50 (3H, m), 
1.22 (9H, s, tBuCOO), 1.04 (3H, s, C14-Me), 0.96 (3H, s, C14-Me), 0.95 (9H, s, lBuSi), 0.18 (3H, s, MeSi), 
0.18 (3H, s, MeSi).
13C NMR (100 MHz, CDC13): 5 =  178.6 (0), 156.3 (0), 98.4 (1), 96.6 (2), 79.2 (1), 77.5 (1), 70.2 (1), 64.4 (2),
56.0 (3), 45.5 (2), 39.0 (0), 38.7 (0), 29.9 (2), 27.4 (3, 3C), 26.3 (2,), 25.9 (3, 3C), 23.3 (3), 19.9 (3), 18.4 (0), 
-4.2 (3), -4.6 (3).
LRMS m/z (Cl, NH3) 524 [(M+NH4 )+, 40%].
HRMS (Cl) Found: (M+H)+, 507.2910. C2 5 H4 8 C1 0 6Si requires M , 507.2909.
Microanalysis: Anal. Calcd for C2 5 H4 7 C1 0 6 Si: C, 59.35; H, 9.23. Found: C, 59.31; H, 9.01.
(21? ,35,45,6/?)-4-[(terf-ButyIdimethylsUyl)oxy]-2-[(LR)-2-(terM)utylcarbonyloxy)-l- 
(methoxymethoxy)ethyl]-6-(3-chloropropyI)-3,4-epoxy-tetrahydro-5,5-dim ethyl-27/-pyran 6.7.
iMe
Piv< .OTBS
6.6
'Me
Piv< .OTBS
mCPBA
CH2CI2, 0°C, 40 min
6.7
C25H47CI06Si C25H47CI07Si
Mol. Wt.: 507.18 Mol. Wt.: 523.17
A solution of w-chloroperbenzoic acid (15.2 g, 57-80% from Aldrich) in CH2 C12  (150 mL) was dried over 
Na2 S 0 4, filtered and stirred with sodium hydrogen orthophosphate (11.2 g, 78.7 mmol) at room temperature 
for 30 min. The mixture was then cooled to 0°C and a solution of enol ether 6 . 6  (8.58 g, 17.0 mmol) in CH2 C12  
(30 + 8  + 8  mL) was added dropwise over 20 min. The reaction mixture was stirred for 40 min, treated with 
saturated aqueous Na2 S 0 3 and hexanes (500 mL). The phases were separated. The organic phase was extracted 
with 2M NaOH(aq) (2 x 70 mL), washed with water (70 mL), brine (70 mL), dried (Na2S04) and concentrated 
to afford crude epoxide 6.7 (9.58g, 18.4 mmol, 108%) as a single diastereoisomer and a clear colourless oil.
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For analysis a sample (200 mg) was removed and purified by column chromatography (SiC>2 , hexanes:Et2 0  
2%).
[a ]D2 °+10.0 (c 2.0, CHCI3 ). 
v max film/cm - 1  1732 (s), 1 152 (s).
*H NMR (360 MHz, CDC13): 5 =  4.78 (1H, d, J = 6.7 Hz, 0C H AtfB0), 4.74 (1H, d, J =  6.7 Hz, O C//a HbO),
4.54 (1H, dd, J  = 12.0, 1.8 Hz, C9-HA/ / B), 4.05 (1H, dd, J=  9.9, 3.2 Hz, C ll-H ), 4.01 (1H, dd, 7 =  12.0, 4.3 
Hz, C9-f/AH B), 3.94 (1H, ddd, J =  9.9, 4.1, 1.6 Hz, C10-H), 3.57-3.47 (2H, m, C18-H2), 3.51 (1H, d, J  = 3.2 
Hz, C12-H), 3.43 (3H, s, OMe), 3.27 (1H, dd, J  = 10.3, 1.4 Hz, C15-H), 1.22 (9H, s, tBuCOO), 1.05 (3H, s, 
C14-Me), 0.98 (3H, s, C14-Me), 0.91 (9H, s, lBuSi), 0.14 and 0.06 (3H each, s, Me2 Si).
13C NMR (90 MHz, CDC13): 8 = 178.5 (0), 96.3 (2), 8 6 . 6  (0), 76.0 (1), 71.7 (1), 68.9 (1), 63.6 (2), 60.4 (1),
56.2 (3), 45.3 (2), 39.1 (0), 38.9 (0), 30.1 (2), 27.4 (3, 3C), 26.9 (2), 25.8 (3, 3C), 18.7 (3), 18.0 (0), 16.8 (3), 
-3.1 (3), -3.4 (3).
LRMS mJz (Cl, NH3) 540 [(M+NH4)+, 100%].
HRMS (El) Found: (M+H)+, 522.2781. C2 5 H4 7 C1 0 7Si requires M, 522.2780.
(lS,5/?,6/?,8/?)-5-(ter/-Butylcarbonyloxy)m ethyl-8-(3-chloropropyl)-9,9-dimethyl-2,4,7- 
trioxabicyclo[4,4,0]decan-10-one 6.10.
)Me
Piv< .OTBS
6.7
Piv<
P20 5, CH(OMe)2
^ 25^ 47^10751 0 -18^290100
Mol. Wt.: 523.17 Mol. Wt.: 376.87
A mixture of crude epoxide 6.7 (3.5 g, 92% pure, 6.17 mmol) from above experiment in CH2 CI2 (10 +5 mL) 
was added to an ice cold solution of dimethoxymethane (30 mL) and P2 O 5  (2.5 g) in CH2 CI2  (15 mL) over 5 
min. The cool bath was removed and the reaction mixture was stirred at ambient temperature for 2 h. After such 
time the reaction mixture was poured onto saturated aqueous N aH C0 3 (50 mL). The phases were separated and 
the aqueous phase was extracted with CH2 CI2  (3 x 100 mL). The combined extracts were washed with brine 
(100 mL), dried (Na2 S 0 4) and concentrated. JH NMR spectrum of crude product showed a 15:1 ratio of 
diastereoisomers by integration of signals derived from C14-Me group [!H NMR (360 MHz, CDC13): 8= 1.06 
ppm (major) and 1.32 ppm (minor)]. The crude product was purified by column chromatography (SiC>2 45 g,
11 8
hexanes:Et2 0  10-40%) to give ketone 6.10 (1.79 g, 4.75 mmol, 77% over 3 steps) as a white solid: mp 88-89°C 
(hexanes :Et2 0 ).
[a]D20 +166.6 (c 1.4, CHC13).
vmax KBr/cm-] 1724 (s) 1282 (m), 1164 (s), 1150 (s).
]H NMR (400 MHz, CDCI3 ): 8=  4.91 (1H, d, /  = 7.6 Hz, C12-H), 4.83 (1H, d, J  = 6 . 8  Hz, OCHAtfB0 ), 4-80 
(1H, d, J  = 6.4 Hz, O C //a HbO), 4.46 (1H, dd, J  = 12.4, 1.6 Hz, C9-HAtfB), 4.27 (1H, dd, J  = 10.8, 7.6 Hz, 
C ll-H ), 4.00 (1H, dd, J  = 12.0, 6 . 8  Hz, C 9-//AHB), 3.86 (1H, ddd, J  = 10.8, 7.2, 1.2 Hz, C10-H), 3.67-3.55 
(2H, m, C18-H2), 3.54 (1H, dd, J  = 12.4, 4.0 Hz, C15-H), 2.10-2.00 (1H, m), 1.85-1.75 (1H, m), 1.65-1.56 (2H, 
m), 1.19 (12H, s, ‘BuCOO and C14-Me), 1.05 (3H, s, C14-Me).
13C NMR (100 MHz, CDCI3 ): 8=  208.6 (0), 178.7 (0), 90.3 (2), 79.0 (1), 73.8 (1), 73.1 (1), 70.5 (1), 63.3 (2),
51.5 (0), 45.4 (2), 39.2 (0), 29.7 (2), 27.5 (3, 3C), 27.1 (2), 19.5 (3), 19.4 (3).
LRMS m/z (Cl, NH3) 394 [(M+NH4 )+, 100%].
HRMS (Cl) Found: (M+H)+, 376.1652. C 18H 3 0 ClO6 requires M, 376.1653.
Microanalysis: Anal. Calcd for C i8 H2 9 C106: C, 57.37; H, 7.70; Cl, 9.43. Found: C, 57.37; H, 7.64; Cl, 9.46.
c r ^ o
Piv< ,,OH Dess-Martin Periodinane
6.11b 6.10
^18^31 ClOe C18H29CIOg
Mol. Wt.: 378.87 Mol. Wt.: 376.87
Dess-Martin periodinane (2.7 g) was added in one portion to a stirred solution of alcohol 6 .11b (1.6 g, 4.3 
mmol) in CH2 CI2  (20 mL). The reaction mixture was stirred at room temperature for 25 min and treated with 
saturated aqueous Na2 S2 0 3  (25 mL) and saturated aqueous N aH C 0 3 (20 mL). After 1 h the phases were 
separated and the aqueous layer was extracted with CH2 CI2  (3 x 20 mL). The combined organic extracts were 
dried (Na2 SC>4 ) and concentrated. The residue was purified by flash column chromatography (S i0 2  10 g, 
hexanes:Et2 0  10-30%) to give ketone 6.10 (1.61 g, 4.3 mmol, 100%).
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(lR,5/?,6R,8/?,10S)-5-(terr-Butylcarbonyloxy)methyl-8-(3-chloropropyl)-9,9-dimethyl-2,4,7- 
tr ioxab icyclo [4 ,4 ,0 ]d ecan -10 -o l 6 .11a and (lR,5J?,6R,8R,10R)-5-(terf-Butylcarbonyloxy)methyl-8-(3- 
chloropropyl)-9,9-dimethyl-2,4,7-trioxabicycIo[4,4,0]decan-10-ol 6.11b.
o"'~Svo
PivO ^ |Y °
6.10 6.11a 6.11b
^18^29^106 C18H31CI06 C18H3-|CIOg
Mol. Wt.: 376.87 Mol. Wt.: 378.87 Mol. Wt.: 378.87
A solution of ketone (1.80 g, 4.8 mmol) and cerium trichloride heptahydrate (2.6 g, 7.1 mmol) in anhydrous 
methanol (90 mL) were stirred at room temperature for 15 min and then cooled to 0°C. Solid KBH4  (740 mg,
14.1 mmol) was added (gas evolution!). After 1.5 h acetone (1 mL) was added to the reaction mixture followed 
by saturated aqueous NaHC0 3  (50 mL). The methanol was removed in vacuo and the aqueous phase extracted 
with CH2 CI2  (3 x 50 mL). The combined organic extracts were washed with brine (50 mL), dried (Na2 SC>4 ) and 
concentrated. 1H NMR spectrum of crude product showed a 1:2 ratio of diastereoisomers by integration of 
signals derived from C14-Me group []H NMR (360 MHz, CDCI3 ): 8  = 1.14 ppm (major) and 1.05 ppm 
(minor)]. The undesired alcohol 6.11b  was the major product. The crude product was purified by column 
chromatography (SiC>2 50 g, hexanes:Et2 0  30-50%) to give a mixture of alcohols 6.11a,b (1.72 g, 4.56 mmol, 
95%) as a colourless oil. The diastereoisomers were separated by column chromatography (SiC>2 150 g, 
hexanes:Et20 20-40%).
CeCI3»7H2 0, KBH4 Piv 
MeOH, 0°C, 1.5 h
Analytical data for 6.11a:
[a ] D 2 0  +87.0 (c 2.0, CHC13).
vmax film /cirr1 3486 (br), 1740 (s), 1728 (s).
lH NMR (400 MHz, CDC13): 8=  4.94 (1H, d, J = 6.4 Hz, OCHa / / bO), 4.80 (1H, d, J  = 6 . 8  Hz, OCtfAHB0), 
4.49 (1H, dd, / =  12.0, 2.0 Hz, C9-HA/ / B), 4.16 (1H, d d d ,/=  10.4, 6 .8 , 1.6 Hz, C10-H), 4.06 (1H, d d , /=  10.4,
6.4 Hz), 4.03-3.94 (3H, m), 3.65-3.50 (2H, m, C18-H2), 3.26 (1H, dd, J  = 10.4, 1.6 Hz, C15-H), 2.24 (1H, br, 
OH), 2.10-1.90 (1H, m), 1.80-1.60 (2H, m), 1.50-1.37 (1H, m), 1.23 (9H, s, tBuCOO), 1.04 (3H, s, C14-Me), 
0.93 (3H, s, C14-Me).
13C NMR (100 MHz, CDCI3 ): 8 = 178.6 (0), 86.7 (2), 78.1 (1), 72.8 (1), 71.4 (1), 69.4 (1), 67.4 (1), 63.8 (2),
45.4 (2), 40.8 (0), 39.0 (0), 29.7 (2), 27.3 (3, 3C), 26.3 (2), 23.1 (3), 12.6 (3).
LRMS m/z (Cl) 379 [(M+H)+, 100%].
1 2 0
Microanalysis: Anal. Calcd for Cig^iClOg: C, 57.07; H, 8.19. Found: C, 57.11; H, 8.10.
Analytical data for 6.11b:
[a]D2 2 +66.3 (c 0.3, CHC13).
vmax film/cm- 1  3496 (s), 1734 (s).
NMR (360 MHz, CDCI3 ): 8=  5.15 (1H, d, J  = 5.8 Hz, OCHaH bO), 4.89 (1H, d, J =  5.8 Hz, 0 C tfAHB0),
4.30 (2H, d , J =  5.7 Hz, C9-H2), 4.21 (1H, dt, J  = 10.4, 5.2 Hz, C10-H), 4.06 (1H, t, J  = 3.8 Hz), 3.75-3.62 (3H, 
m), 3.59 (2H, t, /  = 5.5 Hz, C18-H2), 2.32 (1H, d, J  = 8.1 Hz, OH), 2.00-1.58 (4H, m), 1.21 (9H, s, tBuCOO), 
1.13 (3H, s, C14-Me), 0.96 (3H, s, C14-Me).
,3C NMR (100 MHz, CDC13): 8=  178.3 (0), 89.1 (2), 78.0 (1, broad signal), 74.3 (1, broad signal), 73.1 (1),
70.2 ( 1 ), 65.4 (1), 62.3 (2), 45.1 (2), 38.9 (0), 38.5 (0), 29.3 (2), 27.2 (3, 3C), 24.0 (2), 22.6 (3), 22.2 (3, broad 
signal).
LRMS m/z (Cl) 379 [(M+H)+, 100%].
Microanalysis: Anal. Calcd for C 18H3 1 C106: C, 57.07; H, 8.19. Found: C, 57.05; H, 8.05.
The following additional experiments were performed on a small scale (ca 5-7 mg) using a large excess of 
reagents.
NaBH4, CeCl3 *7H2 0 , MeOH, -78°C <x/p = 2.3:1
NaBH4, CeCl3 »7H2 0 , MeOH, 0°C a /p  = 2.5:1
NaBH4, MeOH, -78°C ex/p = 3.5:1
Na(CN)BH3, MeOH, 0°C—>rt <x>P (slow reaction)
BH3 *THF complex, THF, -78°C —>0°C a  only
/-Selectride, THF, -7 8 °C ^-5 0 °C  a  only
NaBH4, ZnCl2  , MeOH, -85°C->10°C cx/p = 3:1
LiAlH4, THF, -20°C oop
KBH4  (35 mg), CeCl3 »7H20  (30 mg), MeOH (1 m L ), -9 0 °C ^ -2 0 °C  cx/p = 1:1
1 2 1
(li?,5/f,6/J,8/?,105)-5-(tert-Butylcarbonyloxy)methyl-8-(3-chIoropropyI)-10-methoxy-9,9-dimethyl-2,4,7-
trioxabicyclo[4,4,0]decan 6.12.
a) NaHMDS
THF, -78°C, 5 min
,OMe
b) MeOTf 
-7 8 °C ,1 h
6.12
Piv< ►OH
6 .1 1 a
^18^31 ^ io 6 c 19h 33c io 6
Mol. Wt.: 378.87 Mol. Wt.: 392.91
A solution of alcohol 6.11a (1.20 g, 3.16 mmol) in THF (4 + 2 + 1  mL) was added dropwise to a stirred solution 
of sodium bis(trimethylsilyl)amide (2.0 M in PhMe, 2.1 mL, 4.1 mmol) in THF (5 mL) at -78°C. After 5 min 
methyl trifluoromethanesulphonate (0.72 mL, 6.32 mmol) was added. The reaction mixture was stirred at -78°C 
for 1 h, treated with saturated aqueous N aH C03 (40 mL) and extracted with Et2 0  (3 x 30 mL). The combined 
organic extracts were dried (Na2 S0 4) and concentrated. The residue was purified by column chromatography 
(SiC>2 20 g, hexanes:Et2 0  10-30%) to give methyl ether 6.12 (1.14 g, 2.90 mmol, 92%) as a colourless oil: 
[a ] D 2 1  +54.7 (c 1.1,CHC13).
vmax film/cm - 1  1732 (s), 1162 (s), 1112 (s), 1040(s).
'H  NMR (400 MHz, CDC13): 8 = 4.95 (1H, d, 7  = 6 . 8  Hz, OCHa / / bO), 4.80 (1H, d, 7 = 6 . 8  Hz, OCHa Hb O),
4.44 (1H, dd, 7 = 12.0, 2.0 Hz, C9-HAHB), 4.21-4.10 (1H, m, C10-H), 4.11 (1H, dd, 7 = 10.4, 6 . 8  Hz, C12-H), 
3.97 (1H, dd, 7 = 12.0, 7.2 Hz, C9-HAHB), 3.90 (1H, dd, 7 =  10.8, 6 . 8  Hz, C ll-H ), 3.60-3.46 (2H, m, C18-H2), 
3.52 (3H, s, OMe), 3.49 (1H, d, / =  10.4 Hz, C13-H), 3.22 (1H, dd, 7 =  10.4, 1.4 Hz, C15-H), 2.03-1.87 (1H, 
m), 1.78-1.55 (2H, m), 1.38 (1H, ddt, 7 =  14.8, 10.2, 5.0 Hz), 1.19 (9H, s, ‘BuCOO), 0.97 (3H, s, C14-Me), 0.83 
(3H, s, C14-Me).
13C NMR (100 MHz, CDC13): 8=  178.4 (0), 87.0 (2), 79.3 (1), 78.1 (1), 73.5 (1), 71.3 (1), 67.4 (1), 63.8 (2),
61.7 (3), 45.3 (2), 41.7 (0), 38.9 (0), 29.6 (2), 27.2 (3, 3C), 26.2 (2), 23.2 (3), 13.5 (3).
LRMS m/z (Cl) 393 [(M+H)+, 100%].
HRMS (Cl) Found: (M+H)+, 393.2040. C 1 9H3 4 C106  requires M, 393.2044.
Microanalysis: Anal. Calcd for C i9 H3 3 C106: C, 58.09; H, 8.41. Found: C, 58.19; H, 8.41
1 2 2
(LR,5/?,6/f,8/J,105)-5-(tert-ButylcarbonyIoxy)methyl-10-methoxy-9,9-dimethyl-8-(3-phenylselenylpropyl)-
2,4,7-trioxabicycIo[4,4,0]decan 6.13.
Substitution of a halide with sodium phenylselenide is described in the literature1 1 9
>OMePiv<Piv< ,0Me NaBH4> Ph2Se2
EtOH, A, 5 min
SePh
6.12
OigHooCIOg CosHooOgS©
Mol. Wt? 392 91 Mol Wt? 513.53
Sodium borohydride (165 mg, 4.34 mmol) was added in several batches to a stirred suspension of diphenyl 
diselenide (680 mg, 2.17 mmol) in anhydrous ethanol ( 8  mL) to cause exothermic reaction. A solution of 
chloride 6.12 (1.12 g, 2.85 mmol) in THF (2 + 2 mL) was then added via cannula and the resulting mixture was 
heated at reflux for 5 min. The reaction mixture was then cooled to room temperature, poured onto saturated 
aqueous NaHC0 3  (60 mL) and extracted with Et2 0  (3 x 50 mL). The combined organic extracts were washed 
with 2M NaOH(aq) (40 mL), brine (40 mL) dried (Na2 SC>4 ) and concentrated. The residue was purified by 
column chromatography (S i0 2  20 g, hexanes:Et2 0  0-40%) to give selenide 6.13 (1.43 g, 2.79 mmol, 98%) as a 
colourless oil: [a ]o 2 0  +71.3 (c 1.6, CHCI3 ).
vmax film/cm- 1 1732 (s), 1580 (m), 1186 (s), 1162 (s),l 112 (s), 1040 (s).
NMR (400 MHz, CDC13): 8=  7.47 (1H, dd, J  = 8.0, 2.4 Hz), 7.50-7.40 (1H, m), 7.30-7.18 (3H, m), 4.95 
(1H, d, / =  6.4 Hz, OCHa / / b O), 4.81 (1H, d, J =  6.4 Hz, O C//a Hb O), 4.42 (1H, dd, J =  12.0, 2.0 Hz, C9- 
HA/ /B), 4.18-4.08 (1H, m, C10-H), 4.13 (1H, d d , /  = 10.0, 6 . 8  Hz, C12-H), 3.98 (1H, dd, J  = 12.4, 7.2 Hz, C9- 
Ha Hb), 3.91 (1H, dd, J  = 10.4, 6 . 8  Hz, C l 1-H), 3.53 (3H, s, OMe), 3.37 (1H, d, J  = 10.0 Hz, C13-H), 3.21 (1H, 
dd, 7 =  10.0, 1.2 Hz, C15-H), 2.90 (2H, t , J  = 7.2 Hz, C18-H2), 2.00-1.85 (1H, m), 1.75-1.50 (2H, m), 1.38 (1H, 
ddt, J  = 14.7, 10.0, 4.8 Hz), 1.21 (9H, s, lBuCOO), 0.95 (3H, s, C14-Me), 0.83 (3H, s, C14-Me).
13C NMR (100 MHz, CDCI3 ): 8=  178.3 (0), 132.8 (1, 2C), 130.4 (0), 129.0 (1, 2C), 126.8 (1), 86.9 (2), 79.3 
(1), 78.2 (1), 73.4 (1), 71.3 (1), 67.3 ( 1 ), 63.7 (2), 61.7 (3), 41.6 (0), 38.9 (0), 28.7 (2), 28.0 (2), 27.2 (3, 3C; 2, 
1C), 23.2 (3), 13.5 (3).
LRMS m/z (El) 514 [(M+H)+, 33%], 357 (15), 243 (15), 193 (20), 113 (25), 71 (100).
HRMS (El) Found: (M+H)+, 514.1830. C2 5 H3 8 0 6Serequires M, 514.1835.
Microanalysis: Anal. Calcd for C2 5 H3 g0 6 Se: C, 58.48; H, 7.41. Found: C, 58.47; H, 7.48.
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(li?,5/?,6R,8R,105)-5-(terr-Butylcarbonyloxy)methyl-10-methoxy-9,9-dimethyl-8-(prop-2-enyl)-2,4,7-
trioxabicyclo[4,4,0]decan 6.14.
Oxidation of a selenide to a selenoxide and elimination of a selenoxide are described in the literature1 3 , 14
Piv<
SePh
a) Nal04
MeOH-H20 , rt, 15 min
b) NEt-
PhMe, A,3 min
[3
Piv ,OMe
6.13
^25^38^6®®
Mol. Wt.: 513.53
CigH^Og
Mol. Wt.: 356.45
6.14
Sodium metaperiodate (970 mg, 4.52 mmol) was added in one portion to a stirred mixture of selenide 6.13 (1.40 
g, 2.73 mmol), water (16 mL) and MeOH (40 mL) at room temperature. The reaction mixture was stirred for 15 
min then diluted with water (50 mL) and extracted with CH 2 CI2  (5 x 50 mL). The combined organic extracts 
were dried (Na2 S0 4 ) and concentrated. The residue was treated with toluene (10 mL) and triethylamine (10 mL) 
and heated at reflux for 3 min using a heat gun. The yellow reaction mixture was cooled to room temperature, 
poured onto saturated aqueous NaHC0 3  (50 mL) and extracted with CH2 CI2  (3 x 30 mL). The combined 
organic extracts were dried (Na2 SC>4 ) and concentrated at room temperature. The residue was purified by 
column chromatography (Si0 2  20 g, hexanes:Et2 0  0-30%) to give olefin 6.14 (940 mg, 2.64 mmol, 97%) as a 
colourless oil: [a ]o 2 2  +25.9 (c 1.4, CHCI3 ).
vmax film/cm - 1 1732 (s), 1480 (m), 1284 (s).
'H  NMR (400 MHz, CDC13): 8 = 5.84 (1H, ddt, 7 = 18.0, 9.6, 6 . 8  Hz, C17-H), 5.07 (1H, ddm, 7 = 5.6, 1.2 Hz, 
C18-HA/ / B), 5.04 (1H, dm, 7 =  1.2 Hz, C18-//AHB), 4.99 (1H, d, 7  = 6.4 Hz, 0C H AtfB0 ), 4.86 (1H, d, 7 = 6 . 8  
Hz, O C //a HbO), 4.47 (1H, dd ,7  = 12.4, 2.0 Hz, C9-HA/ / B), 4.20-4.15 (1H, m, C10-H), 4.18 (1H, dd ,7  = 10.4,
6 . 8  Hz, C12-H), 4.06 (1H, dd, 7 = 12.0, 6.4 Hz, C9-//AHB), 3.99 (1H, dd, 7 =  10.8, 6 . 8  Hz, C ll-H ), 3.57 (3H, 
s, OMe), 3.44 (1H, d, 7 =  10.4 Hz, C13-H), 3.30 (1H, dd, 7 =  10.0, 2.4 Hz, C15-H), 2.20 (1H, dddt, 7 =  14.4,
6 .8 , 2.2, 1.2 Hz, C16-Ha /7b), 2.07 (1H, dddt, J=  14.4, 10.2, 7.1, 1.2 Hz, C16-HAHB), 1.24 (9H, s, lBuCOO),
1.02 (3H, s, C14-Me), 0.90 (3H, s, C14-Me).
13C NMR (100 MHz, CDC13): 8=  178.5 (0), 136.0 (1), 116.8 (2), 87.2 (2), 79.5 (1), 78.7 (1), 73.6 (1), 71.4 (1),
67.5 (1), 63.6 (2), 61.8 (3), 41.7 (0), 39.0 (0), 33.5 (2), 27.3 (3, 3C), 23.3 (3), 13.6 (3).
LRMS m/z (Cl) 357 [(M+H)+, 100%].
HRMS (Cl) Found: (M+H)+, 357.2277. C 1 9H3 3 0 6  requires M, 357.2276.
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Microanalysis: Anal. Calcd forC ^t^ O g: C, 64.04; H, 9.00. Found: C, 64.04; H, 9.19.
(l/?,5/J,6J?,8/?,10S)-5-hydroxymethyl-10-methoxy-9,9-dimethyl-8-(prop-2-enyl)-2,4,7- 
trioxabicyclo[4,4,0]decan 6.15.
kOMe kOMePi
Red-AI
THF, -78—»0°C, 30 min
6.156.14
C19H3 2O6 C1 4H24O5
Mol. Wt.: 356.45 Mol. Wt.: 272.34
To a solution of ester 6.14 (814 mg, 2.29 mmol) in THF (10 mL) at -70°C was added Red-AI (1.55 M in PhMe 
and THF, 3 mL, 4.65 mmol) in a dropwise fashion over 5 min. The cool bath was removed and the clear 
colourless reaction mixture was allowed to warm up to 0°C over 30 min. After such time acetone (0.4 mL) was 
added. The mixture was then poured onto ice cold 2M NaOH(aq) (10 mL) and CH 2 CI2  (20 mL) and H2 O ( 20 
mL) were added. The clear colourless phases were then separated and the aqueous phase was extracted with 
CH2 CI2  (3 x 30 mL). The combined organic extracts were dried (Na2 SC>4 ) and concentrated. Purification by 
column chromatography (SiC>2 40 g, hexanes/Et2 0  50-60%) afforded the alcohol 6.15 (608 mg, 2.24 mmol, 
98%) as a clear colourless oil: [a]d 2 3  +102.3 (c 1.2, CHCI3 ).
vmax film/cm - 1  3465 (br), 1640 (m), 1468 (s), 1177 (s), 1110 (s).
!H NMR assignments made using 2D H-H correlation spectra.
]H NMR (400 MHz, CDCI3 ): 5= 5.77 (1H, ddt, 7 =  17.0, 10.4, 6 . 8  Hz, C17-H), 5.07 (1H, dm, 7 =  5.2 Hz, C18- 
HA/ / B), 5.04-5.01 (1H, m, C 18-//AH B), 5.01 (1H, d, 7 = 6.4 Hz, OCHa / / b O), 4.82 (1H, d, 7 = 6.4 Hz, 
OCHa H b O), 4.15 (1H, dd, 7 =  10.4, 6.4 Hz, C12-H), 4.05-3.96 (2H, m, C ll-H , C10-H), 3.83 (1H, ddd, 7 =
12.0, 6 .8 , 2.8 Hz collapses to dd, 7 = 12.0, 2.8 Hz after D2 O shake, C7/AHBOH), 3.66 (1H, ddm, 7 =  11.6, 5.6 
Hz collapses to dd, 7 = 11.6, 5.2 Hz after D20  shake, CHA/ /BOH), 3.56 (3H, s, OMe), 3.43 (1H, d, 7 = 10.4 Hz, 
C13-H), 3.26 (1H, dd, 7 = 10.4, 2.0 Hz, C15-H), 2.27 (1H, t, 7 =  6.4 Hz, OH), 2.16 (1H, dddt, 7 = 11.3, 7.4, 2.0,
1.2 Hz, C16-Ha 77b), 2.03 (1H, dddt, 7 =  14.2, 10.3, 6 .8 , 0.8 Hz, C16-tfAHB), 1.00 (3H, s, C14-Me), 0.87 (3H, s, 
C14-Me).
13C NMR (100 MHz, CDCI3 ): S=  135.9 (1), 117.0 (2), 87.0 (2), 79.3 (1), 78.5 (1), 73.5 (1), 73.2 (1), 68.0 (1), 
63.0 (2), 61.9 (3), 41.7 (0), 33.5 (2), 23.2 (3), 13.2 (3).
LRMS m/z (Cl) 373 [(M+H)+, 50%], 231 (100).
HRMS (Cl) Found: (M+H)+, 273.1704. Q 4 H2 5 O5 requires M, 273.1702.
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(1/?, 5/?,6i?,8/?,105)-9,9-dimethyl-10-methoxy-8-(prop-2-enyl)-5-{iV-[(2-
trimethyIsilyl)ethoxycarbonyI]amino}-2,4,7-trioxabicyclo[4,4,0]decan 6.17.
co
Curtius rearrangement performed using the conditions of Shioiri.
c r ^ o
a) PDC, DMF, rt, 24 h
b) TMSEtOH, ('Pr)2NEt 
DPPA, 4A mol. sieves 
PhMe, 65°C, 15 h
kOMe
6.15 6.17
C14H24O5 C19H35 NQBSi
Mol. Wt.: 272.34 Mol. Wt.: 401.57
Pyridinium dichromate (3.0 g, 7.97 mmol) was added to a mixture of alcohol 6.15 (200 mg, 0.735 mmol) in
anhydrous DMF (4 mL) and stirred at room temperature. After 8  h a further portion of pyridinium dichromate
(1.0 g, 2.66 mmol) was added and the mixture stirred for a further 15 h. After such time H2 O (60 mL) was
added and the mixture extracted with EtOAc (5 x 25 mL). The combined organic extracts were washed with
brine (20 mL), dried (Na2 S0 4 ) and concentrated. The residue was taken up in toluene ( 2 x 5  mL) and
concentrated twice to give crude acid 6.16 (290 mg) as a brown oil.
The crude acid 6.16 was dissolved in anhydrous toluene (2 mL) to which freshly activated 4A molecular sieves 
(8 ) and anhydrous A-ethyldiisopropylamine (0.2 mL, 148 mg, 1.15 mmol) were added. 2-Trimethylsilylethanol 
(0.8 mL, 660 mg, 5.58 mmol), dried by the addition of freshly activated 4A molecular sieves (8 ), and diphenyl 
phosphoryl azide (0.2 mL, 255 mg, 0.93 mmol) were then added at concomitantly. The mixture was plunged 
into an oil bath at 65°C and evolution of N2 gas was observed over a period of 8  min. After heating at 65°C for 
1 h the green reaction mixture was quenched by the addition of saturated aqueous NaHCC>3 (18 mL) and 
extracted with CH 2 CI2  (3 x 25 mL). The combined organic extracts were dried (Na2 SC>4 ) and concentrated. The 
residue was purified by column chromatography (SiC>2 15 g, hexanes:Et2 0  10-25%) to give carbamate 6.17 
(171 mg, 4.26 mmol, 58%) as a pale yellow oil: [ « ] d 23 +46.7 (c 0.09, CHCI3 ).
vmax film/cm - 1  1720 (s), 1542 (m), 1109 (s), 1032 (s).
‘H NMR (400 MHz, CDCI3 ): 8  = 5.72 (1H, ddt, J  = 16.8, 10.0, 6 . 8  Hz, C17-H), 5.53 (1H, t, J  = 9.2 Hz, C10- 
H), 5.30 (lh , d, J  = 9.2 Hz, NH), 5.14 (1H, d, J  = 7.2 Hz, OCHAtfB0 ), 5.03 (1H, dq, J  = 17.2, 1.6 Hz, C18- 
HA/ / B), 4.95 (1H, dm, J = 7.2 Hz, C 18-//AH B), 4.86 (1H, d, J  = 7.2 Hz, O C //a Hb O), 4.25-4.18 (3H, m, 
O C//2 CH2 SiMe3 and C l 1-H), 3.80 (1H, dd, J  = 10.0, 6 . 8  Hz, C12-H), 3.57 ( 3H, s, OMe), 3.45 (1H, d, /  = 10.4 
Hz, C13-H), 3.31 (1H, d, J  = 9.2 Hz, C15-H), 2.18 (1H, ddm, / =  6 .8 , 2.0 Hz, C16-HA/ / B), 2.10-2.00 (1H, m, 
C16-//AHB), 1.05-0.98 (2H, m, C7/2 SiMe3), 1.01 (3H, s, C14-Me), 0.88 (3H, s, C14-Me), 0.05 (9H, s, SiMe3).
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13C NMR (90 MHz, CDCI3 ): 8=  156.1 (0), 135.9 (1), 116.3 (2), 86.7 (2), 79.6 (1), 78.6 (1), 76.5 (1), 74.9 (1),
70.8 (1), 64.1 (2), 62.0 (3), 41.9 (0), 33.6 (2), 23.3 (3), 17.8 (2), 13.5 (3), -1 .3  (3, 3C).
LRMS m/z (Cl) 402 [(M+H)+, 70%], 374 (100).
HRMS (Cl) Found: (M+H)+, 402.2315. C i9 H3 6 0 6NSi requires M, 402.2312.
(l/?,5/?,6/?,8/J,10S)-9,9-dimethyl-10-methoxy-5-{Af-(methyloxalyl)-iV-[(2- 
trim ethylsilyl)ethoxycarconyl]amino}-8-(prop-2-enyl)-2,4,7-trioxabicycIo[4,4,0]decan 6.18.
,OMe
Methyl oxalyl chloride
CH2CI2, rt, 60 h
Me >OMe
6.17
Oi9H35N asi 
Mol. Wt.: 401.57
6.18
^ 2 2  ^ 37 Si
Mol. Wt.: 487.62
To a solution of carbamate 6.17  ( 6 8  mg, 0.17 mmol) in CH2 CI2  was added DMAP (124 mg, 1.0 mmol, 
recrystallised from CH 2 Cl2 :Et2 0 :hexanes) and methyl oxalyl chloride (90fiL, 0.98 mmol). The mixture was 
stirred for 91 h and concentrated. The residue was purified by column chromatography (SiC> 2 6  g, 
hexanes:EtOAc 19:1) to give ester 6.18  (55 mg, 0.11 mmol, 6 6 %) as a clear colourless oil and starting 
carbamate 6.17 ( 6  mg, 0.15 mmol, 9%) as a clear colourless oil.
[a]D22 +63.8 (c 0.8, CHC13).
vmax film/cm - 1  1776 (m), 1689 (s), 1644 (s), 1470 (s).
iH N M R  (360 MHz, CDC13): 5= 6 .13  (1H, d,7  = 10.5 Hz, C10-H), 5.68 (1H, dd t,7  = 17.0, 10.1, 6 . 8  Hz, C17- 
H), 5.11 (1H, d, 7 = 6.7 Hz, OCHa / / bO), 5.02-4.93 (2H, m, C18-H2), 4.98 (1H, d, 7 = 6 . 8  Hz, OC//a HbO),
4.86 (1H, dd, 7 = 10.4, 7.3 Hz, C ll-H ), 4.35 (2H, ddd, 7 = 8.5, 6.3, 3.7 Hz, O C//2 CH2 SiMe3), 4.33 (1H, dd, 7 =
10.5, 7.3 Hz, C12-H), 3.90 (3H, s, C(O)OMe), 3.59 (3H, s, OMe), 3.47 (1H, d, 7 = 10.5 Hz, C13-H), 3.29 (1H, 
dd, 7  = 9.9, 2.1 Hz, C15-H), 2.15 (1H, dddt, 7 =  13.0, 7.2, 2.2, 1.5 Hz, C16-HAtfB), 2.03 (1H, dddt, 7 = 14.4,
10.0, 6.9, 1.2 Hz, C16-T/a Hb), 1.12 (2H, ddd, 7 =  8.4, 6.2, 3.7, C //2 SiMe3), 1.02 (3H, s, C14-Me), 0.88 (3H, s, 
C14-Me), 0.07 (9H, s, SiMe3).
,3C NMR (90 MHz, CDCI3 ): 5 =  162.9 (0), 161.3 (0), 152.5 (0), 135.7 (1), 116.6 (2), 87.8 (2), 79.5 (1), 78.9 
(1), 77.2 (1), 75.2 (1), 67.7 (2), 67.0 (1), 62.0 (3), 53.1 (3), 41.8 (0), 33.7 (2), 23.1 (3), 17.5 (2), 13.3 (3), -1.5
(3, 3C).
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LRMS m/z (El) 487 [M+#, 1%], 446 (7), 449 (8 ), 374 (14), 362 (35).
HRMS (El) Found: M+*, 487.2219. C2 2 H3 7 0 9NSi requires M, 487.2238.
(l/?,5/?,6/?,8/?,l()5')-9,9-Dimethyl-10-methoxy-5-[A?-(m ethyloxalyl)amino]-8-(prop-2-enyl)-2,4,7- 
trioxabicyclo[4,4,0]decan 6.19.
TBAF (-95%, 400 mg, 1.45 mmol) was added to a solution of carbamate 6.18 (155 mg, 0.318 mmol) in THF ( 6  
mL) at 0°C. After 2 min the mixture was diluted with CH2 CI2  (40 mL) and washed with H20  (60 mL). The 
aqueous phase was extracted with CH2 CI2  (2 x 20 mL) and the combined organic extracts dried (Na2 SQ4 ) and 
concentrated. The residue was purified by column chromatography (S i0 2  15 g, hexanes:Et2 0  50%) to give the 
desired amide 6.19 (90 mg, 0.262 mmol, 83%) as a white solid: mp 169-170°C (hexanes:Et2 0).
[a ] D 2 3  +76.2 (c 0.6, CHC13).
vmax KBr/cm - 1  1737 (m), 1701 (s), 1036 (s).
lU NMR (360 MHz, CDC13): 8= 7.53 (1H, d, J  = 9.2 Hz, NH), 5.73 (1H, t, J = 9.7 Hz, C10-H), 5.62 (1H, ddt, J  
= 17.0, 10.1, 6.9 Hz, C17-H), 5.15 (1H, d, J =  7.0 Hz, OCHAtfB0 ), 4.97 (1H, dm, 7 =  17.1 Hz, C18-HAHB), 
4.91-4.85 (1H, m, C18-tfAHB), 4.88 (1H, d, J =  7.3 Hz, O C //a HbO), 4.25 (1H, dd, J=  10.3, 6 . 8  Hz, C12-H), 
3.93 (3H, s, C (0)O C //3), 3.90 (1H, dd, J  = 9.8, 6 .8 , C l 1-H), 3.57 (3H, s, OMe), 3.45 (1H, d, J = 10.3 Hz, C13- 
H), 3.28 (1H, dd, J=  9.9, 1.4 Hz, C15-H), 2.16 (1H, d d m ,/=  14.0, 5.5 Hz, C16-HA7/B), 2.0 (1H, d d d / =  17.0, 
5.6, 5.5 Hz, C16-//a Hb), 1.01 (3H, s, C14-Me), 0.88 (3H, s, C14-Me).
13C NMR (90 MHz, CDCI3 ): 8=  160.3 (0), 156.5 (0), 135.7 (1), 116.5 (2), 86.9 (2), 79.5 (1), 78.9 (1), 74.8 (1),
74.3 (1), 70.6 (1), 62.0 (3), 54.0 (3), 41.9 (0), 33.4 (2), 23.2 (3), 13.6 (3).
LRMS m/z (Cl) 344 [(M+H)+, 100%].
HRMS (Cl) Found: (M+H)+, 344.1708. C i6 H2 607N requires M, 344.1709.
Microanalysis: Anal. Calcd for C 16H2 5N0 7: C, 55.98; H, 7.29; N, 4.08. Found: C, 56.08; H, 7.14; N, 4.04.
TBAF
6.18
CppHsyNQbSi 
Mol. Wt.: 487.62
6.19
C16H2 5NO7
Mol. Wt.: 343.37
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(1R,5S, 65 ,8S,10S)-5{[(2/?,3R,4S)-3,4-dihydro-2,3-dimethyl-4-phenylselenyImethyl-2J7-pyran-6-yl]- 
oxoethanam ido}-9,9-dim ethyl-10-methoxy-8-[prop-2-eiiyl]-2,4,7-trioxabicycIo[4.4.0]decane 6.20
SnMe& nBuLi
THF, -78°C
SePh
1.72
C -j yH2gOS0Sn 
Mol. Wt.: 444.06
Me'
SePh
1.56
C14Hi7LiOSe 
Mol. Wt.: 287.19
O
kOMe
6.19
C16H2 5 NO7
Mol. Wt.: 343.37
TMEDA
THF
-78°C
,OMe
Ph:
6.20
C29H3 9NO7 S6  
Mol. Wt.: 592.58
A flame dried 25 mL Schlenk flask was charged with stananne 1.72 (230 mg, 0.52 mmol) in THF (3 mL) and 
cooled to -78°C. "BuLi (0.61 M in hexanes, 0.84 mL, 0.52 mmol) was added dropwise over 10 min keeping the 
reaction mixture at -78°C. After 15 min TMEDA (0.35 mL, 0.44 g, 3.80 mmol) was added dropwise to the 
yellow solution over 1 min. The mixture was stirred for a further 15 min at -78°C before a cold solution of ester 
6.19 (60 mg, 0.174 mmol) in THF (2 + 2 mL) was added via cannula. The clear colourless reaction mixture was 
stirred for 2 h at -78°C before being quenched by the addition of saturated aqueous NH4 CI ( 6  mL) and stirred 
vigorously for 15 min. The mixture was then extracted with CH2 CI2  (3 x 20 mL) and the combined organic 
extracts dried (Na2 SC>4 ) and concentrated. The residue was purified by column chromatography (SiC> 2 7 x 2.5 
cm, hexanes:Et2 0  10-40%) to give the desired product 6.20  (80 mg, 0.135 mmol, 78%) as a white solid. 
Recrystallisation from hexanes:Et2 0  gave clear colourless rock crystals for analysis which were analysed by X- 
ray crystallography to confirm the absolute stereochemistry of 6.20 (see appendix A).
mp 144-145°C (hexanes:Et2 0 )
[a ] D 2 1  -32.0 (c 0.5, CHC13).
vmax K B r/cnr1 1670 (s), 1124 (s), 1024 (s).
NMR (400 MHz, CDCI3 ): 8=  7.56-7.48 (3H, m), 7.31-7.25 (3H, m), 7.09 (1H, dd, J  = 2.0, 1.6 Hz, C5-H),
5.72 (1H, t, J  = 9.6 Hz), 5.62 (1H, ddt, J  = 17.0, 10.2, 6 . 8  Hz, C17-H), 5.16 (1H, d, J  = 6.9 Hz, OCH^HbO),
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5.55 (1H, ddm, J  = 17.2, 2.0 Hz, C18-HAHB), 4.90 (1H, d, / =  6.9 Hz, OCHa HbO), 4.84 (1H, ddm, J  = 10.2,
1.6 Hz, C18-Ha Hb), 4.25 (1H, dd, J  = 10.3, 6.7 Hz, C12-H),4.10 (1H, dq, J  = 1.2, 6.4 Hz, C2-H), 3.92 (1H, dd, 
J  = 9.8, 6.7 Hz, C l 1-H), 3.58 (3H, s, C13-OMe), 3.46 (1H, d, J  = 10.3 Hz, C13-H), 3.29 (1H, dd, J  = 10,0, 2.0 
Hz, C15-H), 2.98-2.93 (2H, m, CH2 SePh), 2.90-2.82 (1H, m, C4-H), 2.15 (1H, ddm, J  = 13.6, 5.5 Hz, C16- 
Ha Hb), 2.08-1.98 (2H, m, C16-HAHB and C3-H), 1.39 (3H, d, / =  6.5 Hz, C2-Me), 1.03 (3H, s, C14-Me), 0.89 
(3H, s, C14-Me), 0.82 (3H, s, d, J  = 7.0 Hz, C3-Me).
13C NMR (90 MHz, CDCI3 ): 8 = 179.7 (0), 160.7 (0), 148.7 (0), 135.8 (1), 133.4 (1, 2C), 129.4 (1, 2C), 129.3
(0), 127.6 (1), 124.8 (1), 116.6 (2), 86.9 (2), 79.6 (1), 78.9 (1), 76.8 (1), 74.8 (1), 74.0 (1), 70.4 (1), 62.0 (3),
41.8 (0), 39.1 (1), 33.4 (1, 2, 2C), 29.6 (2), 23.3 (3), 18.3 (3), 13.7 (3), 6.1 (3).
LRMS m/z (El) 593 [(M+H)+, 3%\, 435 (10), 223 (50), 151 (52), 87 (100).
Microanalysis: Anal. Calcd for C29H39N07Se: C, 58.78; H, 6.59; N, 2.36. Found: C, 58.67; H, 6.58; N, 2.25.
(lR,5S,6S,85,10S)-5{[(2R,3/?,4S,6S)-2,3-Dim ethyl-2,3-dim ethyl-6-m ethoxy-4-phenylselenylm ethyl- 
tetrahydro-2//-pyran-6-yl]-[(2S)-2-benzoylcarbonyloxyethanam ido]}-9,9-dim ethyl-10-m ethoxy-8-[prop-2- 
en yl]-2 ,4 ,7-trioxab icyclo[4 .4 .0]decane 6.21a and (lR,5S,6S,8S,10S)-5{[(21?,3j?,4S,6S)-2,3-dimethyl-2,3- 
dim ethyl-6-m ethoxy-4-phenylselenylm ethyl-tetrahydro-2//-pyran-6-yl]-[(2/?)-2- 
benzoylcarbonyloxyethanam ido]}-9,9-dim ethyl-10-m ethoxy-8-[prop-2-enyl]-2,4,7- 
trioxabicyclo[4.4.0]decane 6.21b
,OMe
Ph:
6.20
C29H39N07Se 
Mol. Wt.: 592.58
a) /-Selectride, THF, -95°C
b) MeOH, CSA, CHoCIo, rt
C) BzCI, ('Pr)2NEt, DMAP, CH2CI2, rt
O M e OMe
OMe kOMe
O Bz OBz
Ph:
6.21a
O37H4Q NOoSe 
Mol. Wt.: 730.75
6.21b
^37^49^9gSe
Mol. Wt.: 730.75
/-Selectride (1 M in THF, 0.27 mL, 0.27 mmol) was added dropwise to a solution of ketone 6.20 (85 mg, 0.144 
mmol) in THF (2.7 mL) at -95°C over 15 min. After stirring at -95°C for 15 min the reaction was quenched by 
the addition of brine (5 mL) and CH 2 CI2  (5 mL). The mixture was stirred vigorously for a further 15 min and 
extracted with CH2 CI2  (3 x 20 mL). The combined organic extracts were dried (Na2 S0 4 ) and concentrated to 
give a clear colourless oil ( 1 0 2  mg).
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The clear colourless oil (102 mg) was dissolved in CH2 CI2  (4.5 mL) and MeOH (0.4 mL) to which camphor 
sulphonic acid (4 mg) was added at room temperature. The mixture was stirred at room temperature for 40 min 
before K2 CO 3  (16 mg) was added. The mixture was then stirred for 30 min and poured onto saturated aqueous 
NaHC03 ( 6  mL). The mixture was extracted with CH2 CI2  (3 x 20 mL) and the combined organic extracts were 
dried (Na2 S0 4 ) and concentrated to give a clear yellow oil (114 mg).
The clear yellow oil (114 mg) was dissolved in CH2 CI2  (4.5 mL) to which DMAP (34 mg, 0.29 mmol), N- 
ethyldiisopropylamine (0.25 mL, 186 mg, 1.44 mmol) and benzoyl chloride (47 fiL, 0.41 mmol) were added at 
room temperature. The mixture was stirred at room temperature for 1 h before MeOH (0.4 mL) was added. 
After stirring for 10 min brine ( 6  mL) was added and the mixture extracted with CH2 CI2  (3 x 20 mL). The 
combined organic extracts were dried (Na2 S 0 4 ) and concentrated to give a yellow solid. Column 
chromatography (Si0 2  20 g, hexanes:Et2 0  1:1) afforded the desired benzoates 6.21a,b  (96 mg, 0.132 mmol, 
91%) as a white solid. JH NMR spectroscopic analysis (C^Dg, referenced to 7.16 ppm) of the mixture revealed 
doublets at 8 = 4.53 (major) and 4.71 (minor) attributed to the O C //a HbO proton corresponding to a favourable 
5:1 mixture of diastereoisomeric benzoates. The diastereoisomers were separated by column chromatography 
(SiC>2 25 g, CH2 Cl2 :Et2 0  2 0 :1 ) to give the desired diastereoisomer 6.21a ( 6 6  mg, 0.090 mmol, 63%) as a white 
foam and the undesired diastereoisomer 6.21b (10 mg, 0.0137 mmol, 10%) as a white foam and a mixture of 
diastereoisomers 6.21a,b (20 mg, 0.027 mmol, 20%) as a white solid.
Analytical data for 6.21a:
mp 72-76°C
[a ] D 2 3  +103.8 (c 0.8, CHC13).
vmax K B r/cnr1 1732 (s), 1704 (s), 1272 (m), 1033 (s).
lB  NMR (360 MHz, C6 D6  referenced to 7.16 ppm): 8=  8.32 (2H, dd, 7 = 8.2, 1.6 Hz), 7.47 (2H, dd, 7 = 7.8, 1.5 
Hz), 7.42 (1H, d, 7 =  9.6 Hz, NH), 7.10-6.92 (6 H, m), 6.06 (1H, ddt, 7 = 16.5, 10.3, 6.9 Hz, C17-H), 5.95 (1H, s, 
C7-H), 5.94 (1H, t, 7 = 9.8 Hz, C10-H), 5.14 (1H, ddm, 7 = 10.1, 0.9 Hz, C18-HAHB), 5.06 (1H, ddm, 7 =  17.1,
1.2 Hz, C18-HAHB), 4.59 (1H, d, 7 = 6.9 Hz, OCHa HbO), 4.53 (1H, d, 7  = 6.9 Hz, OCHa HbO), 4.32 (1H, dd, 7 
= 10.3, 6 . 8  Hz, C12-H), 3.79 (1H, dd, 7  = 9.7, 6 . 8  Hz, C l 1-H), 3.60-3.52 (2H, m, C15-H and C2-H), 3.27 (3H, 
s, OMe), 3.07 (1H, d, 7 =  10.4 Hz, C13-H), 2.89 (3H, s, OMe), 2.87-2.84 (1H, m, CHAHBSePh), 2.83 (1H, dd, 7 
= 14.4, 11.9 Hz, CHAHBSePh), 2.49-2.38 (1H, m with 10 lines, C4-H), 2.29 (1H, dd, 7 =  13.5, 3.6 Hz, C5-H), 
2.17-2.03 (1H, m, C16-HAHB), 2.03 (1H, dd, 7 = 14.4, 7.6 Hz, C16-HAHB), 1.86 (1H, t, 7 = 13.0 Hz, C5-H), 
1.60-1.50 (1H, m, C3-H), 0.87 (3H, s, C14-Me), 0.85 (3H, d, 7 = 6.7 Hz, C2-Me), 0.80 (3H, d, 7 = 6 . 8  Hz, C3- 
Me), 0.79 (3H, s, C14-Me).
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13C NMR (90 MHz, C6 D 6  referenced to 128.4 ppm): <5= 166.7 (0), 166.0 (0), 137.7 (1), 133.6 (1), 133.2 (1, 
2C), 131.4 (0), 130.8 (0), 130.7 (1, 2C), 129.7 (1, 2C), 129.0 (1, 2C), 127.3 (1), 116.3 (2), 99.8 (0), 87.1 (2),
79.4 (1), 78.9 (1), 75.7 (1), 74.9 (1), 72.9 (1), 72.5 (1), 71.0 (1), 61.7 (3), 48.3 (3), 42.0 (0), 35.9 (1), 35.5 (1),
34.4 (2), 32.5 (2), 31.6 (2), 23.5 (3), 18.5 (3), 14.1 (3), 5.0 (3).
LRMS m/z (El) 731 [M+*, 0.4%].
HRMS (El) Found: M+\  731.2575. C3 7 H4 9 N0 9Se requires M, 731.2576.
Analytical data for 6.21b: 
mp 74-79°C
[a ]D23+17.5 (c 0.4, CHC13).
vmax KBr/cm - 1 1733 (s), 1708 (s), 1264 (m), 1128 (s), 1107 (s), 1026 (s).
!H NMR (360 MHz, C6 D6  referenced to 7.16 ppm): 8= 8.32 (2H, dd, J  = 8.2, 1.5 Hz), 7.49-7.38 (3H, m), 7.11-
6.92 (6 H, m), 6.19 (1H, ddt, J = 16.9, 10.2, 6.5 Hz, C17-H), 6.02 (1H, t, J  = 9.8 Hz, C10-H), 5.92 (1H, s, C7-H),
5.55 (1H, dm, / =  10.2 Hz, C18-HAHB), 5.22 (1H, ddm, 7 =  17.0, 2.1 Hz, C18-HAHB), 4.71 (1H, d, J  = 6.9 Hz, 
OCHa HbO), 4.64 (1H, d, J  = 6.9 Hz, OCHa HbO), 4.33 (1H, dd, J  = 10.4, 6 . 8  Hz, C12-H), 3.74 (1H, dd, J = 
10.1, 6 . 8  Hz, C ll-H ), 3.52 (1H, dq, J  = 2.1, 6.5 Hz, C2-H), 3.31 (1H, t, J  = 6.0 Hz, C15-H), 3.27 (6 H, s, C6 - 
OMe and C13-OMe), 3.05 (1H, d, J  = 10.4 Hz, C13-H), 2.57-2.52 (2H, m, CH2 SePh), 2.31-2.20 (1H, m with 10 
lines, C4-H), 2.12-2.03 (3H, m), 1.64 (1H, t, /  = 13.2 Hz, C5-H), 1.55-1.45 (1H, m, C3-H), 0.89 (3H, s, C14- 
Me), 0.84 (3H, d, J  = 6.5 Hz, C2-Me), 0.73 (3H, s, C14-Me), 0.59 (3H, s, d, /  = 7.0 Hz, C3-Me).
13C NMR (90 MHz, C6 D 6  referenced to 128.4 ppm): 8=  167.3 (0), 166.0 (0), 137.1 (1), 133.6 (1), 133.3 (1,
2C), 131.4 (0), 130.8 (0), 130.7 (1, 2C), 129.7 (1, 2C), 129.0 (1, 2C), 127.3 (1), 117.0 (2), 99.9 (0), 87.1 (2),
79.6 (1), 78.9 (1), 76.0 (1), 74.5 (1), 72.7 (1), 72.1 (1), 70.9 (1), 61.7 (3), 49.3 (3), 42.1 (0), 35.7 (1), 35.3 (1), 
34.1 (2), 32.4 (2), 32.0 (2), 23.1 (3), 18.4 (3), 13.8 (3), 4.6 (3).
LRMS m/z (El) 731 [M+*. 0.2%].
HRMS (El) Found: M+*, 731.2581. C3 7 H4 9 N 0 9Se requires M, 731.2576.
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(lR,5S,6S,8S,10S)-5{[(2/?,3K>6S)-2,3-Dim ethyl-2,3-dim ethyl-6-methoxy-4-m ethene-tetrahydro-2ff-pyran-
6-yl] -[(2S)-2-benzoylcarbonyloxyethanam ido] }-9,9-dimethyl - 10-m ethoxy-8-ethanal-2,4,7- 
trioxabicyclo[4.4.0]decane 6.23
OMe
,OM e
O Bz
Ph!
6.21a
^37^49^0gSe
Mol. Wt.: 730.75
a) Dihydroquinine 9-phenanthryl ether 
K3 Fe(CN)6, K2 C 03i KOs04*2H20  
’BuOH, H20 , rt
b) Nal04, H ,0 , MeOH, rt
c) NEt3, PhlOle, A
OMe
,OMe
O Bz
6.23
C3oH4 iN0 10 
Mol. Wt.: 575.65
Olefin 6.21a (50 mg, 0.0685 mmol) and hydrquinine 9-phenanthryl ether (2 mg, 0.004 mmol) were dissolved in 
lBuOH (1 mL) to which water (1 mL) was added followed by K3FeCN6  (45 mg, 0.14 mmol), K2 CO3 (20 mg, 
0.14 mmol) and potassium osmate dihydrate (1 mg, 0.003 mmol). After stirring at room temperature for 8  h 
saturated aqueous Na2 SC>4 (2 mL) was added. The mixture was extracted with EtOAc (3 x 15 mL) and the 
combined organic extracts were dried (Na2 SC>4 ) and concentrated to give a clear yellow oil.
The yellow oil was dissolved in MeOH (2 mL) to which water (0.65 mL) and sodium metaperiodate (100 mg, 
0.047 mmol) were added. The mixture was stirred at room temperature for 1 h then diluted with CH2 CI2  (30 
mL) and washed with water ( 2 x 1 5  mL). The organic phase was dried (Na2 S0 4 ) to which triethylamine (2 mL) 
was added before the mixture was concentrated in vacuo (12 mm Hg, 18°C) to give a yellow oil.
The yellow oil was dissolved in toluene (1 mL) and triethylamine (1 mL) and heated with a heat gun at reflux 
for 2 min. The mixture was allowed to cool to room temperature before saturated aqueous NaHCC>3 ( 8  mL) was 
added. The mixture was extracted with CH2 CI2  (3 x 20 mL), the combined organic extracts dried (Na2 SC>4 ) and 
concentrated. The yellow oil was purified by column chromatography (SiC>2 6  x 2.5 cm, hexanes:Et2 0  1 : 1  and 
1% Et3 N) to give the desired aldehyde 6.23 (27 mg, 0.0470 mmol, 69%) as a white powder: mp 86-87°C.
[ct] D 2 3  +110.3 (c 0.3, CH2 C12).
vmax KBr/cm - 1  1730 (s), 1701 (s), 1654 (m), 1647 (m), 1270 (m), 1126 (m), 1106 (m), 1037 (m).
*H NMR assignments made using 2D H-H correlation spectra.
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lH NMR (400 MHz, C6 D6  referenced to 7.16 ppm): 8 = 9.72 (1H, d, /  = 4.5, C-17-H), 8.38 (2H, dd, J  = 8.0, 1.6 
Hz), 7.47 (1H, d, J  = 9.2 Hz, NH), 7.11-7.00 (3H, m), 5.93 (1H, s, C7-H), 5.91 (1H, t, /  = 9.6 Hz, C10-H), 
4.94(1H, d, / =  1.6 Hz, =CHAHB), 4.85 (1H ,7 = 1.6 Hz, =CHAH#), 4.59 (1H, d, J  = 6 . 8  Hz, OCHaHbO), 4.50 
(1H, d, J  = 6 . 8  Hz, 0C H aH5 0), 4.26 (1H, dd, / =  10.4, 6 . 8  Hz, C12-H), 4.02 (1H, dd, J = 10.4, 2.4 Hz, C15-H), 
3.81 (1H, dq, J = 2.8, 6.4 Hz, C2-H), 3.77 (1H, dd, J  = 9.6, 6 . 8  Hz, C l 1-H), 3.27 (3H, s, C13-OMe), 3.09 (1H, 
d, J = 10.4 Hz, C13-H), 2.91 (1H, d, J = 14.4 Hz, C5-HAHB), 2.90 (3H, s, C 6 -OMe), 2.81 (1H, d, /  = 14.4 Hz, 
C5-HAHB), 2.08 (1H, ddd, J  = 15.6, 10.4, 4.4 Hz, C16-HAHB), 1.93 (1H, dq, / =  2.8, 7.2 Hz, C3-H), 1.82 (1H, 
dd, J  = 16.0, 2.4 Hz, C16-HAHB), 0.99 (3H, d, /  = 7.2 Hz, C3-Me), 0.86 (3H, d, /  = 6 . 8  Hz, C2-Me), 0.70 (3H, 
s, C14-Me), 0.64 (3H, s, C14-Me).
13C NMR (100 MHz, C6 D6  referenced to 128.4 ppm): 8=  200.9 (1), 167.3 (0), 166.1 (0), 145.6, (0), 133.7 (1),
130.8 (1, 2C), 130.7 (0), 129.1 (1, 2C), 111.6 (2), 100.4 (0), 87.3 (2), 79.0 (1), 75.5 (1), 75.0 
(1), 72.7 (1), 70.3 (1), 61.7 (3), 48.4 (3), 44.1 (2), 42.0 (1), 41.5 (0), 35.3 (2), 23.3 (3), 18.0 
(3).
LRMS m/z (El) 575 [M+*, 0.03%], 543 [(M -  OCH3)+, 10%].
HRMS (El) Found: M+*, 575.2734. C3 oH4 1 NOio requires M, 575.2730.
Preparation o f Norm ant Reagent
MeMgCI, Mg 
THF, A
C3H7CIO 
Mol. Wt.: 94.54
Prepared according to literature procedure104.
3-Chloropropan-l-ol (0.9 mL, 8.42 mL) in THF (8.0 mL) was cooled to -20°C  to which MeMgCI (3.1 M in 
THF, 2.72 mL, 8.42 mmol) was added dropwise over 3 min (caution: gas evolution!). After stirring at room 
temperature for 20 min magnesium (314 mg, 14 mmol) and 1,2-dibromoethane (0.016 mL, 0.19 mmol) were 
added. The mixture was refluxed for 1 h before another portion of 1,2-dibromoethane (0.016 mL, 0.19 mmol) 
was added. After refluxing for a further 2 h a homogeneous solution was formed. The mixture was allowed to 
cool to rt and the concentration was found to be 0.38 M in THF by titration122.
C I M ^ ^ ^ 'O M g C I
C 3 H 6 C l 2 M g 2 0  
Mol. Wt.: 177.59
(1), 75.0(1), 73.0 
(3), 13.8 (3), 12.7
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7-0-Benzoyl Theopederin D 6.26a and 17-e/u-7-0-Benzoyl Theopederin D 6.26b.
o cr^o
k0Me C I M s r^ ^ ^ O M g C I
H
THF, -78°C
OH
OH
6.23
C30H4i NO10 
Mol. Wt.: 575.65
6.25
CqqH^ qNOi 1
Mol. Wt.: 635.74
TPAP, NMO 
4A-Mol. sieves  
CH2CI2, MeCN, rt
6.26a
C3 3 H45NO11 
Mol. Wt.: 631.71
6.26b
C 3 3 H 4 5 N O 1 1  
Mol. Wt.: 631.71dr = 1:1
To a solution of aldehyde 6.23 (15 mg, 0.026 mmol) in THF (0.5 mL) at -78°C was added the Normant reagent 
(0.30 M in THF, 0.17 mL, 0.052 mmol). After stirring at -78°C for 2 h the reaction was quenched at -78°C by 
the addition of saturated aqueous NaHCC>3 (2 mL) and EtOAc (1 mL). The mixture was stirred and allowed to 
warm up to room temperature during a 15 min period. The mixture was extracted with EtOAc ( 3 x 4  mL) and 
the combined organic extracts were dried (Na2 SC>4 ) and concentrated. Purification by column chromatography 
in a Pasteur pipette (SiC>2 0.5 g, hexanes:Et2 0  3:7, Et2 0  100% and EtOAc:Et2 0  1 :1 ) afforded a diastereomeric 
mixture of diols 6.25 (20 mg) as a white solid.
The diols 6.25 (20 mg) were dissolved in CH2 CI2  (0.9 mL) and MeCN (0.1 mL) to which 4-methylmorpholine- 
N-oxide ( 6  mg, 0.048 mmol), 4A molecular sieves (16 mg) and TPAP1 0 5  ( 6  mg, 0.018 mmol) were added at 
room temperature. After stirring for 0.5 h Et2 0  (2 mL) was added and the mixture was concentrated. The 
residue was purified by filtration through a pad of silica in a Pasteur pipette (SiC>2 0.5 g, EtOAc:CH2 Cl2  1:1) to 
give a diastereomeric mixture of lactones 6.26a,b (14 mg, 0.022 mmol, 85%) as a clear colourless oil. }H NMR 
spectroscopic analysis referenced to 7.16 ppm) of the mixture revealed singlets at 8= 5.94 and 5.84 ppm
attributed to the C-7 proton corresponding to a 1:1 mixture of diastereoisomeric lactones 6.26a,b.
The diastereoisomers were separated by preparative TLC. The mixture was divided into six portions and each 
portion run on a 5 x 20 cm silica gel 60 F-254 plate, eluting with hexanes:EtOAc 1:1 and 1% Et3 N. Two 
elutions were required for full separation. The top band returned 7-0-benzoyl theopederin D 6.26a ( 6  mg,
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0.0095 mmol, 37%) as a clear colourless oil and the lower band returned 17-e/>i-7-0-benzoyl theopederin D 
6.26b (4 mg, 0.0063 mmol, 24%) also as a clear colourless oil.
7-0-Benzoyl theopederin D 6.26a
[a ] D 2 3  +54.0 (c 0.5, EtOAc).
NMR assignments made using 2D H-H and C-H correlation spectra.
*H NMR (400 MHz, C6 D6  referenced to 7.16 ppm): 5=  8.30-8.20 (2H, m), 7.27 (1H, d, J  = 9.6 Hz, NH), 7.11-
7.00 (3H, m), 5.84 (1H, s, C7-H), 5.76 (1H, t, /  = 9.6 Hz, C10-H), 4.83-4.77 (2H, m, =CH2), 4.57 (1H, d, /  =
7.2 Hz, OCHa HbO), 4.60-4.50 (1H, m, C17-H), 4.50 (1H, d, J  = 7.2 Hz, OCHAHs O), 4.23 (1H, dd, J  = 10.4,
6 . 8  Hz, C12-H), 3.81 (1H, dq, J  = 2.4, 6.4 Hz, C2-H), 3.66 (1H, dd, J  = 9.6, 6 . 8  Hz, C l 1-H), 3.26 (3H, s, C13- 
OMe), 3.15 (1H, d, J = 10.4 Hz, C15-H}, 2.93 (1H, d, J  = 12.4 Hz, C13-H), 2.92 (3H, s, C6 -OMe), 2.78 (1H, bd, 
J = 13.6 Hz, C5-HAHB), 2.72 (1H, d, J  = 14.0 Hz, C5-HAHB), 2.50-2.35 (1H, m), 2.36 (1H, dt, J  = 17.2, 9.6 Hz, 
C19-HAHB), 2.18-2.08 (1H, m,C16-HAHB), 1.90 (1H, dq, J  = 2.8, 7.2 Hz, C3-H), 1.92-1.82 (1H, m, C16- 
Ha Hb), 1.13-1.15 (2H, m, C18-H2), 1.03 (3H, d, J  = 6 . 8  Hz, C3-Me), 0.90 (3H, d, /  = 6.4 Hz, C2-Me), 0.75 
(3H, s, C14-Me), 0.68 (3H, s, C14-Me).
13C NMR (100 MHz, C6 D6  referenced to 128.4 ppm): 8=  176.4 (0), 167.4 (0), 165.8 (0), 145.3 (0), 134.0 (1),
130.5 (1, 2C), 130.2 (0), 129.3 (1, 2C), 111.9 (2), 100.1 (0), 86.9 (2), 79.1 (1), 78.4 (1), 75.5 (1), 75.3 (1), 74.5 
(1), 73.4 (1), 72.4 (1), 70.3 (1), 61.7 (3), 48.8 (3), 41.8 (1), 41.6 (0), 36.0 (2), 35.0 (2), 29.2 (2), 28.6 (2), 23.2 
(3), 18.0 (3), 14.7 (3), 12.6(3)
LRMS m/z (Cl) 649 [(M+NH4)+, 20%], 617 [(M+NH4-O CH 3)+, 75%], 600 [(M-OCH3)+, 10%].
HRMS (Cl) Found: (M+NH4)+, 649.3339. C3 3 H4 9 N 2 0 n  requires M, 649.3336.
17-c/?i-7-0-Benzoyl theopederin D 6.26b 
[a ] D 21  +71.3 (c 0.3, EtOAc).
!H NMR assignments made using 2D H-H correlation spectra.
'H  NMR (400 MHz, C6 D6  referenced to 7.16 ppm): 8=  8.30-8.20 (2H, m), 7.12 (1H, d, J  = 9.2 Hz, NH), 7.09-
7.02 (3H, m), 5.94 (1H, s, C7-H), 5.77 (1H, t, J  = 9.2 Hz, C10-H), 4.80 (2H, dm, J  = 9.7 Hz, =CH2), 4.64 (2H, 
s, OCH2 0 ), 4.55 (1H, ddd, J  = 15.2, 9.2, 3.2 Hz, C17-H), 4.24 (1H, dd, J  = 10.0, 6 . 8  Hz, C12-H), 3.90 (1H, dd, 
J = 9.6, 6 . 8  Hz, C l 1-H), 3.83 (1H, dq, J  = 2.8, 6.4 Hz, C2-H), 3.51 (1H, dd, J  = 8 .8 , 0.8 Hz, C15-H), 3.28 (3H, 
s, OMe),3.04 (3H, s, OMe), 2.99 (1H, d, J  = 10.0 Hz, C13-H), 2.85 (1H, bd, /  = 14.4 Hz, C5-HAHB), 2.78 (1H,
136
d , J  = 14.0 Hz, CS-H^Hb), 2.27 (1H, dt, J  = 17.6, 9.6 Hz, CIO-H^Hb), 2.04 (1H, ddd, J  = 17.2, 9.2, 3.2 Hz, 
C19-HAHB), 1.95 (1H, dq, J  = 2.8, 7.2 Hz, C3-H), 1.74 (1H, d d d d ,/=  12.8, 10.0, 6.4, 3.6 Hz, C18-HAHB), 1.42 
(1H, ddd, J = 14.4, 8 .8 , 1.6 Hz, C ^-H ^H b), 1.30-1.10 (2H, m, C16-HAHB) and C18-HAHB), 1.02 (3H, d, J  =
7.2 Hz, C3-Me), 0.92 (3H, d, / =  6 . 8  Hz, C2-Me), 0.79 (3H, s, C14-Me), 0.78 (3H, s, C14-Me).
13C NMR (100 MHz, C6 D6  referenced to 128.4 ppm): 8=  176.0 (0), 167.1 (0), 166.1 (0), 146.5 (0), 133.8 (1),
130.6 (1,2C), 130.4 (0), 129.2 (1, 2C), 111.2 (2), 100.1 (0), 87.1 (2), 79.4(1), 78.0(1), 76.2(1), 75.4(1), 75.2
(1), 73.7 (1), 71.4 (1), 70.1 (1), 61.7 (3), 48.9 (3), 42.0 (1), 41.5 (0), 36.3 (2), 35.3 (2), 29.3 (2), 29.1 (2), 23.4
(3), 18.1 (3), 14.7 (3), 12.8 (3)
LRMS m/z (El) 600 [(M-OCH3)+, 10%].
HRMS (Cl) Found: (M+NH4)+, 649.3331. C3 3 H4 9 N2 O 11 requires M, 649.3336.
Theopederin D l . l d
O
6.26a
C33H45NO11 
Mol. Wt.: 631.71
Potassium carbonate (1 mg, 0.007 mmol) was added to a solution of 7-(9-benzoyl theopederin D 6.26a (3 mg, 
0.0048 mmol) in anhydrous MeOH (0.3 mL) at room temperature. The mixture was stirred for 1 h before the 
addition of H 2 O (3 mL). The mixture was then extracted with EtOAc ( 3 x 6  mL) and the combined organic 
extracts washed with brine (2 mL), dried (Na2 S0 4) and concentrated. The residue was purified by filtration 
through a pad of silica in a Pasteur pipette (Si0 2  0.5 g, hexanes:EtOAc 1:1) to give theopederin D l . l d  (2 mg, 
0.0038 mmol, 79%) as a white solid: mp = 87-88°C.
Synthetic theopederin D: [a ] ^ 2 3  +86.2 (c 0.1, CHCI3 ).
Natural theopederin D: literature value1 [«]□ +80 (c 0.04, CHCI3 ).
k 2c o 3
MeOH, rt
OMe
,OMe
OH
l.1 d  Theopederin D 
C26H41NO10 
Mol. Wt.: 527.60
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The and 13C NMR spectra were compared with those reported in the literature1 and are shown below.
*H NMR (400 MHz, CDCI3 referenced to 7.24 ppm)
No. Natural Synthetic
9-NH 7.52 d, 9.4 7.51 d, 10.3
1 0 5.81 dd, 9.4,9.4 5.80 dd, 9.5
IO-OCH2 5.13 d, 7.0 5.11 d, 7.0
4.87 d, 7.0 4.86 d, 7.0
4=CH2 4.86 bs 4.84 t,
4.74 bs 4.73 t, 1.7
17 4.45 ddd, 14.2, 8.4, 6.0 4.42 ddd, 14.1,8.2, 5.9
7 4.27 d, 3.1 4.25 d, 3.2
1 2 4.21 dd, 10.2, 6.4 4.19, d, 9.7, 6.4
7-OH 4.08 d, 3.1 4.11 d, 3.2
2 4.03 dq, 2.7, 6.5 4.01 dq, 2.8, 6 . 6
1 1 3.82 dd, 9.4, 6.4 3.80 dd, 9.2, 6.4
13-OMe 3.56 s 3.54 s
13 3.44 d, 10.2 3.42 d, 9.5
15 3.42 d, 10.2 3.40 d, 9.0
6 -OMe 3.28 s 3.28 s
19 2.51 ddd, 17.6, 10.0,3.8 2.55-2.48 m
2.45 dd, 17.6, 11.1 2.46 dd, 18.0, 10.3
18 2.40 m 2.41-2.35 m
5 2.35 d, 14.0 2.33 d, 13.9
3 2.26 dq, 2.7, 7.1 2.24 dq 2.6, 7.1
5 2.21 bd, 14.0 2.18 d, 14.1
16 1.94 m 1.97-1.87 m
18 1.75 m 1.80-1.68 m
16 1.59 dd, 14.2, 8.3 1.58 ddd, 14.3, 8.3, 1.3
2-Me 1.20 d, 6.5 1.18 d, 6 . 6
14-Me 1 . 0 2  s 1 . 0 0  s
3-Me 1.01 d, 7.1 0.98 d, 7.1
14-Me 0 . 8 8  s 0 . 8 6  s
13C NMR (100 MHz, CDCI3 referenced to 77.0 ppm):
No. Natural Synthetic
20 176.7(0) 177.5(0)
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8 171.7 (0) 172.3 (0)
4 144.6 (0) 145.0 (0)
4=CH2 1 1 1 . 0  (2 ) 1 1 1 . 0  (2 )
6 99.7 (0) 99.8 (0)
10-OCH2 86.4 (2) 86.5 (2)
13 79.2(1) 79.5 (1)
17 79.1 (1) 79.2 (1)
15 75.8(1) 76.0 (1)
1 2 73.9(1) 74.0 (1)
1 0 73.4(1) 73.6(1)
7 71.5(1) 71.6(1)
1 1 70.0 (1) 69.5 (1)
2 69.4 (1) 69.5 (1)
13-OMe 61.4 (3) 61.7 (3)
6 -OMe 48.2 (3) 48.5 (3)
3 41.1(1) 41.3(1)
14 41.1 (0) 41.1 (0)
16 34.6 (2) 35.0 (2)
5 32.9 (2) 33.3 (2)
19 28.1 (2 ) 28.7 (2)
18 27.6 (2) 28.0 (2 )
14-Meeq 23.0 (3) 22.6 (3)
2-Me 17.4 (3) 18.0 (3)
14-Meax 13.5 (3) 14.1 (3)
3-Me 11.5 (3) 12.0 (3)
LRMS m/z (Cl) 496 [(M-OCH3)+, 100%], 513 [(M-OCH 3 +NH4)+, 10%].
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17-fipi-Theopederin D 6.27
k 2C 0 3
MeOH, rt
O O
6.26b
C 3 3 H 4 5 N O 11 
M ol. W t.: 631.71
6.27
C 2 6 H 4 1 N O 10  
M ol. W t.: 527 .60
Potassium carbonate (1 mg, 0.007 mmol) was added to a solution of 17-e/n-7-0-benzoyl theopederin D 6.26b (2 
mg, 0.0032 mmol) in anhydrous MeOH (0.3 mL) at room temperature. The mixture was stirred for 1 h before 
the addition of H2 O (3 mL). The mixture was extracted with EtOAc ( 3 x 6  mL) and the combined organic 
extracts washed with brine (2 mL), dried (Na2 S0 4 ) and concentrated. The residue was purified by filtration 
through a pad of silica in a Pasteur pipette (Si0 2  0.5 g, hexanes:EtOAc 1:1) to give 17-e/?/-theopederin D 6.27 
(1 mg, 0.0019 mmol, 59%) as a white solid: mp = 80-82°C.
[a]D23 +43.2 (c 0 .2 , CH2 C12).
]H NMR (400 MHz, CDCI3 referenced to 7.24 ppm): 8=  7.41 (1H, d, J = 9.4 Hz, NH), 5.83 (1H, t, J  = 9.2 Hz, 
C10-H), 5.12 (1H, d, J  = 7.0 Hz, OCHa HbO), 4.87 (1H, d, J  = 6 . 8  Hz, OCHa HbO), 4.87 (1H, t, J  = 2.0 Hz, 
=CHAHB), 4.75 (1H, J  = 1.7 Hz, =CHAHg), 4.48 (1H, ddd, J  12.1, 9.1, 6.4, C17-H), 4.26 (1H, d, J  = 2.4 Hz, 
C7-H), 4.19 (1H, dd, /  = 9.7, 6.5 Hz, C12-H), 4.05 (1H, dq, /  = 2.8, 6 . 6  Hz, C2-H), 3.83 (1H, d, J  = 2.5 Hz, C7- 
OH), 3.82 (1H, dd, J  = 9.0, 6.5 Hz, C l 1-H), 3.65 (1H, dd, J  = 9.8, 1.5 Hz, C15-H), 3.54 (3H, s, OMe), 3.44 (1H, 
d, /  = 9.7 Hz, C13-H), 3.30 (3H, s, OMe), 2.49-2.42 (2H, m, C19-H2), 2.36 (1H, d, J  = 13.9 Hz, C5-H), 2.28 
(1H, dq, J  = 2.7, 7.1 Hz, C3-H), 2.22-2.17 (1H, m, C18-HAHB), 2.16 (1H, dm, J  = 14.1 Hz, C5-H), 1.83-1.70 
(2H, m, C16-Ha Hb and C18-HAHB), 1.60 (1H, dd, J  = 9.7, 3.0 Hz, C16-HAHfi), 1.19 (3H, d, /  = 6 . 6  Hz, C2- 
Me), 1.02 (3H, s, C14-Me), 0.99 (3H, d, J  = 7.1 Hz, C3-Me), 0.84 (3H, s, C14-Me).
13H NMR (100 MHz, CDC13 referenced to 77.0ppm): 5=  176.5 (0), 171.5 (0), 145.4 (0), 111.1 (2), 99.8 (0),
86.5 (2), 79.5 (1), 78.1 (1), 77.2 (1), 76.0 (1), 74.2 (1), 74.05 (1), 71.5 (1), 69.4 (1), 61.7 (3), 48.7 (3), 41.2 (1),
40.9 (0), 35.4 (2), 33.3 (2), 29.0 (2), 28.7 (2), 22.7 (3), 18.0 (3), 14.1 (3), 12.5 (3).
LRMS m/z (Cl) 496 [(M-OCH3)+, 100%].
HRMS (El) Found: (M -OCH3)+, 496.2516. C2 5 H38NO requires M, 496.2546.
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Appendix A X-ray data for intermediate 6.20
Table 1. Crystal data and structure refinement for pk3.
I d e n t i f i c a t i o n  c o d e  
E m p i r i c a l  f o r m u l a  
F o r m u l a  w e i g h t  
T e m p e r a t u r e  
W a v e l e n g t h
C r y s t a l  s y s t e m ,  s p a c e  g r o u p  
U n i t  c e l l  d i m e n s i o n s
V o l u me
Z,  C a l c u l a t e d  d e n s i t y  
A b s o r p t i o n  c o e f f i c i e n t  
F (000)
C r y s t a l  s i z e
T h e t a  r a n g e  f o r  d a t a  c o l l e c t i o n
L i m i t i n g  i n d i c e s
R e f l e c t i o n s  c o l l e c t e d  /  u n i q u e
C o m p l e t e n e s s  t o  t h e t a  -  2 5 . 9 7
A b s o r p t i o n  c o r r e c t i o n
Max.  a n d  m i n .  t r a n s m i s s i o n
R e f i n e m e n t  m e t h o d
D a t a  /  r e s t r a i n t s  /  p a r a m e t e r s
G o o d n e s s - o f - f i t  o n  F A2
F i n a l  R i n d i c e s  [ I > 2 s i g m a ( I ) ]
R i n d i c e s  ( a l l  d a t a )
A b s o l u t e  s t r u c t u r e  p a r a m e t e r  
L a r g e s t  d i f f .  p e a k  a n d  h o l e
pk3
C2 9 H39 N 07  S e
5 9 2 . 5 7
2 9 1 ( 2 )  K
0 . 7 1 0 7 3  A
M o n o c l i n i c ,  P 21
a  = 8 . 5 0 3 5 ( 5 )  A a l p h a  = 90 d e g .  
b = 1 0 . 0 7 0 4 ( 9 )  A b e t a  = 1 0 3 . 7 6 8 ( 3 )  d e g ,
c  = 1 7 . 6 7 7 7 ( 6 )  A gamma = 90 d e g .
1 4 7 0 . 3 1 ( 1 7 )  Aa 3
2 ,  1 . 3 3 8  Mg/ mA3
1 . 3 2 1  mmA- 1
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0 . 3 0  x  0 . 2 3  x  0 . 0 7  mm 
2 . 3 4  t o  2 5 . 9 7  d e g .
- l < = h < = 1 0 , - l < = k < = 1 2 , - 2 1 < = 1 < = 2 1  
4 1 0 4  /  3 4 0 2  [ R ( i n t )  = 0 . 0 2 3 4 ]
9 9 . 9  %
P s i - s c a n
0 . 8 3 0 6  a n d  0 . 6 8 1 5
F u l l - m a t r i x  l e a s t - s q u a r e s  o n  F A2
3 4 0 2  /  1 /  332
1 . 0 0 1
Rl  = 0 . 0 3 6 1 ,  wR2 = 0 . 0 6 2 6  
R1 = 0 . 1 0 1 4 ,  wR2 = 0 . 0 7 7 4  
- 0 . 0 1 0 ( 1 1 )
0 . 2 3 3  an d  - 0 . 2 6 9  e . A A- 3
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T a b l e  2 .  A t o m i c  c o o r d i n a t e s  ( x  1 0 * 4 )  a n d  e q u i v a l e n t  i s o t r o p i c  
d i s p l a c e m e n t  p a r a m e t e r s  (Aa2 x 1 0 * 3 )  f o r  p k 3 .
U ( e q )  i s  d e f i n e d  a s  o n e  t h i r d  o f  t h e  t r a c e  o f  t h e  o r t h o g o n a l i z e d  
U i j  t e n s o r .
X y z U ( e q )
C (2) - 1 0 6 8 1 ( 5 ) - 2 1 1 0 ( 6 ) - 1 9 1 8 ( 2 ) 4 8 ( 1 )
C(2A) - 1 1 6 7 1 ( 6 ) - 1 1 5 1 ( 7 ) - 1 5 7 5 ( 3 ) 6 9 ( 2 )
C (3) - 8 9 1 0 ( 5 ) - 2 2 3 1 ( 6 ) - 1 5 1 3 ( 2 ) 4 9 ( 1 )
C(3A) - 7 9 6 9 ( 6 ) - 9 4 1 ( 7 ) - 1 4 9 8 ( 3 ) 6 7 ( 2 )
C (4) - 8 2 1 1 ( 5 ) - 3 3 5 8 ( 6 ) - 1 9 1 6 ( 2 ) 4 6 ( 1 )
C(4A) - 6 3 8 7 ( 5 ) - 3 5 8 7 ( 7 ) - 1 6 3 7 ( 2 ) 5 9 ( 2 )
C (5) - 8 6 6 5  (5) - 3 0 9 4 ( 6 ) - 2 7 8 9 ( 2 ) 4 2 ( 1 )
C (6) - 9 8 9 1 ( 5 ) - 2 3 1 4 ( 6 ) - 3 1 1 0 ( 2 ) 4 3 ( 1 )
C (7) - 1 0 3 9 5 ( 6 ) - 1 9 3 4 ( 6 ) - 3 9 4 5 ( 2 ) 4 8 ( 1 )
C (8) - 9 6 1 4 ( 5 ) - 2 5 6 9 ( 6 ) - 4 5 6 7 ( 2 ) 4 0 ( 1 )
C( 1 0 ) - 9 3 2 0 ( 5 ) - 2 1 6 7 ( 6 ) - 5 8 8 3  (2) 4 2 ( 1 )
C( 10A) - 9 8 1 0 ( 6 ) - 3 1 8 5 ( 7 ) - 7 0 8 6 ( 3 ) 6 6 ( 2 )
C ( l l ) - 9 0 2 9 ( 5 ) - 8 5 8 ( 6 ) - 6 2 6 2 ( 2 ) 3 9 ( 1 )
C ( 12) - 8 5 2 4 ( 5 ) - 1 0 8 2 ( 6 ) - 7 0 2 9 ( 2 ) 4 5 ( 1 )
C ( 13) - 6 7 4 3 ( 5 ) - 1 4 1 0 ( 6 ) - 6 9 1 8 ( 2 ) 4 4 ( 1 )
C (13A) - 6 0 1 5 ( 8 ) - 2 5 9 0 ( 8 ) - 7 9 5 9 ( 3 ) 1 0 0 ( 2 )
C ( 14 ) - 5 6 5 4 ( 5 ) - 4 4 6 ( 6 ) - 6 3 4 6 ( 3 ) 4 5 ( 1 )
C (14A) - 3 9 0 4 ( 5 ) - 9 4 1 ( 7 ) - 6 1 9 1 ( 3 ) 6 4 ( 2 )
C( 14B) - 5 7 5 5 ( 5 ) 9 6 9 ( 7 ) - 6 6 8 3 ( 3 ) 6 3 ( 1 )
C ( 15 ) - 6 2 5 5 ( 5 ) - 4 6 3 ( 6 ) - 5 5 9 5 ( 2 ) 4 7 ( 1 )
C ( 16 ) - 5 3 6 0 ( 5 ) 42 3  (6) - 4 9 2 8 ( 3 ) 62 (2)
C ( 17) - 5 9 7 8  (7) 2 0 5 ( 8 ) - 4 2 0 6 ( 3 ) 82 (2)
C ( 18) - 5 2 0 9 ( 9 ) - 3 3 7 ( 8 ) - 3 5 8 0 ( 4 ) 108  (3)
C (21A) - 3 6 5 4 ( 5 ) - 3 8 4 9 ( 1 0 ) - 2 7 8 ( 5 ) 4 5 ( 5 )
C( 22A) - 2 4 9 3 ( 1 0 ) - 4 5 2 3 ( 9 ) - 5 6 5 ( 5 ) 6 0 ( 4 )
C (23A) - 8 6 1 ( 8 ) - 4 2 3 4 ( 1 2 ) - 2 7 9 ( 6 ) 5 7 ( 3 )
C ( 24A) - 3 9 0 ( 7 ) - 3 2 7 2 ( 1 4 ) 2 9 4 ( 5 ) 5 3 ( 3 )
C( 25A) - 1 5 5 2  ( 13) - 2 5 9 9 ( 1 1 ) 5 8 1 ( 4 ) 6 8 ( 3 )
C( 26A) - 3 1 8 4 ( 1 1 ) - 2 8 8 7  (9) 2 9 5 ( 5 ) 6 4 ( 3 )
C ( 2 IB) - 3 5 8 5 ( 7 ) - 3 6 7 3 ( 1 4 ) - 2 4 3 ( 7 ) 5 1 ( 8 )
C( 22B) - 2 6 6 9 ( 1 5 ) - 2 8 6 9 ( 1 1 ) 3 3 6 ( 6 ) 4 5 ( 4 )
C( 23B) - 9 8 8 ( 1 5 ) - 2 9 2 7 ( 1 3 ) 5 0 4 ( 5 ) 3 4 ( 3 )
C( 24B) - 2 2 3  (7) - 3 7 8 9 ( 1 7 ) 9 2 ( 7 ) 4 9 ( 3 )
C( 25B) - 1 1 3 9 ( 1 4 ) - 4 5 9 4 ( 1 5 ) - 4 8 8 ( 7 ) 6 7 ( 5 )
C( 26B) - 2 8 2 0 ( 1 3 ) - 4 5 3 6 ( 1 3 ) - 6 5 5 ( 7 ) 6 5 ( 6 )
N ( 9 ) - 9 9 8 7 ( 5 ) - 1 9 0 4 ( 6 ) - 5 2 3 0 ( 2 ) 4 4 ( 1 )
0 ( 1 ) - 1 0 8 6 3  (4) - 1 6 7 4 ( 5 ) - 2 7 1 6 ( 2 ) 5 0 ( 1 )
0 ( 2 ) - 1 1 4 4 8  (5) - 1 1 3 1 ( 5 ) - 4 1 6 8 ( 2 ) 7 5 ( 1 )
0 ( 3 ) - 8 7 7 3  (4) - 3 5 6 1 ( 5 ) - 4 4 5 3  (2) 6 6 ( 1 )
0 ( 4 ) - 1 0 4 8 2 ( 3 ) - 2 9 0 3  (5) - 6 4 5 2 ( 2 ) 5 5 ( 1 )
0 ( 5 ) - 9 5 8 3  (4) - 2 0 2 8  (5) - 7 4 9 9  (2) 6 0 ( 1 )
0 ( 6 ) - 7 9 2 2  (3) - 3 8 ( 4 ) - 5 7 4 9  (2) 4 4 ( 1 )
0 ( 7 ) - 6 3 3 5  (4) - 1 3 6 6 ( 5 ) - 7 6 5 8  (2) 6 2 ( 1 )
S e ( 1 A ) - 5 8 8 4  ( 10) - 4 2 2 3  (5) - 5 6 9 ( 5 ) 79 (2)
S e ( I B ) - 5 8 7 8  ( 14) - 3 7 4 3  ( 13) - 4 6 4 ( 5 ) 8 1 ( 2 )
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Table 3. Bond lengths [A] and angles [deg] for pk3.
c 2 ) - 0 ( 1 ) 1 . 4 5 0 ( 5 )
c 2 ) - C( 2A) 1 . 5 0 1 ( 7 )
c 2 ) - C (3) 1 . 5 1 0 ( 6 )
c 3 ) - C( 3A) 1 . 5 2 3  (7)
c 3 ) - C (4) 1 . 5 3 4 ( 6 )
c 4 ) - C (5) 1 . 5 2 2 ( 5 )
c 4 ) - C( 4A) 1 . 5 2 9 ( 5 )
c 4 A ) - S e ( l A ) 1 . 9 4 2 ( 8 )
c 4 A ) - S e ( I B ) 2 . 0 2 0 ( 1 0 )
c 5 ) - C (6) 1 . 3 2 1 ( 6 )
c 6 ) - 0 ( 1 ) 1 . 3 6 4 ( 5 )
c 6 ) - C (7) 1 . 4 8 5 ( 6 )
c 7 ) - 0 ( 2 ) 1 . 2 0 0 ( 5 )
c 7 ) - C (8) 1 . 5 5 1 ( 6 )
c 8 ) - 0 ( 3 ) 1 . 2 1 7 ( 6 )
c 8 ) - N ( 9 ) 1 . 3 2 3 ( 6 )
c 1 0 ) - N ( 9 ) 1 . 4 2 7 ( 5 )
c 1 0 ) - 0 ( 4 ) 1 . 4 3 6 ( 5 )
c 1 0 ) - C ( l l ) 1 . 5 2 5 ( 7 )
c 1 0 A ) - 0 ( 4 ) 1 . 4 0 3  (5)
c 1 0 A ) - 0 ( 5 ) 1 . 4 1 2 ( 6 )
c 1 1 ) - 0 ( 6 ) 1 . 4 0 9 ( 5 )
c 1 1 ) - C ( 12) 1 . 5 3 3 ( 6 )
c 1 2 ) - 0 ( 5 ) 1 . 4 3 3 ( 5 )
c 1 2 ) - C ( 13) 1 . 5 1 6 ( 6 )
c 1 3 ) - 0 ( 7 ) 1 . 4 3 1 ( 5 )
c 1 3 ) - C ( 14) 1 . 5 4 2 ( 6 )
c 1 3 A ) - 0 ( 7 ) 1 . 3 9 5  (7)
c 1 4 ) - C ( 15) 1 . 5 3 2 ( 6 )
c 1 4 ) - C( 14A) 1 . 5 3 1 ( 6 )
c 1 4 ) - C ( 14B) 1 . 5 3 9  (7)
c 1 5 ) - 0 ( 6 ) 1 . 4 4 4 ( 5 )
c 1 5 ) - C ( 16) 1 . 5 3 0 ( 6 )
c 1 6 ) - C ( 17) 1 . 5 0 6 ( 7 )
c 17)  - C ( 18) 1 . 2 6 8 ( 8 )
c 21A)  - C( 22A) 1 . 3 9 0 0
c 2 1 A ) - C ( 2 6 A ) 1 . 3 9 0 0
c 2 1 A ) - S e ( l A ) 1 . 8 8 1 ( 9 )
c 2 2 A ) - C ( 2 3 A ) 1 . 3 9 0 0
c 2 3 A ) - C ( 2 4 A ) 1 . 3 9 0 0
c 2 4 A ) - C ( 2 5 A ) 1 . 3 9 0 0
c 2 5 A ) - C ( 2 6 A ) 1 . 3 9 0 0
c 2 I B ) - C ( 2 2 B ) 1 . 3 9 0 0
c 2 I B ) - C ( 2 6 B ) 1 . 3 9 0 0
c 2 I B ) - S e ( l B ) 1 . 8 9 7 ( 1 3 )
c 2 2 B ) - C ( 2 3 B ) 1 . 3 9 0 0
c 2 3 B ) - C ( 2 4 B ) 1 . 3 9 0 0
c 2 4 B ) - C ( 2 5 B ) 1 . 3 9 0 0
c 2 5 B ) - C ( 2 6 B ) 1 . 3 9 0 0
0 1 ) - C ( 2 ) - C( 2A) 1 0 5 . 0  (4)
0 1 ) - C ( 2 ) -C (3) 1 1 0 . 4  (3)
c 2A) -C (2)  -C (3 ) 1 1 6 . 9  (4)
c 2 ) - C ( 3 ) - C( 3A) 1 1 3 . 6 ( 4 )
c 2)  -C (3)  -C (4) 1 0 7 . 0  (4)
c 3 A ) - C ( 3 ) - C (4) 1 1 2 . 3 ( 4 )
c 5 ) - C ( 4 ) - C( 4A) 1 1 0 . 3  (3)
c 5 ) - C ( 4 ) -C (3) 1 0 8 . 0  (4)
c 4 A ) - C ( 4 ) -C (3) 1 1 5 . 9 ( 4 )
c 4 ) - C ( 4 A ) - S e ( l A ) 1 0 9 . 6 ( 4 )
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C ( 4 ) - C ( 4 A ) - S e ( I B ) 1 0 7 . 2  (4)
S e ( l A ) - C ( 4 A ) - S e ( I B ) 1 4 . 8 ( 4 )
C 6)  - C (5)  - C (4) 1 2 1 . 6 ( 4 )
C 5 ) - C ( 6 ) - 0 ( 1 ) 1 2 5 . 0  (4)
C 5 ) - C ( 6 ) - C (7) 1 2 6 . 3 ( 4 )
0 1 ) - C ( 6 ) - C (7) 1 0 8 . 6  (4)
0 2 ) - C ( 7 ) - C ( 6 ) 1 2 1 . 1 ( 4 )
0 2 ) - C ( 7 ) - C (8) 1 1 7 . 2 ( 4 )
C 6) - C ( 7 ) -C (8) 1 2 1 . 7  (5)
0 3)  - C ( 8 ) - N ( 9 ) 1 2 4 . 7 ( 4 )
0 3 ) - C ( 8 ) - C (7) 1 2 3 . 8 ( 4 )
N 9 ) - C ( 8 ) - C (7) 1 1 1 . 5 ( 5 )
N 9 ) - C ( 1 0 ) - 0 ( 4 ) 1 0 8 . 8 ( 4 )
N 9 ) - C ( 1 0 ) - C ( l l ) 1 0 9 . 4 ( 4 )
0 4 ) - C ( 1 0 ) - C ( l l ) 1 0 7 . 1 ( 3 )
0 4 ) - C ( 1 0 A ) - 0 ( 5 ) 1 1 2 . 2 ( 5 )
0 6 ) - C ( l l ) - C ( 1 0 ) 1 1 2 . 1 ( 3 )
0 6 ) - C ( l l ) - C ( 12) 1 1 1 . 7 ( 4 )
C 1 0 ) - C ( l l ) - C ( 12) 1 1 1 . 8 ( 4 )
0 5)  - C ( 1 2 ) - C ( 13) 1 1 3 . 6 ( 4 )
0 5)  - C ( 1 2 ) - C ( l l ) 1 0 9 . 9 ( 4 )
c 1 3 ) - C ( 1 2 ) - C ( l l ) 1 1 3 . 5 ( 3 )
0 7 ) - C ( 1 3 ) - C ( 12 ) 1 0 9 . 1 ( 3 )
0 7)  - C ( 1 3 ) - C ( 14) 1 1 0 . 0 ( 4 )
c 1 2 ) - C ( 1 3 ) -C ( 14) 1 1 1 . 9 ( 4 )
c 1 5 ) - C ( 1 4 ) - C( 1 4 A) 1 1 0 . 5 ( 4 )
c 1 5)  -C ( 14 )  -C ( 13) 1 0 6 . 8 ( 4 )
c 14A)  -C ( 14)  -C ( 13) 1 0 8 . 6 ( 4 )
c 1 5)  -C ( 14 )  -C (14B) 1 1 0 . 3 ( 4 )
c 14A)  -C ( 14)  -C ( 14B) 1 0 9 . 5 ( 4 )
c 13)  -C ( 14)  -C (14B) 1 1 1 . 1 ( 4 )
0 6 ) - C ( 1 5 ) - C ( 16) 1 0 5 . 0 ( 4 )
0 6 ) - C ( 1 5 ) - C ( 14) 1 1 0 . 3  (3)
c 1 6 ) - C ( 1 5 ) - C ( 14) 1 1 7 . 0 ( 4 )
c 17)  -C ( 16)  -C ( 15) 1 1 1 . 0 ( 4 )
c 1 8 ) - C ( 1 7 ) - C ( 16) 1 2 6 . 2 ( 6 )
c 2 2 A ) - C ( 2 1 A ) - C ( 2 6 A ) 1 2 0 . 0
c 2 2 A ) - C ( 2 1 A ) - S e ( l A ) 1 2 4 . 1 ( 5 )
c 2 6 A ) - C ( 2 1 A ) - S e ( l A ) 1 1 5 . 8  (5)
c 2 3 A ) - C ( 2 2 A ) - C ( 2 1 A ) 1 2 0 . 0
c 2 4 A ) - C ( 2 3 A ) - C ( 2 2 A ) 1 2 0 . 0
c 2 3 A ) - C ( 2 4 A ) - C ( 2 5 A ) 1 2 0 . 0
c 2 6 A ) - C ( 2 5 A ) - C ( 2 4 A ) 1 2 0 . 0
c 2 5 A ) - C ( 2 6 A ) - C ( 2 1 A ) 1 2 0 . 0
c 2 2 B ) - C ( 2 I B ) - C ( 2 6 B ) 1 2 0 . 0
c 2 2 B ) - C ( 2 I B ) - S e ( I B ) 1 2 2 . 8  (7)
c 2 6 B ) - C ( 2 1 B ) - S e ( I B ) 1 1 7 . 1 ( 7 )
c 2 3 B ) - C ( 2 2 B ) - C ( 2 1 B ) 1 2 0 . 0
c 2 2 B ) - C ( 2 3 B ) - C ( 2 4 B ) 1 2 0 . 0
c 2 3 B ) - C ( 2 4 B ) - C ( 2 5 B ) 1 2 0 . 0
c 2 4 B ) - C ( 2 5 B ) - C ( 2 6 B ) 1 2 0 . 0
c 2 5 B ) - C ( 2 6 B ) - C ( 2 1 B ) 1 2 0 . 0
c 8 ) - N ( 9 ) - C ( 1 0 ) 1 2 4 . 5  (5)
c 6 ) - 0 ( 1 ) - C (2) 1 1 4 . 7  (4)
c 1 0 A ) - 0 ( 4 ) - C ( 1 0 ) 1 0 8 . 7  (3)
c 1 0 A ) - 0 ( 5 ) - C (12) 1 1 3 . 2  (3)
c 1 1 ) - 0 ( 6 ) - C ( 15) 1 1 5 . 0  (3)
c 1 3 A ) - 0 ( 7 ) - C (13) 1 1 5 . 7 ( 4 )
c 2 1 A ) - S e ( l A ) - C ( 4 A ) 1 0 0 . 1 ( 5 )
c 2 I B ) - S e ( I B ) - C ( 4 A ) 9 9 . 6  (6)
S y mme t r y  t r a n s f o r m a t i o n s  u s e d  t o  g e n e r a t e  e q u i v a l e n t  a t o m s :
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T a b l e  4 .  A n i s o t r o p i c  d i s p l a c e m e n t  p a r a m e t e r s  (Aa 2 x  1 0 A3) f o r  p k 3 . 
The a n i s o t r o p i c  d i s p l a c e m e n t  f a c t o r  e x p o n e n t  t a k e s  t h e  f orm:
- 2  p i A2 [ h A2 a * A2 U l l  + . . .  + 2 h k a*  b*  U12 ]
Ull U22 U33 U23 U13 U12
C (2) 5 7 ( 3 ) 54 4) 3 4 ( 2 ) 8 ( 2 ) 13 2) 2 ( 3 )
C(2A) 7 5 ( 4 ) 84 5) 4 9 ( 3 ) 6 ( 3 ) 20 3) 2 0 ( 4 )
C (3) 6 0 ( 3 ) 52 4) 33 (2) - 2 ( 2 ) 8 2) - 5 ( 3 )
C(3A) 8 1 ( 4 ) 62 4) 5 6 ( 3 ) - 7 ( 3 ) 9 3) - 9 ( 4 )
C (4) 4 8 ( 3 ) 51 4) 3 6 ( 2 ) 4 ( 2 ) 2 2) - 1 ( 3 )
C(4A) 5 4 ( 3 ) 84 5) 3 5 ( 2 ) 1 0 ( 3 ) 5 2) 8 ( 3 )
C (5) 4 3 ( 2 ) 47 3) 3 3 ( 2 ) - 4 ( 2 ) 3 2) - 1 ( 3 )
C (6) 4 6 ( 3 ) 50 3) 3 2 ( 2 ) - 4 ( 2 ) 7 2) - 2 ( 3 )
C (7) 4 6 ( 3 ) 57 4) 3 8 ( 3 ) 1 ( 3 ) 7 2) 9 ( 3 )
C (8) 3 4 ( 2 ) 49 4) 3 5 ( 2 ) - 1 ( 3 ) 4 2) 0 ( 3 )
C ( 1 0 ) 3 8 ( 3 ) 56 4) 3 4 ( 2 ) 2 ( 3 ) 10 2) 3 (3)
C( 10A) 80 (4) 76 5) 4 6 ( 3 ) - 2 4 ( 3 ) 20 3) - 2 5 ( 3 )
C ( l l ) 3 8 ( 3 ) 36 3) 4 0 ( 3 ) 3 ( 2 ) 2 2) 4 ( 2 )
C ( 1 2 ) 4 8 ( 3 ) 49 4) 3 8 ( 2 ) 7 ( 3 ) 8 2) 1 ( 3 )
C ( 13) 5 1 ( 3 ) 45 3) 4 1 ( 2 ) 7 ( 2 ) 19 2) 8 ( 3 )
C (13A) 1 5 8 ( 6 ) 87 6) 7 3 ( 4 ) 1 ( 4 ) 62 4) 2 5 ( 5 )
C ( 14) 43 (3) 4 1 3) 5 3 ( 3 ) 7 ( 3 ) 12 2) 2 (3)
C( 14A) 43 (3) 56 4) 9 1 ( 4 ) 0 ( 3 ) 11 3) 0 ( 3 )
C( 14B) 6 2 ( 3 ) 54 4) 7 8 ( 3 ) 2 0 ( 4 ) 25 2) - 2 ( 4 )
C ( 15) 4 5 ( 3 ) 42 3) 5 0 ( 3 ) 0 ( 2 ) 5 2) - 1 ( 3 )
C ( 16) 6 2 ( 3 ) 52 4) 6 3 ( 3 ) - 1 5 ( 3 ) - 3 3) - 1 1 ( 3 )
C ( 17) 8 6 ( 4 ) 84 5) 6 5 ( 4 ) - 2 8 ( 4 ) - 2 3) - 1 6 ( 4 )
C ( 18) 1 3 5 ( 6 ) 103 7) 7 6 ( 4 ) - 1 0 ( 5 ) 7 4) - 5 ( 5 )
N (9) 4 6 ( 2 ) 52 3) 3 4 ( 2 ) 8 ( 2 ) 12 2) 12 (2)
0 ( 1 ) 5 6 ( 2 ) 61 2) 3 4 ( 2 ) 1 ( 2 ) 13 2) 1 0 ( 2 )
0 ( 2 ) 8 1 ( 3 ) 107 4) 4 3 ( 2 ) 1 9 ( 2 ) 26 2) 5 1 ( 3 )
0 ( 3 ) 8 0 ( 2 ) 72 3) 4 9 ( 2 ) 1 2 ( 2 ) 23 2) 32 (2)
0 ( 4 ) 5 4 ( 2 ) 69 3) 4 5 ( 2 ) - 1 1 ( 2 ) 16 2) - 2 0  (2)
0 ( 5 ) 6 1 ( 2 ) 84 3) 3 0 ( 2 ) - 1 2 ( 2 ) 3 2) - 1 6 ( 2 )
0 ( 6 ) 3 8 ( 2 ) 45 2) 47 (2) - 9 ( 2 ) 6 1) 0 (2)
0 ( 7 ) 7 6 ( 2 ) 66 3) 52 (2) 9 ( 2 ) 33 2) 4 ( 2 )
Se  (1A) 5 9 ( 2 ) 108 3) 60 (2) 3 9 ( 2 ) - 2 2) - 9 ( 2 )
S e ( I B ) 60 (2) 144 7) 3 7 ( 1 ) 1 5 ( 3 ) 7 1) 2 2 ( 4 )
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T a b l e  5 .  H y d r o g e n  c o o r d i n a t e s  ( x  10 A4)  a n d  i s o t r o p i c  
d i s p l a c e m e n t  p a r a m e t e r s  (Aa 2 x  1 0 a3)  f o r  p k 3 .
X y z U ( eq)
H (2) - 1 1 1 7 5 - 2 9 9 0 - 1 9 2 8 57
H (2A1) - 1 1 5 7 9 - 1 3 6 7 - 1 0 3 7 83
H (2A2) - 1 2 7 8 5 - 1 2 0 8 - 1 8 5 4 83
H( 2A3) - 1 1 2 8 2 - 2 6 4 - 1 6 1 4 83
H( 3) - 8 8 3 8 - 2 4 9 8 - 9 7 3 59
H (3A1) - 6 9 2 0 - 1 0 3 2 - 1 1 5 1 81
H( 3A2) - 8 5 4 6 - 2 3 1 - 1 3 2 3 81
H ( 3 A3 ) - 7 8 4 7 - 7 4 6 - 2 0 1 3 81
H (4) - 8 7 5 3 - 4 1 8 1 - 1 8 2 4 56
H (4A1) - 5 8 1 3 - 2 7 6 4 - 1 6 6 7 70
H ( 4 A 2 ) - 6 0 3 9 - 4 2 3 5 - 1 9 6 9 70
H (5) - 8 0 6 6 - 3 4 9 3 - 3 1 0 3 51
H ( 10 ) - 8 3 0 7 - 2 6 6 7 - 5 7 2 1 51
H( 10A) - 1 0 5 1 8 - 3 7 9 0 - 7 4 3 7 80
H( 10B) - 8 7 7 5 - 3 6 2 4 - 6 8 9 9 80
H ( 11 ) - 1 0 0 6 6 - 3 8 5 - 6 3 9 1 47
H( 1 2 ) - 8 7 0 1 - 2 3 7 - 7 3 1 2 54
H ( 13 ) - 6 5 5 6 - 2 3 1 3 - 6 7 1 0 53
H ( 13A) - 5 0 6 0 - 2 9 7 0 - 7 6 2 9 120
H( 13B) - 5 8 4 8 - 2 4 6 7 - 8 4 7 3 120
H( 13C) - 6 9 1 7 - 3 1 7 6 - 7 9 8 4 120
H ( 14A) - 3 5 8 4 - 1 0 0 8 - 6 6 7 5 77
H ( 14B) - 3 8 2 7 - 1 7 9 8 - 5 9 4 7 77
H ( 14C) - 3 2 0 5 - 3 2 8 - 5 8 5 4 77
H ( 14D) - 5 7 5 8 928 - 7 2 2 5 76
H ( 14E) - 4 8 3 8 1475 - 6 4 1 0 76
H ( 14F) - 6 7 3 3 1 3 8 8 - 6 6 2 2 76
H ( 15) - 6 1 9 8 - 1 3 8 0 - 5 4 0 4 56
H( 16A) - 4 2 1 0 228 - 4 8 1 4 74
H ( 16B) - 5 5 0 9 1347 - 5 0 8 4 74
H ( 17) - 7 0 2 3 496 - 4 2 2 2 98
H ( 18A) - 4 1 5 9 - 6 4 4 - 3 5 3 6 129
H( 18B) - 5 6 9 4 - 4 2 8 - 3 1 6 3 129
H( 22A) - 2 8 0 7 - 5 1 6 6 - 9 4 8 72
H (23A) - 8 3 - 4 6 8 5 - 4 7 1 68
H( 24A) 702 - 3 0 7 9 4 8 6 63
H ( 25A) - 1 2 3 7 - 1 9 5 5 965 82
H( 26A) - 3 9 6 1 - 2 4 3 6 487 77
H( 22B) - 3 1 8 0 - 2 2 9 2 611 54
H ( 23B) - 3 7 5 - 2 3 8 9 891 41
H( 24B) 901 - 3 8 2 8 204 59
H( 25B) - 6 2 8 - 5 1 7 1 - 7 6 3 80
H (2 6B) - 3 4 3 3 - 5 0 7 4 - 1 0 4 3 78
H (9) - 1 0 5 6 0 ( 5 0 ) - 1 2 3 0 ( 5 0 ) - 5 2 6 0 ( 3 0 ) 4 5 ( 1 7 )
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Appendix B results of MM2 calculations for intermediate C
MM2: 12.5Kcal/mo)e
MM2: 12.0 Kcal/mole
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